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SYNTHESIS AND APPLICATIONS OF ONE- AND TWO-DIMENSIONAL 
POLYMER–CARBON NANOMATERIAL COMPOSITES  
Wanji Seo, PhD 
University of Pittsburgh, 2016 
This dissertation describes the synthesis of polymer and carbon nanomaterial composites and 
their applications in drug delivery, chemical sensing, and catalytic oxidative patterning.  The first 
part studies polyethylene glycol functionalized oxidized single-walled carbon nanotubes (PL-
PEG/ox-SWCNT) as a drug nanocarrier to prolong the circulation of two mitochondria targeting 
radiomitigators TPP-IOA and XJB-5-131.  In in vivo tests with mice exposed to a single total 
body irradiation of 9.25 Gy, the PL-PEG/ox-SWCNT nanocarrier prolongs the circulation of 
TPP-IOA without developing apparent toxicity and exhibits radiation mitigating effects, slightly 
better than that of free TPP-IOA.  The in vivo drug effect of the XJB-5-131 conjugate is 
inconclusive.  The stability of Doxorubicin-loaded PL-PEG/ox-SWCNT is investigated under 
oxidative bursts that occur in neutrophils and macrophages.  Myeloperoxidase-catalyzed and 
peroxynitrite-mediated oxidations of the drug conjugate are studied ex vivo, and the in vitro tests 
in B16 melanoma cells and tumor-activated myeloid cells are conducted.  Both ex vivo and in 
vitro results indicate that the nanocarrier protects Doxorubicin from the oxidative degradation. 
The second part of the dissertation discusses the synthesis and applications of two-
dimensional polymers.  A novel crystalline polybenzobisimidazole-based two-dimensional 
supramolecular polymer (2DSP-PBBI) is synthesized by condensation/precipitation 
polymerization under solvothermal conditions.  The surface morphology of 2DSP-PBBI is 
v 
analyzed with electron and atomic force microscopy, revealing planar surfaces formed by 
hydrogen bonding.  An iron(III)-coordinated porphyrin-based covalent organic framework (Fe-
DhaTph-COF) is synthesized for the fabrication of oxidatively patterned graphite in the presence 
of H2O2 and/or NaOCl.  The vertical channel created by patterning is ~3 nm in depth, and liquid-
exfoliation of the patterned graphite provides few-layer porous graphene.  Although the shape 
and size of the pores are not uniform, this study demonstrates that metallated COFs can be 
utilized as surface catalysts and master templates for patterning.
vi 
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PREFACE 
Thank you Dr. Star! 
Prefer what is positive and multiple, difference over uniformity, flows over unities, mobile 
arrangements over systems. Believe that what is productive is not sedentary but nomadic.  
― Michel Foucault 
1 
1.0 INTRODUCTION 
Carbon nanomaterials (CNMs) such as carbon nanotubes and graphene have demonstrated a 
wide range of applications in nanotechnology over the last two decades.  CNMs are used 
independently or in combination with other materials to create a variety of novel properties that a 
single carbon material cannot provide.   Therefore, studies of CNMs often cross many disciplines 
and will continue to have a broad impact on many fields in the future.   
An overwhelming number of studies of carbon nanotubes (CNTs) have been published 
over the past couple of decades, and much of fundamental and applied graphene research has 
already surpassed the number of CNT publications.  Each of these materials offers its own merit 
and exhibits distinct properties arising from the unique geometry and size, resulting in 
outstanding optical, thermal, mechanical, and chemical properties.
1
  To investigate and identify
extraordinary novel properties of CNMs, all available characterization techniques and even 
unorthodox methods should be implemented.  Despite the tremendous efforts, interpretation of 
acquired data is occasionally highly challenging especially for new hybrid materials possessing 
multiple different characteristics and novel properties.    
To understand diverse subjects covered in this dissertation, the fundamental chemistry 
and properties of one-dimensional CNTs and two-dimensional graphene will be discussed in 
Chapter 1.  Despite the interesting properties exhibited in the pure form of carbon allotropes, 
their poor solubility often necessitates chemical modification of carbon atoms prior to utilization 
2 
in real world applications such as complex devices, reinforced composites, and organic/inorganic 
hybrid materials.  Therefore, the chemical functionalization of CNMs, which has been developed 
on the basis of organic chemistry, is an important step that should be considered in the design of 
new materials as well as in the realization of scalable applications.  On the basis of tunable 
chemical characteristics, CNMs are readily modified and integrated into the components of 
materials, and ultimately their performance as functional materials is evaluated in various 
contexts.    
This dissertation introduces the synthesis and characterization of two different types of 
polymer–carbon nanomaterial composites: (1) polymer–carbon nanotubes and (2) polymer–
graphene composites.  Then the demonstration of these composites as functional materials will 
be described in the context of drug delivery (Chapter 2 and 3), chemical sensing (Chapter 4), and 
oxidative patterning (Chapter 4 and 5).   Despite the focus on completely different applications, 
each subject has significantly contributed to the study of CNMs.  To better understand the 
research projects discussed in Chapter 2–5, the backgrounds of CNMs and polymer 
nanocomposites will be overviewed in Chapter 1.  Particular polymers are chosen to achieve 
compatibility with CNMs for specific applications, and therefore polymers are an integral part of 
this dissertation.  However, Chapter 1 is centered on the types of CNMs and their basic 
properties that have been studied mostly over the last decade.  Relevant information on each 
polymer employed in the research projects will be discussed in depth in later chapters.     
3 
1.1 CARBON NANOMATERIALS 
CNMs are commonly based on carbon allotropes, composed of sp
3
-, sp
2
-, and sp-hybridized
carbon atoms.
2
  Since the discovery of Buckminsterfullerene in 1985, new carbon allotropes
have been developed besides naturally existing graphite and diamond.
2
  Generally, carbon
allotropes are stable and can serve as versatile building blocks in the synthesis of numerous 
materials.  Synthetic carbon allotropes play significant roles in materials chemistry and 
nanotechnology.  Several synthesis and growth methods such as arc discharge (>1700 °C), laser 
ablation, and chemical vapor deposition (>800 °C), which are mostly performed at high 
temperatures, successfully afforded commercial CNMs with competitive prices.
3
  The physical
parameters of CNMs such as size, diameter, and the number density of defects slightly vary from 
one supplier to another.  However, the mass production of batch-by-batch structurally 
homogeneous materials is not easy to control, and the post-synthetic purification process of 
monodisperse CNMs precludes the low-end fabrication.  Advances in modern organic synthetic 
chemistry offer novel bottom-up routes
4
 for the synthesis of structurally well-defined carbon
allotropes.  Although the total synthesis of carbon allotropes is not common, the approach to 
incorporating different hybridizations into a single material offers limitless resources for 
designing a variety of structures and novel properties of CNMs on demand.
5
Among carbon allotropes that have been developed to date, fullerenes, CNTs, and 
graphene/graphite have been most extensively studied with respect to both theory and 
applications.  Both carbon nanotubes and graphene are composed of sp
2
-hybridized carbon atoms
in a honeycomb lattice.
1
  The conjugated network of π–electrons confined in low dimensions
imparts unique electronic properties and redox activity.
6
  The excellent mechanical strength (e.g.,
elastic modulus of CNTs, ~1000 GPa) has already resulted in a rapid growth of commercial 
 4 
structural materials and reinforced composites.
6
    CNTs are essentially rolled up graphene sheets 
(Figure 1.1), but their unique shapes have imparted them different properties and enabled various 
applications.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Carbon allotropes based on dimensionality.
6
 
Reprinted with permission from Chem. Rev. 2015, 115 (11), 4744–4822. 
Copyright (2015) American Chemical Society. 
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1.1.1 One-dimensional carbon nanotubes 
Important parameters to determine the properties of CNTs are the number of walls (e.g., single-
walled (SWCNT), double-walled (DWCNT), and multi-walled (MWCNT)), length, diameter, 
and chiral angle.
7-8
  As Chapter 2 and 3 deal with SWCNT-based drug nanocarriers, this
dissertation focuses only on SWCNTs.   
As the size of SWCNTs and even the degree of impurities vary with manufacturing 
processes,
3,9
 an appropriate commercial brand should be chosen before chemical treatments.
Most as-prepared SWCNTs are sold as bundles with ca. 1–1000 μm in length and ca. 1–2 nm in 
diameter.
10
  They are poorly dispersible in most organic solvents as well as water.
11
  N,N-
Dimethylformamide (DMF) and N-methylpyrrolidone (NMP) are solvents most frequently used 
in fabrication processes although 1,2-dichlorobenzene has shown the best dispersibility with 
CNTs.
12
  To suspend CNTs in solutions, cutting as-prepared CNTs by sonication, an oxidation
reaction occurring at the ends of CNTs, or surface modifications are required.
13
  When graphene
sheets are rolled up, they form different chiral indices (n,m) and angles (θ) (Figure 1.2a).7-8,10
These major characteristics of CNTs impart varying degrees of strains which influence their 
stability and reactivity in different conditions.
8
  Generally, cylindrical CNTs exhibit better
chemical reactivity than graphene.
14
  The chiral indices (n,m) in the chiral vector (Ch = na1 +
ma2) indicate the electronic properties of CNTs: metallic nanotubes are n − m = 3k with k being 
an integer, semimetallic for n = m, and semiconducting for n − m ≠ 3k.10  Most as-synthesized
SWCNTs contain different chiral species unless they are separated in post-synthetic steps.
15
Different chirality determines the energy band gap of semiconducting CNTs.
15
  Although most
bundled semiconducting CNT samples have a band gap of ~1 eV, each chiral species has a 
distinct energy band gap ranging 0.5–3 eV.16  Therefore, bundles of CNTs may behave
 6 
differently depending on the relative amount of different chiral species contained in a sample 
(Figure 1.2b), and a sample consisting of an isolated single chiral species is ideal for achieving 
homogenous properties.
10,17
       
 
 
 
 
 
 
Figure 1.2  Physical properties of single-walled carbon nanotubes. (a) Chiral vector of nanotubes (Ch = na1 + ma2) 
where a1 and a2 are unit vectors with the chiral angle (θ). (b) SWCNTs with identical chiral vectors but different 
chiral handedness. (c) Sorting SWNTs with different diameters by density gradient ultracentrifugation (DGU) and 
corresponding optical absorbance spectra for the different fractions.
10 
Reprinted with permission from Nat. Nanotechnol. 2008, 3 (7), 387–394. 
Copyright (2008) Nature Publishing Group. 
 
  
 
1.1.2 Two-dimensional graphene 
Graphene is a single-layer material isolated from three-dimensional graphite, and has a 
hexagonal honeycomb lattice with a sp
2
-hybridized C–C bond length of 1.42 Å and an interlayer 
spacing of 3.35 Å.
1
  The properties of a single layer graphene are very different from those of 
bulk graphite.  Graphene layers strongly form AB stacks supported by van der Waals forces.
18
  
The most remarkable characteristic of graphene is π–electrons delocalized on the atomically thin 
plane where sp
2
 carbon atoms provide two orbitals π and π* to form the valence and conduction 
 7 
bands.
19
  The orthogonal π and π* orbitals touching at the hexagonal lattice points (Dirac points) 
do not overlap with each other, rendering graphene zero band gap semimetallic.
19-20
  The 
massless electrons with high carrier mobility, which is dramatically different from epitaxially 
grown conventional 2D semiconducting layers, have garnered much attention primarily as an 
alternative to silicon electronics.
20
  However, the zero band gap property limits the direct 
applications of graphene, especially in standard logic circuits and devices such as transistors due 
to high current leakage and energy dissipation.
21
  In addition to the excellent electron 
conductivity and ambipolarity in the field effect configuration, graphene possesses outstanding 
mechanical, thermal, and optical properties.
21-22
  For example, the optical transparency of 
graphene is particularly advantageous for conductive electrodes in touch screens and flexible 
electronics.
22
  
 Few-layer graphene can be isolated by both top-down and bottom-up approaches.  
Generally, top-down approaches have been found more efficient, such as liquid-phase exfoliation 
of graphite, mechanical exfoliation (e.g., pull-off by cellophane tape and cleavage with a razor), 
reduction of graphite oxide (GO), and unzipping of CNTs.
23-26
  Preparation of free-standing, 
atomically thin layered graphene without generating additional defects is crucial.  Random 
defects generated in the course of mechanical and chemical treatment reduce the homogeneity of 
samples, and may degrade device performance.
20,27
  The exfoliated graphene should be 
transferred to a different substrate without creating wrinkles and folds, which can be highly 
challenging.  Some bottom-up methods can remove the cumbersome step of transfer by directly 
growing graphene from organic precursors on a substrate using chemical vapor deposition.
28-30
   
Common substrates are SiC, Si, SiO2, and metal substrates (e.g., Cu, Ni, Au).
20,31
  The direct 
 8 
growth is convenient in that a separate graphene transfer step is not necessary and single-layer 
graphene on a dielectric substrate can be directly incorporated into device fabrication.
30
   
 Once single- or few-layer of graphene is isolated, the energy band gap should be tuned 
for electronic devices.  To open the energy band gap of graphene, precise manipulation of 
defects, edges, and strain is required to provide high quality 2D crystal lattice.  These graphene-
like materials bearing semiconducting properties include reduced graphene oxide (rGO) prepared 
from graphene oxide (GO), holey graphene, and graphene nanoribbons.
6,22-23,32
  Fabrication 
methods for obtaining the controlled nanostructures of these graphene-based materials will be 
continuously investigated to develop excellent semiconducting materials.     
 
1.1.3 Characterization methods 
Microscopy and spectroscopy are implemented to characterize CNMs and CNM composites.
20,33
 
Transmission electron microscopy (TEM) and scanning electron microscopy (SEM) are imaging 
techniques most commonly employed in nanoscience.  TEM provides information on size, shape, 
and aggregation/dispersion using high-energy electron beam (up to 300 keV) and is especially 
useful for identifying structural integrity and changes after surface modification.
34
  Atomic force 
microscopy (AFM) employs a cantilever to measure the force (attraction/repulsion) between the 
sample surface and the probe on the order of nanometers.  The most powerful feature of AFM is 
to resolve the height profile of a sample–substrate.  Theoretically the vertical (or depth) 
resolution can be achieved up to 0.1 nm, allowing estimation of the thickness of single-layer 
graphene.
21
   
 9 
 Optical spectroscopy is a noninvasive tool for analyzing structure-dependent optical 
transitions of CNMs.  Major techniques routinely used in CNM characterization are UV-Vis-
Near Infrared (UV-Vis-NIR), infrared (IR), Raman, and photoluminescence (PL).
8,33-34
  UV-Vis-
NIR spectroscopy has been frequently used to characterize the distinct electronic transition (i.e., 
energy gap) of metallic and semiconducting carbon nanotubes (Figure 1.3a) corresponding to the 
energy density states.
15
  In addition, the dispersion condition (e.g., bundled vs. separate 
nanotubes) and the electronic perturbation caused by the conversion from sp
2
 to sp
3
 hybridization 
upon covalent functionalization are translated into the absorption profile (Figure 1.3b).
35
   
 Raman spectroscopy has provided insights into the properties of sp
2
 carbon allotropes 
including CNTs and graphite/graphene (Figure 1.3c).
36-37
  The major peaks characteristic of the 
graphitic lattice are shown in Figure 1.3c.  G (1584 cm
−1) and G′ (2700 cm−1) bands are 
attributed to the intrinsic pristine sp
2
 graphitic structure.
21
   If a sample consists of pure sp
2
 
carbon atoms, a sharp G peak is observed.
38
  The G′ peak is most useful for probing the thickness 
of graphite flakes (i.e., the number of layers) based on the peak shape and intensity.
38
  D (1350 
cm
−1) and D′ (1617 cm−1) bands are associated with the density of defects where symmetry is 
broken due to the formation of vacancy and the altered hybridization of carbon bonds.
37
  The 
ratio of ID/IG estimated by measuring the height or the area under the curve can provide a 
convenient metric of sp
3
-defects to pristine sp
2 graphitic carbons, and the bandwidth of D′ band 
indicates the degree of vacancy-defect.
36-37
  The 2D peak (2680 cm
−1
) provides information on 
the number and the relative orientation of graphene layers by showing significant changes in 
shape and intensity (Figure 1.3d).
36
 
 FTIR and X-ray photoelectron spectroscopy (XPS) are used to identify organic functional 
groups incorporated into the graphitic lattice.
34
  Bulk samples can be analyzed with FTIR, but 
10 
some functional groups show weak signals for accurate characterization.
33
  Thus XPS, which
quantifies the binding energy of photoelectrons ejected from the sample, is utilized to probe 
defects and covalently functionalized samples.
33
  XPS measures the atomic content and identifies
the chemical environment of an atom of interest when samples are irradiated with X-rays, but the 
surface sensitivity is limited to the small inelastic mean free path (<10 nm) of the ejected 
photoelectrons.
34
  Although it can be crucial to the analysis of some elemental information and
bond types, the deconvolution data process of XPS spectra can be sometimes ambiguous and 
subjective.
34
 11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3  UV-Vis-NIR and Raman spectroscopy.  (a) UV-Vis-NIR absorption spectra corresponding to the energy 
band gaps of different types of SWCNTs.
8
 (b) UV-Vis-NIR absorption spectra for pristine SWCNT (black), 
oxidized ox-SWCNT (red), and iodinated I-SWCNT (green).
39
 (c) Raman spectra of pristine (top) and defected 
(bottom) graphene.
36
 (d) Different shapes and shift of the 2D peak dependent on the number of graphene layers.
36
  
Ref 8. Reprinted with permission from Accounts. Chem. Res. 2002, 35 (12), 1105–1113. 
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Ref 39. Reprinted with permission from Chem. Mater. 2007, 19 (5), 1076–1081.  
 Copyright (2007) American Chemical Society 
Ref 36. Reprinted with permission from Nat. Nanotechnol. 2013, 8 (4), 235–246. 
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1.2 POLYMER–CARBON NANOMATERIAL COMPOSITES 
Polymer–carbon nanomaterial composites refer to systems made of a polymer matrix and CNM 
particles, which can be found in a broad range of materials such as biomaterials and surface 
catalysts as well as structural reinforcement.  Polymers and CNMs are ideal for producing 
lightweight materials, and a variety of new composites can be designed with the diverse types of 
polymers available on the market.
40
  To integrate the unique characteristics of each component
into a composite, the surface properties, polarity, and dispersibility in solvents of each 
component should be examined to ensure good compatibility and long-term stability.
41
  To
prepare CNM-based polymer composites, chemical modification (i.e., covalent and noncovalent 
functionalization) of CNMs is often required to optimize the compatibility before blending with 
polymers.
42
  Therefore, the types of chemical treatment are discussed first, and then examples of
polymer–CNM composites are selected to introduce the subjects covered in this dissertation.   
1.2.1 Covalent and noncovalent chemistry of carbon nanomaterials 
Generally, noncovalent functionalization, also often described as physical adsorption onto the 
graphitic surface, offers relatively convenient routes to modify the surface properties of CNMs 
without undergoing rigorous chemical alteration of the original material.
43
  On the other hand,
covalent functionalization of conjugated π-systems requires aggressive reaction conditions to 
break the inert sp
2
 C–C bond in the graphitic lattice.13  Nevertheless, the oxidation process is the
most important covalent functionalization method, which introduces oxygen-containing 
functionalities (e.g., carboxylic, hydroxyl, and epoxy groups) into both the edge and the basal 
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plane of CNMs.
13,44
  These new functional groups impart hydrophilicity to inherently 
hydrophobic CNMs and also alter the original solubility.
13
  Oxidation of CNTs with strong 
oxidants (e.g., H2O2/H2SO4 or HNO3/H2SO4) provides a means to shorten the length, and more 
oxidized samples tend to have a greater number of defects than pristine CNTs.
45
  Oxidation of 
graphene provides a chemical route for exfoliation as well as newly incorporates oxygen-
containing groups, which facilitates delamination between graphene layers.
46
  Both oxidized 
CNTs and GO can be kinetically suspendable even in water for ca. 100 days due to hydrogen 
bonding,
47
 but aggregates slowly form and precipitate out over an extended period of time.  The 
extent of dispersibility range can be further controlled by the oxidation method and the degree of 
oxidation.
48
  Thus oxidized CNTs and GO are common precursors for multiple synthetic steps by 
covalent functionalization.
49
  Figure 1.4 shows covalent chemistry schemes utilized in CNTs and 
graphene.
50-51
   
 Two different methods for functionalization with polymers have been developed: (1) 
Grafting-To approaches involve coupling between functional groups (e.g., carboxylic and 
hydroxyl groups) on CNMs and the end-group of polymer chains, resulting in the formation of 
covalently linked polymer–nanocomposites.41,52  Occasionally, linkers (or spacers) such as amide 
and ester derivatives are connected to CNMs, followed by coupling reaction with a polymer.
49, 52
 
(2) Grafting-From approaches require a polymerization initiator reacting on the CNM surface 
where in situ polymerization occurs on the activated functional groups of CNMs.  Atom transfer 
radical polymerization (ATRP), reversible addition-fragmentation chain transfer (RAFT), ring 
opening polymerization (ROP), and many other methods were developed.
41,52
  Grafting-From 
methods provide higher grafting density than Grafting-To methods because the polymer growth 
is impeded by steric hindrance.
41
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 Another type of covalent functionalization is chemical doping which facilitates the 
substitution of heteroatoms (e.g., nitrogen and boron) with graphitic carbon atoms without 
altering the original sp
2
 hybridization of carbons.
50
  The doping process is based on catalysis and 
disproportionation, in which CNMs are subject to an atomic-nitrogen flow and nitrogen atoms 
are doped by N2 dissociation in microwave plasma.
53
  Doping is employed mainly to control the 
Fermi level and the properties of CNM-based electronics.
20, 53
   
 Noncovalent functionalization is achieved by intermolecular interactions between the 
polymer and the CNM, such as π–π stacking, CH–π, van der Waals, electrostatic, and 
nonspecific hydrophobic interactions.
43
  Oxidized CNMs such as ox-SWCNT and GO can have 
significant contributions from hydrogen and ionic bonding interactions in addition to π–π 
stacking.
50
  Noncovalent functionalization may form weak interfaces because of the dynamic 
nature of noncovalent bonding, and thus the stability of composites can be dependent on the 
polymer–solvent interaction in solution.43  However, when cooperative intermolecular bonding 
occurs between polymers and CNMs that have a large number of aromatic rings fused together 
on the surface, the bond strength can significantly increase, allowing the formation of 
sufficiently robust polymer–CNM composites.43  The extended π–conjugation and planarity of 
graphene impart stronger π−π interactions with small aromatic molecules (e.g., pyrene, 
quinoline, and porphyrin) than rGO and GO.
43,54
  Even rGO reduced from GO with sp
3
 defects 
exhibits much higher binding affinity with sulfonated aluminum phthalocyanine than GO and 
SWCNTs.
54-55
  Therefore, the planar nanostructure can result in enhanced dispersibility, 
biocompatibility, binding capacity, and sensing properties.
43
  The one-dimensionality of CNTs 
does not impart the binding affinity arising from π–π stacking as strong as two-dimensional 
graphene.
55
  However, CNTs have shown effective, strong binding with linear polymers that can 
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wrap around the CNT sidewall and remain undisrupted in solution.
13
  The binding strength 
dependent on hydrophilicity/hydrophobicity can be further tuned by the functional groups of 
CNTs and polymers.
56
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4  Covalent functionalization of SWCNTs. (a) Oxidation, (b) carbine addition, (c) fluorination, (d) 
followed by alkylation, (e) Birch reduction, (f) 1,3-dipolar cycloaddition, (g) diazonium coupling, (h) radical 
addition, and (i) ozonolysis.
49
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1.2.2 Applications of polymer–carbon nanomaterial composites 
Polymer–carbon nanomaterial composites composed of CNTs and graphene have demonstrated 
excellent properties particularly in mechanical, electrical, and thermal applications.
41,57
  Both
CNTs and graphene find numerous applications as composite reinforcers,
40,52
 conducting
materials for electrical devices,
58-59
 biomedical devices,
60
 etc.  The production of CNT-based
composites is generally more costly than graphene due to the use of metal catalysts in the CNT 
synthesis.
20
  Nonetheless, needle-like 1D CNT composites would be more effective for particular
applications such as intracellular drug delivery.
61
  Flat 2D polymer−graphene composites
featuring large surface coverage would make excellent surface catalysts and gas separation 
membranes.
46
  Here we focus on polymer–CNM composites used in three different areas, whose
relevant research topics will be investigated in later chapters.  
1.2.2.1 Polymer reinforcement 
Polymer reinforcement finds useful applications in structural materials because low density and 
high aspect ratios provide extraordinary mechanical properties.
40
  Reinforced materials are
manufactured for lightweight with CNT loadings of 0.1–20 wt % while increasing the tensile 
modulus and strength to bear strong deformations.
40
  Composites are prepared by blending the
low fraction of CNM-fillers with a polymer matrix
44
 or by in situ polymerization which provides
better interaction during the growth stage.
41
  Before blending with a polymer matrix, CNM fillers
are chemically treated to ensure good dispersion.
40
  Even moderate agglomeration of CNTs
impacts the diameter and length distributions of the filler, decreasing the surface aspect ratio and 
stress transfer.
40
  Further investigations of tunable mechanical properties are undergoing to
optimize the interface between polymers and CNMs.    
 17 
Polymers such as epoxy resin, polyvinyl alcohol, polyurethane, etc., have been used as 
matrices.
41
  These polymer composites prepared with CNTs are already commercialized in 
sporting goods and automotive industry.
62
  Electrically conductive CNT fillers in plastics and 
unconventional devices such as strain sensors utilizing the flexibility of stretchable reinforced 
polymer nanocomposites are good examples of future applications.
63
   
1.2.2.2 Drug delivery 
Biocompatibility, biodegradability, low immunogenicity, and antibacterial property are 
important parameters considered in biomedical applications of CNMs.
20
  Thus modification of 
the inherent hydrophobic surface of CNMs by incorporating auxiliary components is 
unavoidable.
64
  In drug delivery, polymers and low molecular weight surfactants were used as 
nonfouling surface coatings by noncovalent physisorption.
65
  Polymers are resistant towards 
biochemical interactions compared to low-molecular weight surfactants such as sodium 
cholate.
66
  The large surface contact with the drug carrier also provides stability in biological 
fluids during circulation.
67-68
  Natural biopolymers (e.g., polysaccharides and proteins) and 
synthetic polymers (e.g., hydrophilic polymers and highly charged amphiphilic polymers) have 
been employed to surface-coat pristine and pre-functionalized CNMs bearing carboxylic and 
amine groups.
69-73
   
Among synthetic polymers, polyethylene glycol (PEG) is most frequently utilized in 
biomedical applications.
74
  Numerous examples of drug carriers utilizing PEG derivatives were 
studied in CNM-based drug delivery systems.
74-75
  Other synthetic polymers including 
polyethyleneimine (PEI), poly-L-lysine (PLL),  poly(vinyl alcohol) (PVA), and poly(N-
isopropylacrylamide) (PNIPAM) exhibit significantly reduced cellular toxicity.
76
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In addition to biocompatibility, polymer topology (e.g., linear, branched, star, and 
dendrimer) can be an important parameter to be considered with respect to drug loading and 
circulation.
77
  Linear chains of PEG and PEG derivatives can efficiently wrap around CNTs and 
also be grafted on GO.
64,78
  Two-dimensional polymers could provide more effective surface 
coverages with graphene.
69
  However, most 2D polymers have not been much explored as 
nonfouling surface coating in biomedical applications due to poor solubility in water.
79
   
1.2.2.3 Chemical sensing 
Polymer–CNM composites have garnered a great deal of interest in the design of electrochemical 
sensors and have shown promise for use in flexible devices.
20,59,80
  The sensor response relies on 
charge/electron transfer upon chemical interactions of the analyte and the sensing moiety.
81
  
Large surface areas, high adsorption sites in thin composite films, and the excellent surface 
contact between conjugated polymers and graphene allow for high sensitivity in the detection of 
analytes and enhanced current signals in conductance compared to bulk materials.
82
  Especially, 
many 2DPs are composed of aromatic ring-based conjugated macromolecules that impart 
planarity and rigidity, and thus the 2DP–graphene composite can be an excellent heterostructure 
self-assembled by cooperative π–π stacking.80  The high surface-to-volume ratio and the charge 
mobility of graphene (or reduced graphene oxide) provide an excellent semiconducting channel 
for field-effect transistor (FET) sensors.
83
  Despite the successful synthesis of 2DP–graphene 
composites, their applications to electronic devices have been rarely studied.
84
 
Various polymers have been utilized in electronic sensing devices.
46
  Both intrinsically 
conducting (e.g., polyacetylene, polythiophene, and polyaniline)
85
 and nonconducting polymers 
(e.g.,  polystyrene, poly(vinylalcohol), poly(methyl methacrylate), and polyurethane)
86
 were 
employed to achieve particular goals and synergistic effects.  As good conductivity can be 
19 
achieved with low CNM loading (<10 wt %),
57
 the use of conducting polymers is not critical.
However, to be applicable in electronic sensing devices, polymer–CNM composites should be 
semiconducting.  CNTs were found to provide sufficient sensitivity for detecting gas analytes 
(NO2 and NH3) without employing a sensing material,
87
 but polyethyleneimine-coated SWCNTs
showed enhanced selectivity and sensitivity to the same analytes.
88
  To achieve high selectivity
in analyte detection, the sensing moiety, which is designed primarily based on molecular 
recognition of the analyte, can be incorporated into devices by chemically modifying either 
polymers or CNMs.
89
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1.3 OXIDATION OF CARBON NANOMATERIALS 
The oxidative reaction pathways of CNMs have been studied in the context of biological and 
nonbiological settings, in which oxidation results in simple chemical transformation to 
aggressive defect generation.
45,90-91
  Oxidation in biological settings involves endogenous species
such as enzymes and reactive oxidation species (ROS) in situ generated in many complex 
metabolic pathways.
92
  The biological oxidation of CNMs began to be studied only a few years
ago in relation to nanotoxicology mainly focusing on environmental health and safety.
93
 The
oxidative metabolism investigated in earlier studies was inflammatory responses by the innate 
immune system.
94
  Despite the recent efforts to elucidate the toxicity of CNMs, only a few
studies have investigated polymer–CNM composites in the context of oxidation.95  Thus more
studies for predicting the long-term safety of chemically diverse CNMs should be pursued in the 
future, as these issues will have a direct impact on their palpable applications to biomedical 
technology.
93
Oxidation of CNMs in nonbiological settings is not restricted to any particular conditions. 
Previous studies introduced the degradation of GO using well-established oxidation methods 
such as Fenton chemistry.
91,96
  Surface modification, especially oxidation of CNMs has been
indispensable as a prefabrication treatment method,
13,50
 and thus exploration of new oxidation
routes will provide convenient means for flexible fabrication and manufacturing processes.  The 
easiest way to come up with a new nonbiological method would be mimicking biosystems.
97-98
Here, iron-catalyzed oxidation pathways in nonbiological systems will be briefly discussed as 
ferric and ferrous ions are involved in many catalytic oxidation systems as well as Fenton 
chemistry. 
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1.3.1 Oxidation in biological systems 
A variety of oxidative metabolisms occur in biological systems such as mutation, inflammation, 
aging carcinogenesis, and degenerative diseases.
92
  Biological oxidations often occur in the 
presence of enzymes such as cytochrome P-450, peroxidases, chloroperoxidases, and catalases, 
well-known iron-containing heme enzymes.
99
  Along with these catalysts, generally highly 
reactive and short-lived reactive oxygen species (ROS) participate in catalytic oxidation.  ROS 
causing oxidative stress and damage to organs in living systems can include both radicals (e.g., 
superoxide, hydroxyl, nitric oxide, peroxyl, and alkoxyl) and nonradical species (e.g., singlet 
oxygen, hydrogen peroxide (H2O2), hypochlorous acid, aldehyde, and ozone).  Among these 
compounds hypochlorous acid (HOCl) and hydrogen peroxide (H2O2) are produced in relatively 
high concentrations in living cells.  The vast sources of the ROS and relevant oxidative 
mechanisms cannot be summarized in this chapter.  This section focuses on (1) peroxidase-
catalyzed and (2) peroxynitrite-mediated oxidative schemes.  Chapter 3 focuses on the central 
role of catalytic and noncatalytic pathways to the oxidative degradation of the drug carrier 
composed of a polymer–CNM composite that activates the innate immune system, neutrophils 
and macrophages, respectively.  Therefore, the discussion of oxidative degradation in biological 
settings is limited to the peroxidase catalytic cycle and peroxynitrite.   
 
1.3.1.1 Enzyme-catalyzed oxidation 
The classic peroxidase oxidative cycle is illustrated in Figure 1.5, which is the basis of redox 
reactions of most peroxidases such as myeloperoxidase (MPO), lactoperoxidase (LPO), and 
horse radish peroxidase (HRP).
100
  MPO released from neutrophils by the immune response is an 
 22 
enzyme containing two heme iron centers.
101
  Respiratory burst comprising NADPH oxidase and 
O2 produces H2O2, one of a reactive oxygen species (ROS).
101
  The H2O2 concentration in 
stimulated neutrophils and monocytes is about 1.5 nmol/10
4
 cells per hour.
102
  Once H2O2 is 
generated, MPO (native enzyme, Fe
III
) is converted into MPO-I (Fe
IV
=O
+•
) in a two-electron 
process, yielding hydroxyl radical (•OH) and a subsequent conversion into MPO-II (FeIV=O) 
proceeds in a one-electron reducing process.
100
 The original state of MPO is restored through 
another one electron reduction in which a reducing substrate (RH) reacts with MPO-II an order 
of magnitude slower than with MPO-I.
100
  Important by-products generated from the oxidation 
cycle are reactive radical species hydroxyl radical (•OH) and alkyl radical (R•).103   
A major difference between MPO and HRP is the generation of a strong oxidant HOCl in 
the MPO-catalyzed oxidative cycle.  Once MPO-I is formed in Step I, it oxidizes chloride (Cl
−
), 
abundant in physiological fluids (about 0.14 mM), and produces a strong oxidant HOCl.
100
  
Hypochlorous acid in equilibrium with hypochlorite (
−
OCl/HOCl) at physiological conditions is 
one of the most important antimicrobial agent that can effectively kill bacteria, germs, and any 
harmful species.
100
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Figure 1.5  Scheme of classic peroxidase cycle activated by H2O2. (a) Generation of H2O2 in respiratory burst. 
NADPH oxidase and O2 present in phagosomal and vascular endothelial membranes initiate the formation of 
H2O2.
103
 (b) Conversion of MPO that undergoes a two-electron oxidation (Step I) and subsequent one-electron 
reductions (Step II and III).  MPO is the resting state; MPO-I produces HOCl capable of oxidation of CNTs.
 
HRP 
has the same catalytic pathway except the generation of HOCl/
−
OCl.
103
   
 
 
 
 
1.3.1.2 Peroxynitrite-mediated oxidation 
Peroxynitrite (pka=6.8) is spontaneously produced from the diffusion-controlled reaction of 
highly reactive radical species nitric oxide (•NO) and superoxide radical anion (O2
−•
).
104
  A large 
amount of peroxynitrite can form in the phagosomal compartments of macrophages over a 60–
120 min period.
105
  The generation of nitric oxide (•NO) is catalyzed by a group of nitric oxide 
synthases (NOS)s.
106
 In macrophages, the peroxynitrite formation requires immunostimulation 
 24 
with cytokines that induce iNOS expression.
107
  Upon the phagocytic process initiated by 
pathogens, the plasma membrane NADPH oxidase is activated to produce O2
−•
.
106-107
  
Superoxide radical anion is ubiquitous in normal cellular metabolism, and the rate of superoxide 
generation increases several-fold during cellular redox homeostasis and inflammation.
108
 The 
reaction of •NO with O2
−•
 occurs biologically even in the presence of superoxide dismutase 
(SOD).
92
   
As is the case with H2O2 and HOCl, peroxynitrite can be an endogenous toxicant and a 
cytotoxic effector against pathogens, serving as either an oxidant or a nucleophile.
106
  The great 
stability of peroxynitrite (ONOO
−
) in alkaline conditions enables it to diffuse through cells to 
reach a target.
106
  Peroxynitrous acid (ONOOH) is a strong oxidant that can attack biological 
molecules by very complex mechanisms.
109
  In the excited state of trans-peroxynitrous acid, 
hydroxyl radical (•OH) and nitrogen dioxide (•NO2) radical are generated.
109
  Another important 
oxidative mechanism is a heterolytic cleavage to form hydroxide and nitronium (NO2
+
) catalyzed 
by transition metal ions especially contained in metalloenzymes or reaction of peroxynitrite with 
SOD.
106
  
 
 
 
 
 
 
Figure 1.6 Scheme of peroxynitrite formation. Generation of both superoxide and nitric oxide in alveolar 
macrophages upon stimulation by pathogens.
109
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1.3.1.3 Oxidative biodegradation of carbon nanomaterials 
Currently, two different oxidative pathways have been investigated concerning the CNT 
degradation: (1) enzyme (MPO, LPO, and HRP)-catalyzed and (2) peroxynitrite-mediated 
oxidations.
107,110-113
 Since our research group demonstrated the horseradish peroxidase (HRP)-
catalyzed degradation of CNTs in the seminal work,
113
 the degradation of SWCNTs,
114
 
MWNTs,
115
 and GO
116-117
 have been investigated further.  In addition, the role of peroxidases 
and their varying degrees of oxidation of pristine and functionalized CNMs were investigated 
with myeloperoxidase (MPO)
110,118
 and eosinophil peroxidase.
111
  The CNM biodegradation was 
also corroborated by evidence of the mitigating effect of an antioxidant glutathione in the MPO 
oxidative system.
118
  
Our research group and others conjectured that hypochlorite/hypochlorous acid and the 
reactive intermediates formed in the course of MPO cycle were capable of degrading carbon 
nanotubes.
110,116,119
  MPO-catalyzed degradation occurs both intra- and extra-cellularly 
(neutrophil extracellular trap).
95
    Three major steps are involved in the CNT degradation by the 
MPO catalytic cycle: (1) formation of a HOCl (Step I), (2) oxidation of Ar–H (Step II and III), 
and (3) the resulting formation of free radical species.
118
  EPO oxidation has the same catalytic 
cycle except for the formation of hypobromous acid (HOBr) instead of HOCl.
111
  The role of 
reactive free radical species has not been fully explained.  It is highly likely that aromatic as well 
as hydroxyl radicals generated during the peroxidase cycle may induce a variety of radical 
transformations with sp
2
 carbon atoms.  Either H2O2 or HOCl alone can be a strong oxidant, and 
thus oxidation of CNTs was investigated ex vivo.  However, these oxidants alone did not degrade 
SWCNTs as effectively as the MPO system.  Although it seems reasonable that the coexistence 
of H2O2 and HOCl can create a very powerful oxidation condition, the mechanistic details of 
 26 
how the reactive radical species and HOCl formed in the MPO cycle have not been elucidated.  
When the oxidative cleavage of sp
2
 C–C bonds proceeds extensively in the basal plane, vacancy 
defects are formed, generating large holes and by-products (e.g., CO, CO2, and oxidized 
carbonaceous products).
90
  Graphene oxide (GO) treated with HRP and H2O2 was degraded 
whereas reduced graphene oxide (rGO) was intact under the same oxidative condition.
117
  
Computational docking studies showed that HRP was preferentially bound to the basal plane 
rather than the edge.  When GO was treated with MPO, aggregated GO failed to degrade.
117
  
However, highly dispersed samples were completely metabolized.
116
     
Noncovalently functionalized CNTs coated with pulmonary phospholipid surfactants 
(e.g., phosphatidyl choline and phosphatidyl serine)
120
 and polyethylene glycols (PEG)
95, 121
 were 
also investigated.  Anionic phosphatidyl serine showed a 1.8 times higher uptake of ox-SWCNT 
by neutrophils than phosphatidyl choline.
120
  PEGylated ox-SWCNTs were exposed to activated 
neutrophils ex vivo and in vitro.
95,121
  Both covalent and noncovalent functionalization methods 
were employed for MPO-catalyzed degradation.
95
  The in vitro study revealed that covalently 
functionalized samples degraded faster, and that the low molecular weight PEG (e.g., 2 kDa vs. 
10 kDa) was more efficient in the oxidative degradation.
95
  The small PEG features low grafting 
density, allowing for better exposure of SWCNTs to MPO and facile degradation without the 
MPO–PEG interaction.95  Despite the faster degradation rates observed in the ex vivo study, the 
molecular weight and the type of functionalization of PEG did not influence the degradation 
kinetics as much as they appeared in the in vitro study.
95
  In addition, this study also suggests 
that other enzymes released from neutrophils ex vivo, such as neutrophil elastase and 
antibacterial serine proteases, could participate in PEG stripping besides MPO. Therefore, 
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different ex vivo experimental methods, i.e., the addition of isolated MPO vs. activated 
neutrophils, can impact the degradation kinetics.
95
 
Under the same oxidative condition, the degree of nanotube degradation was found to be 
dependent upon the different functional groups of the nanotube.
90
  It was also reported that 
oxidized nanotubes (ox-CNTs) were more susceptible to oxidative biodegradation than pristine 
samples (nonfunctionalized nanotubes).
90,110,115,122
  Because functionalization introduces new 
defect sites on the sidewalls, such as chemically reactive bonds and heteroatoms on the graphitic 
lattice, a large number of covalently functionalized CNTs become susceptible to oxidation.
123
  
The peroxidase-catalyzed systems indicated that the type of surface functionalization was critical 
in influencing the fate of degradation, and that the strong electrostatic interaction between 
positively charged residues of MPO and an anionic species (e.g., carboxylate of ox-SWCNT) 
promoted the enzymatic degradation based on a docking study.
110
 
The peroxynitrite-mediated degradation of ox-SWCNTs in vitro was investigated in 
activated macrophages known to produce peroxynitrite.
107
  Although NADPH oxidase and iNOS 
synthases are involved in the peroxynitrite generation,
104,106
 these enzymes do not directly 
interact with CNTs, different from the specific binding interaction between CNTs and the 
reactive intermediates of peroxidases (MPO and EPO).
107
  Thus peroxynitrite-mediated oxidation 
appears less dependent on the surface charge of initial CNTs (i.e., the number of carboxylate 
groups).
107
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1.3.2 Catalytic oxidation of nonbiological systems 
One of the important strategies for nonbiological catalytic oxidation is to mimic biological 
processes and implement green chemistry.
124
  For example, redox enzymes for catalytic 
oxidation in biological systems are often translated into synthetic models consisting of transition 
metals as catalysts and clean oxidants such as O2 and H2O2.
124
  Catalytic oxidation that can 
proceed at room temperature and ambient pressure instead of high temperatures are ideal for the 
environment and economy.  However, only a few nonbiological catalytic oxidations have been 
studied with respect to CNMs.
91,96,125-126
  They are employed mainly to modify the original zero 
energy band gap of graphene, rather than aiming at degrading CNMs.
126
  Fenton-like reactions 
based on the original Fenton chemistry have been known to be very efficient in the formation of 
oxidative defects,
91
 but further applications have not been actively pursued.  Slight changes in 
reaction condition using UV light-promoted or Cu(I)/Cu(II)
127
 instead of Fe(II)/Fe(III) have been 
most frequently employed.  In Chapter 4, the Fenton-like reactions using a Cu(II) coordinated 
supramolecular polymer catalyst will be discussed.  In the same vein, metalloporphyrin 
complexes have been widely used as catalysts in various organic reactions with oxidants (e.g., 
PhIO, NaOCl, KHSO5, and H2O2).
98
  However, the use of a synthetic metalloporphyrin complex 
in the fabrication of CNMs has not been reported other than in the case of the patterned graphite 
described in Chapter 5 of this dissertation.      
 
1.3.2.1 Fenton-like oxidation 
The Fenton-like mechanism is based on an electron transfer between hydrogen peroxide and a 
metal catalyst (e.g., Fe
2+
, Cu
+
).
128
  The classic Fenton reaction is catalyzed by ferrous ions (Fe
2+
) 
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in acidic conditions and the regeneration of Fe
2+ 
is catalyzed by the ferric ions (Fe
3+
) upon 
reaction with hydrogen peroxide, eq (1).
128
  While the catalytic cycle propagates between Fe
2+ 
and Fe
3+, hydroxyl (•OH) and hydroperoxyl (HO2•) radicals form as by-products.  Generally, the 
reactivity, i.e., oxidizing power, of the former is much higher than the latter.
128
   Fenton-like 
reaction (2) is much slower than (1), but the presence of HO2• can speed up the conversion of 
Fe
3+
 into Fe
2+
 (3).
128
  This conversion is also observed in the presence of organic radials (•R) 
generated by hydroxyl radical (•OH) eq (4) and (5) but at a much faster rate.128   The reaction 
rate of aromatic organic compounds and the formation of phenolic species was found to be very 
efficient.
128
   
 
(Fenton reaction)   Fe
2+
 + H2O2 + H
+
   →   Fe3+ + H2O + •OH         (1) 
        (k2 = 63 M
-1
 s
-1
) 
(Fenton-like reaction)  Fe
3+
 + H2O2   →   Fe
2+
 + HO2• + H
+
          (2) 
        (k = ~3 × 10
-3
 s
-1
) 
    Fe
3+
+ HO2•  →    Fe
2+
 + O2 + H
+  
          (3) 
        (k2 = 2 × 10
3
 M
-1
 s
-1
) 
(Organic radical formation) RH + •OH   →   R• + H2O                 (4) 
         (k2 = 10
7–109 M-1 s-1) 
    Fe
3+
 + R•   →   Fe2+ + R+                  (5) 
          (k2 = 10
7–108 M-1 s-1) 
    ArH + •OH   →   ArHOH• 
    ArHOH• + O2   →  ArOH + HO2 •          (6) 
           (k2 = 10
8–109 M-1 s-1) 
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To enhance the catalytic activity in different environments, this basic oxidative model has 
been modified into various conditions and is referred to as Fenton-like reactions.  In addition to 
Fe(II), copper(II)
127
 and cobalt(II) can be used as catalysts in the decompositions of polycylic 
aromatic hydrocarbons and small aromatic compounds such as benzene, toluene, ethylbenzene, 
and xylenes.
129
  Fenton chemistry is effective under acidic conditions (pH 2–4) whereas cobalt 
and copper catalysts can be useful in the wide range of pH 3–9. 129  In addition, different organic 
ligands influence the catalytic activity by forming a metal–ligand–radical complex in the 
presence of H2O2, which may prevent the aggregation of metal ions in solution and accelerate the 
interaction with H2O2.
129
       
 
1.3.2.2 Synthetic iron porphyrin catalysts 
Porphyrin derivatives are probably the most versatile ligands, capable of forming well-defined 
complexes with various transition metal ions, notably iron(III), Mn(III), Co(II), and Ru(II).
130
  
The tetrapyrrole ligand structure of porphyrin allows for modification with substituents that can 
be linked to pyrrolic β sites or the methines.97  Compared to heme-containing enzymes, synthetic 
metalloporphyrin catalysts can be more robust when exposed to a large amount of oxidants.
131
  
Many early examples of metalloporphyrin catalysts were reported in the epoxidation of alkenes 
and hydroxylation of alkanes.
131
  Although electron-rich aromatic substrates have not been 
employed for iron porphyrin-catalyzed oxidation, oxidative degradation of lignin and organic 
pollutants have also been reported.
132
  Lignin dimers composed of benzylic and phenyl carbons 
were subjected to oxidative cleavage which was sensitive to porphyrin substituents and oxidants 
(oxygen donors).
133
  When immobilized on graphene supports, hemin and iron porphyrin 
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derivatives with H2O2 showed high catalytic activity in the oxidation of a small aromatic 
molecule pyrogallol.
134
1.3.2.3 Nonbiological catalytic oxidation of carbon nanomaterials 
Photo-Fenton reactions have been used in the oxidative degradation of MWCNTs
135
 and GO.
96
The mechanism of the photo-Fenton reaction of GO was elucidated by mass spectrometer 
analysis and density functional theory (DFT) calculations.
96
  The oxidation mechanism of GO
seems similar to that of CNTs in that the oxidant H2O2 is dissociated by UV irradiation into •OH, 
a very powerful oxidant, and generates hydroxide, quinone, and carboxylic groups.
136
Ultimately, the functional groups with low oxidation states will be converted to higher oxidation 
states such as carboxylic acid, followed by decarboxylation and return to the C–H bond 
formation.  Zhang and coworkers prepared graphene quantum dots (GQDs) with an average size 
of 40 nm (width) × 1.2 nm (thickness) using a photo-Fenton oxidation of GO sheets (about 
1μm).91  They found that the photo-Fenton reaction of GO was initiated at carbon atoms
connected with oxygen containing groups, and that GQDs were functionalized with carboxylic 
groups along the edges.
91
The use of metal nanoparticles (NPs) as catalysts is another type of catalytic thermal 
oxidation, in which metal NPs are deposited on graphene sheets and annealed at elevated 
temperatures.  Bulk preparation of holey graphene was demonstrated with an AgNP catalyst on 
graphene that was exposed to controlled air oxidation at 250–400 °C, and the high annealing 
temperature yielded a high oxygen content in the graphene sample.
125
  Similarly, AuNPs were
deposited on rGO and catalyzed the oxidation of rGO by •OH as well as the generation of •OH 
by UV photolysis.
126
  The catalytic role of AuNP was attributed to changes in localized oxidation
potentials at the AuNP surface effectively assisting the reaction of •OH with rGO.126
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2.0  SYNTHESIS OF POLYMER–CARBON NANOTUBE COMPOSITES FOR DRUG 
DELIVERY 
2.1 CHAPTER PREFACE 
This research was conducted in collaboration with the Professor Valerian Kagan group, 
Departments of Environmental and Occupational Health, and the Professor Peter Wipf group, 
Department of Chemistry at the University of Pittsburgh.  These groups provided mitochondria 
targeting drugs, TPP-IOA and XJB-5-131, respectively.  W. Seo synthesized and characterized 
the drug nanoconjugates; Michael W. Epperly administered in vivo experiments; Alexandr A. 
Kapralov, Vladmir A. Tyurin, and Yulia Y. Tyurina performed in vitro experiments and 
analyzed biological data; E. Skoda synthesized XJB-5-131.  W. Seo thanks Seth C. Burkert for 
performing X-ray photoelectron spectroscopy (XPS).  As biological studies were conducted in 
other groups, only the key results of drug conjugates are highlighted in this dissertation.          
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2.2 INTRODUCTION 
Chapter 2 and Chapter 3 investigate drug nanocarriers composed of phospholipid-polyethylene 
glycol (PL-PEG) functionalized ox-SWCNTs in the context of drug circulation.  In Chapter 2, 
the PL-PEG/ox-SWCNT nanocarrier is employed to improve the in vivo circulation time of two 
mitochondria targeting drugs TPP-IOA and XJB-5-131, and the role of polymer nanocomposite 
as a drug carrier is examined.  These drugs aim to serve as radiomitigators/radioprotectors in 
biomedicine and biodefense applications.  Chapter 2 focuses on the synthesis and 
characterization of drug conjugates and their in vivo pharmacokinetic properties upon exposure 
to ionizing radiation.  Chapter 3 centers on the oxidative degradation and clearance of the drug 
carrier specifically triggered by the innate immune system.  
A similar drug carrier prepared from PL-PEG and SWCNT was reported by Hongjie Dai 
and coworkers, demonstrating excellent in vivo drug delivery properties.
137
  They studied PL-
PEG models with some slight variations in chemical structure for coating SWCNT-based 
carriers.  Based on the noncovalently functionalized short pristine SWCNTs with PL-PEG 
studied earlier, we prepared drug conjugates by noncovalently attaching drug molecules, TPP-
IOA and XJB-5-131 onto the PL-PEG/SWCNT surface (Figure 2.1).  The therapeutic effects of 
the TPP-IOA and XJB-5-131 as mitochondria targeting free drugs were previously 
investigated.
138-140
  Both TPP-IOA and XJB-5-131 are employed as radiation mitigators.  TPP-
IOA is a highly aqueous soluble whereas XJB-5-131 exhibits poor solubility in water.  The 
pharmacokinetic properties of the drug conjugates are investigated in vivo.   
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Figure 2.1  Representation of a nanocarrier and drugs. (a) ox-SWCNT and PL-PEG. (b) TPP-IOA, and (c) XJB-5-
131. 
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2.2.1 Drug nanocarriers and carbon nanotubes 
Many different types of drug delivery systems, including the first generation nontargeted and 
targeted (or smart) delivery, have been developed to improve the therapeutic effects of 
conventional drug administrations.
141 Generally, drug carriers are employed to improve 
pharmacological properties of existing drugs (e.g., solubility and circulation), and are designed 
primarily to protect drug molecules from the external environment.
142
  Some carriers are built 
upon sophisticated molecular systems made of multiple components and functions, resulting in 
localized release of therapeutic agents near target cells and tissues with minimal side effects.
143-
144
CNT-based molecular vehicles have been utilized in drug and gene delivery, imaging, 
and photothermal therapy.
74,94
  Many examples of these devices have also been developed into a 
carrier capable of multiple functionalities such as theranostics, a combination of therapeutic and 
imaging contrast agents. The shape of drug carriers plays a role in permeation of the drug 
carrier.
145
  Compared to spherical nanoparticles such as liposomes and micelles, CNTs featuring 
1D needle shapes and high aspect ratios (>200:1 of length to width for HiPco SWCNT) are 
reportedly advantageous for intracellular drug delivery by endocytosis, allowing facile 
translocation of drug carriers into the cytoplasm through cell membranes.
146-147
HiPco SWCNTs prepared by high-pressure carbon monoxide disproportionation
148
 are 
employed in drug delivery due to their small diameters (0.8–1.2 nm).  For biological 
applications, most commercial HiPco CNTs are cut short by chemical and mechanical treatments 
(<300 nm in length).
149
  It is widely accepted that short CNTs are relatively safe whereas pristine 
CNTs as long as 10 μm have been shown to cause pulmonary inflammation and mesothelioma in 
mice.
150
 Semiconducting nanotubes have intrinsic fluorescence in the NIR region (λemission =
36 
1100–1400 nm, λexcitation = 750–900 nm), which eliminates the need for using toxic fluorophores 
in biological studies.
151
  CNTs are capable of passive self-accumulation near the tumor site
without the aid of the ligand–receptor interaction programmed in targeted drug delivery.145, 152
This phenomenon, referred to as the enhanced permeation and retention (EPR) effect, can also be 
observed in other nanoparticle-based drug carriers that are easily trapped onto the irregular, 
abnormal surface of cancer cells and tissues.
153
Examples of SWCNT-based drug conjugates functionalized by different auxiliary 
components are illustrated in Figure 2.2.
69
  Incorporation of surfactants or hydrophilic polymers
to impart biocompatibility is a common procedure.
74
  Occasionally, functional modules such as
fluorescence tags for cellular imaging and ligand–target recognition (e.g., antigen–antibody) are 
also incorporated into CNT carriers.
60,69
  Drug molecules can be attached to CNTs covalently as
prodrugs or can be noncovalently bound to the CNT surface through intermolecular interactions 
(Figure 4a–c).154  Generally, covalently linked drug molecules can be resistant to random
adsorption by various biomolecules in serum unless the linker is cleaved by metabolic processes.  
However, covalent attachment of drug molecules may result in low drug payloads because CNTs 
have insufficient anchoring sites for drug conjugation, localized only at the ends and some 
defects on the sidewall.
151,155-156
  To increase the loading capacity, drug molecules are linked to
PEG instead of CNTs.   
Drug molecules can also be noncovalently loaded onto SWCNTs.
154
  Hydrophobic drugs
bearing aromatic moieties such as Doxorubicin are good substrates because the sidewall of 
SWCNTs drives π–π stacking.154,157  In addition, the carboxylate of ox–SWCNTs form
electrostatic interactions with positively charged groups (e.g., RNH3
+
) under physiological
conditions.
157
  Despite the functionalization of CNTs with hydrophilic or amphiphilic coatings,
37 
the inherent poor aqueous solubility of drugs significantly influences the stability and the 
pharmacokinetics of drug conjugates as observed in the in vivo pharmacokinetics study of 
paclitaxel.
155
  It was suggested that the high hydrophobicity of paclitaxel would compromise the
biological inertness of a PEG-functionalized SWCNTs, significantly reducing blood circulation 
times.
155
Figure 2.2 SWCNT-based drug conjugates.
69
 
Reprinted with permission from Chem. Commun. 2012, 48 (33), 3911–3926. 
Copyright (2002) Royal Society of Chemistry 
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2.2.2 Functionalization with phospholipid-polyethylene glycol 
Polyethylene glycol (PEG) derivatives have been extensively used in biomedical applications 
mainly due to excellent biocompatibility although PEG is not biodegradable.
60,68,158
  The
molecular weight (MW) range of PEG  used for drug delivery is usually between 1 and 40 
kDa.
159
  As many studies reported the rapid uptake of NPs by the reticuloendothelial system
(RES) and the resulting short blood circulation times, PEGylation became an important strategy 
to improve drug circulation.  It was believed that PEG suppressed the formation of protein 
corona (i.e., stealth effect) and prevented the nonspecific cellular uptake of nanocarriers as well 
as drugs.
160
  However, Mailänder and Wurm have recently found that PEG has specific binding
affinity with clusterin in blood plasma, which reduces the macrophage uptake.
158
  This result was
further corroborated by the high phagocytic uptake of PEGylated NPs incubated in water without 
plasma.
158
Bottini and coworkers reported that coagulation proteins, immunoglobulins, 
apolipoproteins, and proteins of the complement system were most strongly bound to a 
noncovalently functionalized PL-PEG (MW=2 kDa)–SWCNT composite among 240 proteins 
screened in the study.
160
   They also found that the protein recruitment was independent of the
isoelectric point, molecular weight, and total hydrophobicity of proteins.
160
  Phospholipid (PL)
moieties are strongly adhered to the sidewall of SWCNTs while the PEG chains extends and help 
dispersion into water.
161
  Interestingly, neither PL nor PEG has any functional groups that can
drive selective binding with proteins.
158
  Based on the in vivo results, the topology of PEG (e.g.,
mushroom vs. brush forms illustrated in Figure 2.3) was found to be more important in protein 
selectivity than the surface charge (e.g., amine vs. methyl groups).
160
  With the lack of the
biochemical mechanistic understanding of PEG–protein adsorption, some of the findings 
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reported in the past have been often debated.
159
  It is generally believed that large PEG chains 
prevent protein corona.
158,160
  The dependence of nonspecific cellular uptake upon the PL-PEG 
size was confirmed with PL-PEG (MW= 5 kDa), but PL-PEG (MW= 2 kDa) did not show 
improved drug circulation.
159
  With the same molecular weight of 5 kDa, in vivo
161-162
 and in 
vitro
163
 stealth effects were very inconsistent.  The surface coverage (or packing density) of PL-
PEG on the SWCNT would affect the interaction with proteins.  Phospholipids can randomly 
adsorb to the CNT during functionalization, which may expose the bare CNT surface to plasma.  
Similarly, branched PL-PEG/SWCNTs that were developed to improve the blood circulation of 
the carrier showed PL-PEG’s size- and packing density-dependent circulation results.67  While 
exploration of new parameters in the study of the PEG–protein interaction continues, a few 
changes in the structure of CNTs as well as PEG and biological environments may impart 
completely different properties and stability to drug conjugates.  
 
 
 
 
 
 
 
Figure 2.3  Topology of Polyethylene glycol. (a) Mushroom and (b) brush hydrodynamic conformations of 
polyethylene glycol.  Brush conformations can develop steric interactions with protein in plasma, attenuating the 
formation of protein corona.   
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2.2.3 Mitochondria targeting drugs 
Protective medical countermeasures need to be developed to prevent ionizing radiation injury 
potentially caused by accidental exposure during radiation therapy and terrorism.
140
  Ionizing
radiation triggers generation of reactive oxygen species (ROS) and radicals arising from 
radiolysis of water, inducing mitochondria-mediated cell apoptosis.
164
 To date, no effective
medical radiation countermeasures against acute and delayed radiation injuries are currently 
available.
165
  Based on the new finding that cytochrome c in mitochondria oxidizes cardiolipin as
the result of radiation-induced apoptosis, 3-hydroxypropyl-triphenylphosphonium-conjugated 
imidazole-substituted oleic acid (TPP-IOA) was developed.
140
  The lipophilic
triphenylphosphonium moiety promotes the drug molecules to efficiently traverse the highly 
negative mitochondrial lipid membrane, serving as an excellent selective targeting agent to treat 
ROS-induced mitochondrial damage.
166
  TPP-IOA demonstrated the suppression of cell death
induced by irradiation and protected C57BL6 mice against total body irradiation.
140
XJB-5-131 possesses a nitroxide group functionalized into the S segment of a natural 
product gramicidin, a peptide-mimetic mitochondrial targeting radiomitigators.
167
  XJB-5-131
delivers 4-amino-TEMPO, a stable nitroxide radical-based antioxidant scavenging electrons and 
ROS.
168
  The sterically hindered free radical can serve as either an electron-accepting or
electron-donating group, depending on the redox potential of the environment.
169
  This drug was
found effective in preventing superoxide production in cells and cardoilipin (CL) oxidation in 
mitochondria and also in protecting cells against a range of pro-apoptotic triggers such as 
actinomycin D and radiation.
167
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2.3 EXPERIMENTAL 
2.3.1 Synthesis of drug carrier (PL-PEG/ox-SWCNT) 
Raw HiPco (NanoIntegris®) SWCNTs (25 mg) were oxidized in 50 mL of an acid mixture 
(H2SO4 /HNO3, 3/1, v/v) in an ultrasonic bath set at 25 ˚C over 3 h 20 min.  After thorough 
washing with distilled water several times, the ox-SWCNTs were dried under vacuum over 24 h, 
which yielded 18 mg.  A phospholipid–polyethylene glycol (PL-PEG) was prepared by amide 
coupling of DSPE-050PA (115 mg) and TMS(PEG)12 (71 mg) in anhydrous CH2Cl2 (3.0 mL).  
After 12 h, N,N-dicyclohexylcarbodiimide (DCC) (20 mg, 97 mmol) and 4-
dimethylaminopyridine (DMAP) (10 mg, 82 mmol) were added to ensure reactivation of the 
hydrolyzed N-hydroxysuccinimide (NHS) group of TMS(PEG)12 for amide coupling.  After 24 h 
of stirring at room temperature, the reaction solvent (CH2Cl2) was dried on a rotary vacuum 
evaporator.  The reaction mixture was washed with nanopure water (61 mL) and was collected 
by vacuum filtration.  Excess DMAP was further removed by dialysis.  MALDI:  m/z ~7.4 kDa.   
2.3.2 Preparation of the TPP-IOA conjugate (TPP-IOA-SWCNT) 
After sonication of ox-SWCNTs (4.00 mg) in phosphate buffer (pH 8.2, 7 mL) for 30 min, TPP-
IOA (8.71 mg, 0.01 mmol) was added to the nanotube suspension.  Immediately, a PL-PEG(17.2 
mg) solution in phosphate buffer (pH 8.2, 20 mL) was added to the mixture.  The mixture of 
TPP-IOA/PL-PEG/ox-SWCNT was sonicated for 30 min and allowed to stir for 24 h.  TPP-IOA 
was added before PL-PEG addition because binding of the long alkyl chain of TPP-IOA to the 
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SWCNT sidewall may be interfered with the phospholipid moiety of the PL-PEG.   The drug 
conjugate was collected by vacuum filtration and washed further with phosphate buffer (pH 8.2) 
by centrifugation (11,000 rpm, 30 min × 5) using a 100 kDa centrifuge filter.  The final wash 
solution was analyzed with 
1
H NMR spectra to ensure that no trace of TPP-IOA remained in the 
solution.  The drug conjugate was dried under high vacuum over 12 h.  
 
2.3.3 Preparation of the XJB-5-131 conjugate (XJB-SWCNT) 
PL-PEG/ox-SWCNT (1.00 mg) was dissolved and sonicated in PBS solution (5.0 mL, pH 8.20, 
0.1 M) for 5 min.  An aliquot of XJB-5-131 solution in ethanol (500.0 µL, equivalent to 2.24 mg 
of XJB-5-131) was injected dropwise to the solution of PL-PEG/ox-SWCNT.  The reaction 
solution was pale gray, and a fine white powder of XJB-5-131 was dispersed in the solution.  
After 30 min of sonication to break the drug aggregates, the reaction was stirred at room 
temperature over 24 h under N2.  The reaction solution was filtered using a 100 kDa MWCO 
Amico centrifugal filter (11,000 rpm, 20 min).   The solid drug conjugate (XJB-SWCNT) was 
purified further through four wash cycles with phosphate buffer (pH 8.20, 0.05 M).  In each wash 
cycle, the collected drug conjugate in the centrifugal filter was sonicated again for about 2 min in 
the same phosphate buffer and filtered by centrifugation.  After drying under high vacuum over 
15 h, the sample was sonicated in 1.5 mL of PBS solution (0.01 M, pH 7.4). The approximate 
concentration of XJB-SWCNT was 0.7 mg/mL.  
 An alternate protocol was employed to optimize the maximum drug loading using zeta 
potential titration that provides an approximate threshold value for the maximum solubility of the 
XJB-SWCNT conjugate.  The titration experiment was performed with a PL-PEG/ox-SWCNT 
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solution in water (0.09 mg/mL).  Then an aliquot of XJB-5-131 in ethanol (5.0 mg/mL, 5.2 mM) 
was added to the PL-PEG/ox-SWNT solution and sonicated for 10 min.  The serial titration 
continued until the zeta potential value did not change.  The total amount of XJB-5-131 present 
in the solution was 0.25 mg and the concentration of the drug conjugate was estimated 0.08 
mg/mL, in which a loading capacity of 90% was achieved in contrast with 50% observed in the 
previous method.   
2.3.4 In vivo experiments of the TPP-IOA conjugate (TPP-IOA-SWCNT) 
All procedures were approved and performed according to the protocols established by the 
Institutional Animal Care and Use Committee (IACUC) of the University of Pittsburgh.  
C57BL/6NTac female mice were exposed to total body irradiation (TBI) to a dose of 9.25 Gy (n 
= 10).  Intraperitoneal injection with TPP-IOA (5 mg/kg body weight) and TPP-IOA-SWCNT 
(2.5 mg of TPP-IOA/kg body weight) was performed on the mice 24 h after TBI.
165
   
 
2.3.5 In vivo experiments of the XJB-5-131 conjugate (XJB-SWCNT) 
C57BL/6NHsd female mice were irradiated with 9.25 or 9.5 Gy TBI using a J. L. Shepherd Mark 
1 Model 68 cesium irradiator at a dose rate of 80 cGy/min.  As soon as the mice developed the 
hematopoietic syndrome, they were sacrificed for analysis.  Mouse embryonic cells were 
cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 15% fetal bovine 
serum, 25 mM HEPES, 50 mg/L of uridine, 110 mg/L of pyruvate, 2 mM of glutamine, 1 × 
nonessential amino acids, 0.05 mM of 2-mercaptoethanol, 0.5 × 106 U/L of mouse leukemia 
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inhibitory factor, 100 U/L of penicillin, and 100 μg/L of streptomycin in humidified atmosphere 
of 5% CO2 and 95% air at 37 °C.
170
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2.4 RESULTS AND DISCUSSION 
2.4.1 Characterization of PL-PEG/ox-SWCNT 
The degree of oxidation of pristine HiPCo SWCNTs was analyzed by Raman Spectroscopy 
(Figure 2.4) based on the Raman signature peaks of graphitic structures.
171
  The ID/IG value of 
the oxidized SWCNTs (0.35) was substantially larger than that of the pristine SWCNTs (0.08).  
The increased ID/IG indicates the presence of defects newly formed on the sidewalls and the ends 
of SWNTs.
172
  After the acid treatment, the D band became wider and was blue-shifted (Table 
2.1).  
 
 
 
 
 
 
Figure 2.4  Raman spectroscopy of pristine HiPco SWCNT and ox-SWCNT. 
 
Table 2.1  Raman characteristic peaks and the ratio of D to G.  
 
 
 
 
 
 
Nanotube D band (cm
−1
) G band (cm
−1
) ID/IG 
Pristine 
SWCNT 
1309 1591 0.08 
ox-SWCNT 1327 1596 0.35 
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In addition, FTIR (Figure 2.11 and Table 2.2 in the section 2.6) and XPS data (Figure 
2.12 in the section 2.6) indicate the oxidation of pristine SWCNTs.  Carboxylic acid (1728 and 
3433–2684 cm−1) and phenolic (3587 cm−1) groups are present in IR absorption spectrum.  XPS 
analysis reveals a large amount of carboxylic and ketone groups.  TEM micrographs show each 
stage of preparing the PL-PEG/ox-SWCNT composite (Figure 2.5a–c).  Pristine CNTs are long 
and aggregated.  After oxidation, the CNTs became short and less bundled with an average 
length of 162 nm.  PEGylation did not significantly change the high aspect ratios, but the 
diameter increased due to multiple PL-PEG chains covering the ox-SWCNT surface.    
 
 
 
 
 
 
 
 
Figure 2.5  TEM micrographs of (a) Pristine SWCNT, (b) ox-SWCNT, and (c) PL-PEG/ox-SWCNT. 
 
 
2.4.2 Characterization of the TPP-IOA conjugate  
TEM analysis indicates that the TPP-IOA conjugate (TPP-IOA-SWCNT) did not substantially 
aggregate (Figure 2.6a).  To quantify the drug loading and predict the dispersibility of the drug 
conjugate, we implemented zeta potential (ζ) titration which determines the maximum drug 
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loading (Figure 2.6b).  Binding of TPP-IOA to PL-PEG/ox-SWCNT becomes saturated between 
0.8 and 1.6 wt equiv, suggesting that the maximum drug loading is about 160%.  Because free 
TPP-IOA is highly water-soluble (ζ= +55.7 mV), the TPP-IOA conjugate remained well-
dispersed in solution throughout the titration experiment and even after a week of storage at 
room temperature.      
 
 
 
 
 
 
 
 
Figure 2.6  (a) TEM micrograph and (b) zeta potential measurement of TPP-IOA-SWCNT at pH 7.0.  Data are 
means ± SD of five replicate measurements. 
 
 
2.4.3 Characterization of the XJB-5-131 conjugate  
A TEM image (Figure 2.7a) did not show significant degrees of bundled SWCNTs despite the 
presence of highly hydrophobic XJB-5-131 which is only soluble in polar organic solvents such 
as dimethyl sulfoxide (DMSO) and ethanol.  Zeta potential titration data indicate that the binding 
of XJB-5-131 with ox-SWCNTs was saturated between 0.1 and 0.6 wt equiv (ζ= −20.0 mV) 
while still being dispersible in water (Figure 2.7b).  Further addition of XJB-5-131 up to 0.9 wt 
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equiv did not reduce the zeta potential dramatically.  In order to maximize the drug loading, we 
chose 0.9 equiv of XJB-5-131 to PL-PEG/ox-SWCNT (i.e., 90% drug loading).  The loading 
capacity at a lower PL-PEG/ox-SWCNT concentration (0.09 mg/mL) significantly improved 
compared to higher concentrations of the carrier (0.2 mg/mL and 0.7 mg/mL).  The prepared 
drug conjugate in water appeared stable for about 24 h without significant change in zeta 
potential (within ±1.0 mV).  However, slow precipitation of XJB-5-131 from the solution was 
increasingly noticeable over time due to the intrinsically poor solubility of XJB-5-131.  After 
about 1 week, the drug conjugate solution had to be resonicated for 30 min to disperse the 
nanoconjugate.      
  
 
 
 
 
 
 
 
 
Figure 2.7  (a) TEM micrograph(average length: 82 ± 44 nm) and (b) zeta potential titration of XJB-SWCNT under 
pH 7.5.  Data are means ± SD of five replicate measurements. 
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2.4.4 In vivo results of the TPP-IOA conjugate  
The TPP-IOA conjugate (TPP-IOA-SWCNT) was shown more effective as a radiomitigator than 
free TPP-IOA.  The therapeutic effect of TPP-IOA-SWCNT began to show after 12 h and the 
mouse survival rate was markedly higher than untreated mice (Figure 2.8a).  However, the 
mitigating effect of TPP-IOA-SWCNT was very similar to that of free TPP-IOA up to 16 d and 
slowly differed by ~15% after 20 d.  The drug conjugate showed consistently higher rates 
throughout the given time period whereas a lower survival rate of free TPP-IOA was observed in 
the early stages of the experiment, which may be due to the high potency of free TPP-IOA.  The 
TPP-IOA-SWCNT conjugate clearly demonstrated a prolonged life span of TPP-IOA especially 
over 1 h and maintained about a 35% margin over 24 h (Figure 2.8b).     
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Figure 2.8  In vivo results of TPP-IOA-SWCNT. (a) Radiomitigative effect by TPP-IOA-SWCNT. (b) Free TPP-
IOA and TPP-IOA-SWCNT remaining in plasma over 24 h after intravenous injection into of C56BL mice.  The 
drug concentration was analyzed by LC-MS.  Data are means ± S.E., n=5.
165 
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2.4.5 In vivo results of the XJB-5-131 conjugate  
The drug efficacy of XJB-5-131 after exposure of 9.5 Gy is shown in Figure 2.9a.  In an earlier 
in vivo study of free XJB-5-131, the drug concentration administered to a mouse was 1 mg/kg.
139
   
A high dose of XJB-SWCNT was intravenously injected into mice (XJB-5-131, 0.35 mg/mL; 
PL-PEG/ox-SWCNT, 0.7 mg/ml).  The dose administered was very toxic and no mouse survived 
in 5 min after the injection probably due to intrinsically hydrophobic drug aggregation (Figure 
2.9b).  The toxicity of the drug conjugate was not reduced even when the drug dosage was 
diluted to × 1/3.  The concentration of PL-PEG/ox-SWCNT was much lowered to 0.09 mg/mL 
and the amount of XJB-5-131 loaded onto the carrier was about 180 times lower than the first 
failed experiment.  Interestingly, with the lower carrier concentration, a higher drug loading 
capacity (0.9:1) was achieved, and a control group treated with XJB-SWCNT survived over 40 d 
(Figure 2.9c).  However, all mice treated with a single dose of 9.25 Gy TBI without XJB-
SWCNT survived after 40 d whereas 80% of those treated a 9.25 Gy TBI and XJB-SWCNT 
survived, showing no therapeutic effect.  In contrast, the mouse survival rate with exposure to a 
9.5 Gy TBI showed above 80% for 20 d, higher than that of untreated mice.  However, the 
survival rate dramatically dropped after 20 d, far lower than control mice exposed to the same 
TBI without drug treatment.  In Figure 2.9d, the same dose of XJB-5-131 was mixed with a 
nonionic solubilizer Cremophor ELP (XJB-Cremophor), and the data was compared to XJB-
SWCNT.  Although XJB-SWCNT outperformed the XJB-Cremophor, the mouse survival rates 
of both administration routes were lower than untreated mice with a 9.5 Gy TBI throughout the 
experiment.  Because of the unexpected failure and inconsistent data repeatedly observed, no 
further study was continued.  
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Figure 2.9  In vivo results of XJB-SWCNT. (a) Protection effect of free XJB-5-131. Intraperitoneal injection with 
XJB-5-131 (10 mg/kg of body weight) was performed on mice and irradiated to 9.5 Gy 10 min later.  (b)Toxicity of 
XJB-SWCNT after intravenous injection (PL-PEG/ox-SWCNT: 0.7 mg/ml and XJB-5-131: 0.35 mg/ml). (c) Effect 
of XJB-SWCNT on the mouse survival rate after TBI 9.25 and 9.5 Gy, respectively.  The concentration of XJB-5-
131 was 0.18 mg/ml. (d) Effect of XJB-SWCNT and XJB-Cremophor on the mouse survival rate after a TBI of 9.5 
Gy.  Mice were intravenously injected with 200 μL of XJB-SWCNT (0.018 mg) 20 h after the TBI irradiation.  10 
mg/kg XJB-5-131 (0.2 mg in 100 uL) dissolved in Cremophor EL/ethanol (10% Cremophor EL, 10% ethanol, and 
80% water).
170
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2.5 CONCLUSION 
The PL-PEG/ox-SWCNT composite was employed to improve the circulation time of 
mitochondria targeting drugs TPP-IOA and XJB-5-131.  The in vivo study of the TPP-IOA-
SWCNT conjugate revealed that the drug efficacy for 8–20 d after exposure to a TBI of 9.25 Gy 
was marginally better than free TPP-IOA without an apparent sign of toxicity.  The in vivo 
experiments of the XJB-SWCNT conjugate did not show reasonable ground to employ a 
nanocarrier.  An interesting finding is that the drug loading capacity actually improved with a 
low concentration of the nanocarrier.  This result suggests that the high density of PEG chain 
does not provide the high number of anchoring site for drugs, which seems counterintuitive.  PL-
PEG successfully imparted biocompatibility to XJB-5-131, but failed to demonstrate the 
nanocomposite as a reliable drug carrier.   
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2.6 SUPPORTING INFORMATION 
2.6.1 Materials and instrumental 
HiPco SWCNT was purchased from NanoIntegris®.  Lyophilized human myeloperoxidase 
(MPO) was received from Athens Research and Technology, INC. (Athens, GA, USA).  N-
(aminopropylpolyethyleneglycol)carbamyl-disteaoyl phosphatidylethanolamine (DSPE-050PA) 
was purchased from NOF Corporation.  (Methyl-PEG12)3-PEG-NHS Ester (TMS(PEG)12) was 
obtained from Thermo Scientific.  N3-(2-hydroxy-2-nitroso-1-propylhydrazino)-1-propanamine 
(Papa NONOate) was purchased from Cayman Chemical Company (Ann Arbor, MI).  All other 
chemicals were purchased from Sigma Aldrich, and were used without further purification.  All 
samples were prepared by dispersing dry solid in either nanopure water or phosphate buffer (pH 
7.4).  
 Nanopure water was collected from Thermo Scientific BarnsteadTM NanopureTM. 
Branson 5510 was used for ultrasonication.  Thermo Scientific Savant SPD 1010 SpeedVac was 
employed to dry aqueous samples (pressure: 5.6 Torr, temperature: 45 ˚C).  The size distribution 
and the morphology were analyzed with Transmission Electron Microscope (FEI-Morgani, 80 
keV).  Renishaw inVia Raman microscope was utilized to collect Raman spectra (laser λexcitation: 
633 nm).  Dried CNTs were drop-cast on a microscope slide.  Spectra were collected with a 10 
second exposure time and averaged across 5 scans per location. The collected spectra were 
normalized to 1 with respect to the maximum intensity.  MALDI mass spectra were recorded on 
a Voyager-DE PRO Instrument.  Zeta potential was measured using a Brookhaven ZetaPals at 25 
˚C under specified conditions of pH.  NMR spectra were acquired on a Bruker Avance III 
400MHz NMR.  Fourier Transform spectroscopy (FTIR) was performed employing an IR-
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Prestige spectrophotometer (Shimadzu Scientific) outfitted with an EasiDiff accessory (Pike 
Technologies).  X-ray photoelectron S2 spectroscopy (XPS) was obtained via a Thermo 
Scientific ESCALAB 250xi photoelectron spectrometer using monochromated Al K Alpha X-
rays as the source. 
 
2.6.2 Characterization of PL-PEG and ox-SWCNT 
2.6.2.1 Matrix-assisted laser desorption ionization (MALDI) 
A matrix solution was prepared with α-Cyano-4-hydroxycinnamic acid (10.0 mg) in a mixture of 
0.2 % trifluoroacetic acid (TFA) in H2O/CH3CN (2 mL).  A PL-PEG was dispersed in water (1 
mg/mL) and then mixed with the prepared 0.2% TFA solution/CH3CN (1:1, v/v). 
 
 
 
 
 
 
Figure 2.10  MALDI mass spectrum of PL-PEG.  The average molecular weight was estimated around 7.4– 8.2 
kDa. 
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2.6.2.2 Fourier transform infrared spectroscopy 
A dried ox-SWCNT sample was homogeneously mixed with KBr.  Using KBr as the background 
and taking 32 scans per sample, a spectrum was obtained over the range of 800 to 4000 cm
−1
 
with a resolution of 4 cm
−1
. 
 
 
 
 
 
 
 
Figure 2.11  IR absorption spectrum of ox-SWCNT. 
 
          Table 2.2  Identification of functional groups by FTIR analysis. 
Peak  (cm
-1
) Functional group 
3587 Ar–OH 
2684–3433 (C=O)–OH 
1728 (C=O)–OH 
1567 –C=C– 
1334 –S=O– 
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2.6.2.3 X-ray photoelectron spectroscopy 
The spot size of the sample was 400 μm (microns) prepared on an aluminum plate.  Charge 
compensation was provided by a low energy electron source and Ar
+
 ions.  Survey scans were 
collected using a pass energy of 150 eV, and high resolution scans were collected using a pass 
energy of 50 eV.  The average percentage indicates a mean obtained by analyzing three different 
sample spots.  
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Figure 2.12  X-ray photoelectron spectroscopy of ox-SWCNT. (a) Survey scan of the sample, (b) deconvolution of 
high resolution spectra of C 1s and corresponding functional groups, and (c) deconvolution of high resolution 
spectra of O 1s and corresponding functional groups. 
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3.0  OXIDATIVE BIODEGRADATION STUDIES OF DOXORUBICIN-SINGLE 
WALLED NANOTUBE DRUG CONJUGATE 
3.1 CHAPTER PREFACE 
Collaborative efforts were made to investigate the stability of a drug nanoconjugate in the 
context of the innate immune response.  A communication based on this work was published in 
Nanoscale (DOI: 10.1039/C5NR00251F)
173
 and all figures were reproduced by permission of 
The Royal Society of Chemistry.  The Professor Michael Shurin group, Department of Pathology 
at the University of Pittsburgh Medical Center, and the Professor Valerian Kagan group, 
Department of Environmental and Occupational Health at the University of Pittsburgh conducted 
the biological studies.  W. Seo prepared a Doxorubicin nanoconjugate and performed ex vivo 
experiments for the degradation of the drug nanoconjugate;  Gallina V. Shurin conducted in vitro 
experiments and analyzed data.  W. Seo thanks Prof. Valerian E. Kagan and Prof. Michael R. 
Shurin for their help in the course of manuscript preparation, and also acknowledges Alexandr A. 
Kapralov for sharing the ex vivo experimental details of peroxynitrite-mediated degradation.         
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3.2 INTRODUCTION 
Chapter 3 focuses on the oxidative degradation of a drug nanoconjugate by the components of 
innate immune system and addresses issues implicated in drug circulation.  The susceptibility of 
the drug and the nanoconjugate to enzymatic reactions occurring in inflammatory cells can 
shorten the circulation time and alter drug efficacy.
174-175
  This issue can be especially 
problematic if a drug nanocarrier degrades upon immune response.  As described in Chapter 1, 
CNTs and PEGylated CNTs are able to undergo oxidative degradation.
95,121
  Thus drug carriers 
consisting of those materials may need strategies to protect drug conjugates from oxidation and 
facilitate controlled drug release.   
 For a proof-of-concept study, a Doxorubicin conjugate (DOX-SWCNT) is prepared for a 
model system by noncovalent functionalization of an anticancer agent Doxorubicin (DOX) with 
the PL-PEG/ox-SWCNT composite that was described in Chapter 2 (Figure 3.1).  Several DOX 
conjugates with slight modifications in the functional group and topology of PEG were 
developed.  In vivo studies of pharmacokinetics demonstrated that the use of PL-PEG/SWCNT 
composites resulted in the prolonged circulation of DOX.
137
  Thus DOX-SWCNT conjugates 
provide a good starting point for investigating the role of the immune system within the context 
of drug circulation.  Furthermore, knowledge of the degradation and stability of DOX under 
various conditions will help us analyze results accurately.  
 Our study aims at investigating the lifespan of the drug and the degradation behavior of 
DOX-SWCNT upon exposure to oxidative conditions mimicking oxidative burst of phagocytes.  
For oxidative conditions, we chose (1) myeloperoxidase and hydrogen peroxide in the presence 
of chloride (MPO/H2O2/Cl
−
) and (2) peroxynitrite (ONOO
−
), which neutrophils and 
macrophages spontaneously release to intra- and extracellular domains during the host-immune 
 61 
response, particularly phagocytosis.
103-104
  The degradation kinetics of DOX-SWCNT is 
compared with that of free DOX, thereby demonstrating a significant role of the drug carrier in 
the oxidative burst.  Despite the presence of PL-PEG coated on the ox-SWCNT surface, which is 
known to mitigate opsonization (or phagocytosis) of NPs,
160,176
  the DOX nanoconjugate is also 
subject to oxidative degradation.  Further evidence is provided by a binding study of MPO–DOX 
conjugate.  In order to establish parameters involved in the binding interaction, we have focused 
on the surface charge effect and utilized the zeta potential measurement of the individual 
components of DOX-SWCNT.  Lastly, the in vitro cytostatic and cytotoxic effects of free DOX 
and the DOX nanoconjugate on melanoma and lung carcinoma cell lines are investigated in the 
presence of tumor-activated myeloid regulatory cells that create unique myeloperoxidase- and 
peroxynitrite-induced oxidative conditions.  Both ex vivo and in vitro studies demonstrate that 
the PL-PEG/ox-SWCNT drug carrier protects DOX against oxidative biodegradation.  Also, 
important insight has been gained in developing strategies for the design of drug nanoconjugates 
in relation to the immune defense system. 
     
 
 
 
 
 
 
Figure 3.1  Doxorubicin is noncovalently bound to the PL-PEG/ox-SWCNT composite (DOX-SWCNT) and major 
oxidation routes activated by the immune system.
173
  
Reprinted with permission from Nanoscale 2015, 7 (19), 8689–8694. 
Copyright (2015) Royal Society of Chemistry 
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3.2.1 Safety and toxicity of drug nanocarriers 
Recent advances in nanotechnology have provided a great opportunity for precise engineering in 
the current state-of-the-art nanomedicine such as drug delivery, in vivo diagnostics, and tissue 
engineering.
177
  Nanoparticles (NPs) have proven to be versatile building blocks for hybrid 
biomaterials.  Controllable synthesis of NPs
178
 and realization of finely tunable functionalities 
have  greatly enhanced the performance of medical therapeutics with specific functions.
178-179
     
 Liposomes, polymers, micelles, proteins, and CNMs have been developed as common 
therapeutic carriers and cargos,
177
 and their biocompatibility/biodegradability has been 
investigated in many biological studies.  However, commercialization of these drug carriers has 
been extremely slow compared to the amount of research accumulated over the past few 
decades.
141
  Accurate assessment of toxicity involved in NP-based drug delivery systems can be 
highly difficult.  For example, toxicity can arise from either intended cytotoxic therapeutic 
agents or intrinsic properties of nanocarriers.
69
  The use of degradable drug carriers is imperative 
in clinical applications,
180
 but their degradation may reduce drug efficacy and cause side 
effects—regardless of whether the degradation is programmed or naturally occurs.181  Further 
challenges lie in elucidating the complex degradation pathways of nanocarriers, frequently 
arising from heterogeneous compositions and propreties.
67,182
  Despite recent findings in 
biodegradable CNTs under certain oxidative conditions, short oxidized CNTs do not guarantee 
absolute long-term safety in drug delivery.  The research of potential toxic effects associated 
with complex biological processes should be further explored.  
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3.2.2 Innate immune responses to nanocarriers and pharmacokinetic implications 
NPs with small sizes and high surface area to volume ratios provide excellent platforms for high 
reactivity in living organisms.
145
  Utilization of nanocarriers allows for better carrier-target 
interactions (e.g., enhanced permeation and retention (EPR) effect) and efficient cellular/tissue 
uptakes.
153
  However, the intrinsically high surface energy of NPs may cause major problems in 
pharmacokinetics: (1) low solubility arising from the formation of aggregates, (2) nonspecific 
binding with plasma proteins and deterioration by other chemical species that exist in the blood 
and lymphatics,
152
 (3) premature drug loss due to size-dependent phagocytosis by innate immune 
cells during circulation,
183
 and (4) fast clearance through reticuloendothelial systems (RES) such 
as liver and spleen.
152
  Despite the enhanced permeability and retention (EPR) effect of NPs, 
generally the rate of drug permeation through cell membranes was found extremely low.
184
  To 
improve clinical efficacy, especially circulation, optimization of the thermodynamic properties 
(e.g., surface free energy) in physiological conditions and investigation of relevant parameters 
(e.g., size, shape, and surface charge) in relation to clearance routes through different organs are 
crucial in the early stage of developing new drug delivery systems (Figure 3.2).
152,175
   All these 
properties interplay with each other, generate fundamentally complex problems, and eventually 
converge into the issue of biocompatibility and biodegradation regulated by the FDA.
180
   
 Behind the success of targeted drug delivery, the issue of designing NPs resistant toward 
the innate immune system has been only marginally addressed.  Because the human body reacts 
to drug conjugates nonspecifically, immune responses vary with the reactivity and toxicity of 
individual drugs and nanocarriers.
185
  As a consequence, fewer drug molecules may reach the 
target than administered doses, thereby dramatically altering the original pharmacokinetics 
properties of drugs.
145,175
  In addition, harmful self-immune responses such as inflammation or 
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even infectious diseases could be induced.
186
  White blood cells (leukocytes), an essential 
component in innate immunity, and various tissues contain neutrophils (polymorphonuclear 
phagocytes) and monocytes/macrophages (typically Kupffer cells or macrophages of the 
liver).
174,176
  Upon cellular ingestion of invading organisms, specific opsonin proteins present in 
serum, particularly C3, C4, and C5, and immunoglobulins, are recognized in the phagocytosis.
176
 
Neutrophils are ready to activate the immune response in the circulating blood, whereas 
macrophages can fight against toxins and infectious agents only in tissues.
187
  In order to initiate 
phagocytosis in tissues, neutrophils in the blood migrate to the tissue and are attracted to an 
inflammatory area by chemotaxis—a chemical signaling process.186  Because neutrophils are 
most abundant among white blood cells and can be very effective for killing pathogens within a 
short time period (about 3–4 d),101 evaluation of the stability of drug conjugates toward 
neutrophils is critical.  In contrast to neutrophils, the immune response activated by macrophages 
persists over weeks of chronic inflammation.
107
  Although the oxidizing power of peroxynitrite is 
weaker than the MPO-catalyzed oxidative cycle, the long-term immune response and 
inflammation can sufficiently influence cellular and tissue environments as well as drug 
conjugates.    
With growing interests in the nonspecific clearance of therapeutic NPs promoted by self-
immune responses, a few recent studies have demonstrated that chemical modification of the NP 
surface may alter their properties and prevent a shortened life span of drug delivery systems and 
premature drug release.
188
  For example, a synthetic molecular ligand incorporated onto the 
surface of a nanocarrier interferes with molecular recognition and signaling processes at the 
initial stage of phagocytosis.
188
  Addition of a polymer that can alter C3 cascade complement 
system reduces nonspecific binding between nanocarriers and hepatic macrophages.
189
  These 
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strategies of chemical modification allow nanocarriers to overcome intrinsic immune responses 
and prolong the circulation time of NPs.
176,190
   
   
 
 
 
 
 
 
 
 
 
Figure 3.2  In vivo biocompatibility, clearance, and cytotoxicity of nanoparticles (NPs) are determined by size, zeta 
potential (surface charge), and dispersibility (hydrophobicity).  Color representation: red (likely toxicity), blue 
(likely safety), and blue–green–yellow (intermediate levels of safety).  Cationic and small particles with high surface 
reactivity are more likely to be toxic (red zone) than the larger relatively hydrophobic particles, which are rapidly 
and safely (blue hue) removed by the reticuloendothelial system (RES).
152
 
Reprinted with permission from Nat. Mater. 2009, 8 (7), 543–557. 
Copyright (2009) Nature Publishing Group 
 
 
3.2.3 Doxorubicin conjugates with PL-PEG/ox-SWCNT composites   
Doxorubicin is an anthracycline anticancer drug utilized in many drug delivery systems for 
cancer treatment.
69,71,157
  Presumably, the drug actions of anthracyclines in cancer cells are 
associated with DNA intercalation, such as inhibition of biochemical processes and DNA 
damage by generation of free radical species, etc.
191
  However, inherent pharmacokinetic and 
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metabolic changes resulting in drug resistance and toxicity, notably cardiotoxicity, are well-
documented in many occasions.
191-192
  Various properties of free Doxorubicin have been 
extensively studied in addition to the pharmacokinetics and side effects,
193-194
 such as photolytic 
and enzymatic degradations
192-193
 and stability in infusion fluids.
195
  Among many examples, the 
one-electron promoted redox cycle of quinone/semiquinone formation has been considered 
important due to the generation of a strong oxidant hydroxyl radical and oxidative damage in 
cells.
191
   
 Such paradigms as target/nontarget delivery and controlled release have been employed 
to improve the clinical efficacy of free DOX.  Liposome carrier-based commercial products such 
as Doxil® and Myocet® have shown therapeutic indices far better than free DOX.
196
  A great 
number of CNM-based DOX conjugates have been developed.
60,69
  The pharmacokinetics (i.e., 
biodistribution and clearance) and toxicity of noncovalently functionalized DOX-SWCNT 
conjugates and PL-PEG/ox-SWCNT carriers were studied previously.
137,197
  The surface density 
of PL-PEG coated on a SWCNT carrier was found about 10% of the total area of SWCNT.
154
  
Generally, the DOX loading capacity of 1–4 mg can be achieved with 1 mg of SWCNT-based 
carriers.
137
  The binding energy of DOX to HiPco SWCNTs commonly used in drug delivery 
was estimated to be approximately 14 kcal/mol in water.
154
  Drug release was found pH-
dependent; at pH 5.5, about 40% of DOX was released from the carrier over 1 day.
154
  DOX-
SWCNT conjugates were demonstrated to be safe in vivo without apparent toxicity over 3–4 
months when drug loading of 2.5 mg/mL (the wt of DOX per SWCNT carrier) was achieved.
197-
198
  The intravenously administered DOX-SWCNT accumulated largely in the liver and the 
spleen after 6 h in mice.
198
  While increasing the half-life time of DOX, the drug uptake by 
tumors was doubled with DOX-SWCNT and was far better than Doxil.
137
  The improved 
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therapeutic efficacy was attributed mainly to the longer circulation half-life time.
137
   When only 
the PL-PEG/SWCNT carrier was tested, the nanocomposite began in vivo clearance from the 
liver through biliary excretion without significant adverse effects.
197
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3.3 EXPERIMENTAL 
3.3.1 Preparation of the Doxorubicin conjugate (DOX-SWCNT) 
PL-PEG/ox-SWCNT was prepared using the same method as described in Chapter 3. 
Doxorubicin (4.8 mg) was dissolved in 10 mL of phosphate buffer (0.1 M, pH 8.2). The DOX 
solution was sonicated for 30 min and was stirred overnight.  After thorough washing with the 
same buffer solution through centrifugation, the amount of DOX wash-off was calculated from a 
UV-Vis calibration curve. The calculation showed that about 2.3 mg of DOX was bound to 3.0 
mg of PL-PEG/ox-SWCNT, which corresponds to a 77% of drug loading. This estimation differs 
by 23% from the UV-Vis titration (Figure 3.10). 
  
3.3.2 Ex vivo oxidation of the Doxorubicin conjugate  
3.3.2.1 Myeloperoxide-catalyzed degradation 
Each DOX-SWCNT sample was prepared by dispersing 0.03 mg of DOX-SWCNT in 720 μL of 
phosphate buffer (pH 7.4, 0.1 M). The concentration of free DOX was 0.02 mg/mL.  Stock 
solutions of DTPA and NaCl were added to the DOX-SWCNT solution, and their final 
concentrations were adjusted to 0.38 mM and 0.14 M respectively.  The concentration of DOX-
SWCNT was 0.04 mg/mL.  For the experiment of +MPO/+H2O2/+Cl
−, 4.4 μg of MPO was 
added every 24 h, and the H2O2 stock solution (18.75 mM) was added every 4 h (total volume of 
30 μL per day).  For −MPO/−H2O2/+Cl
−
, the same amount of the pH 7.4 buffer solution was 
added.  The samples were stored in a standard cell culture incubator at 37 ˚C.  For UV-Vis-NIR 
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analysis, samples were cooled at ambient temperature for about 10 min.  Each spectrum was 
collected with 700 μL of a sample solution in a quartz sample holder (path length: 1 cm), and 
further absorbance was recorded after each new addition of H2O2.  A 0.02 mg/mL PL-PEG/ox-
SWCNT solution was prepared in the same buffer condition.  Then the same procedure was used 
to monitor the degradation of the nanocarrier.  TEM analysis of degraded PL-PEG/ox-SWCNT 
samples were prepared by diluting the original 1:20 or 1:50 times with ethanol, and 3 μL of the 
diluted solution was placed on a lacey carbon copper grid and then permitted to dry in ambient 
conditions over 24 h. 
3.3.2.2 Peroxynitrite-mediated degradation 
Each DOX-SWCNT sample had a concentration of 0.03 mg of DOX-SWCNT in 808 μL of 
phosphate buffer (pH 7.4, 0.1 M), and 0.02 mg/mL of free DOX was prepared in the same 
buffer.  Stock solutions of all other reagents were prepared every day. Then 7.5 μL of a xanthine 
oxidase (XO) solution (×50 diluted from the original enzyme) containing 0.15–0.3 mU of XO, 
was added once per day, followed by additions of 7.5 μL of xanthine solution (7.0 mM) and 7.5 
μL of a PAPA NONOate solution (3.5 mM) every 2 h (total 6 times per day).  Due to the dilution 
effect, the concentrations of both xanthine and PAPA NONOate solutions were raised after 6 
additions, maintaining the same amount of each reagent relative to the total volume of the DOX-
SWCNT solution.  After incubation over a given time period, all the samples were filtered using 
Amicon centrifuge filters (size: 1,000 Da).  The filtrate and the concentrate were separately 
collected by ultracentrifugation (14,000 × g, 10 min), and the concentrate was further diluted in 
phosphate buffer (0.1M, pH 7.4) for proper analysis.  Then fluorescence emission spectroscopy 
(λexcitation=488 nm, λemission=592 nm) was utilized to measure the concentration of DOX-SWCNT 
within a linear calibration range at room temperature.  Due to some loss of DOX-SWCNT after 
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the ultracentrifugal filtration, a separate test determining the average recovery rate of DOX-
SWCNT was performed to estimate the concentration accurately. The average recovery rate of 
five replicated samples was 62 ± 4 (%) from the original amount. 
 
3.3.3 Zeta potential of MPO and DOX-SWCNT 
The laser of the zeta potential analyzer was set at 532 nm.  The zeta potential of unbound pure 
MPO was measured separately, which gave a negative potential (−9.0 ± 1.7 mV).  A rapid color 
change to a very bright yellow upon the laser irradiation suggests the photosensitive heme of 
MPO.
199
  After each titration, a sample containing DOX-SWCNT and MPO solutions was placed 
under ambient temperature and pressure over 1 h until their binding reached equilibrium, and 
then zeta potential was recorded.  For the titration sample, solutions of DOX-SWCNT (0.3 
mg/mL) and MPO were prepared in a mixture of nanopure water and 0.05 M, pH 7.4 phosphate 
buffer (17:1, v/v). 
 
3.3.4 In vitro oxidation of the Doxorubicin conjugate  
Pathogen-free C57BL/6 mice (7–8 week old) obtained from Jackson Labs (Bar Harbor, ME, 
USA) were individually housed and acclimated for 2 weeks.  Animals were supplied with water 
and food ad libitum and housed under controlled light, temperature, and humidity conditions.  
All animal studies were conducted under a protocol approved by the Institutional Animal Care 
and Use Committee.  Data were analyzed using one-way ANOVA and Student unpaired t-test 
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with Welch's correction for unequal variances.  All experiments were either done in triplicates or 
repeated at least twice, and the results were presented as means ± SEM (standard error of the 
mean). P values of < 0.05 were considered to be statistically significant. 
B16 melanoma cells were obtained from American Type Culture Collection (ATCC, 
Manassas, VA, USA) and maintained in RPMI 1640 medium that was supplemented with 2 mM 
L-glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin, 10 mM HEPES, 10% heat-
inactivated FBS, 0.1 mM nonessential amino acids, and 1 mM sodium pyruvate (Invitrogen Life 
Technologies, Inc., Grand Island, NY, USA).  Tumor conditioned medium was collected from 
sub-confluent cultures by centrifugation (300 g, 15 min).  The cell-free supernatant was 
collected, aliquoted, and used to treat MDSC.  
For MDSC generation, bone marrow cells from tibia were isolated, filtered through a 70 
μm cell strainer, and red blood cells were lysed with lysing buffer (155 mM NH4Cl in 10 mM 
Tris-HCl buffer pH 7.5, 25°C) for 3 min.  After RBC lysis, cells were washed and used for 
MDSC sorting.  CD11b+ Gr-1+ MDSC were isolated from the bone marrow cell suspensions by 
magnetic cell sorting using a mouse MDSC Isolation Kit (MACS, Miltenyi Biotec, Auburn, CA, 
USA) according to the manufacturer’s instructions.  Isolated MDSC were cultured in 
supplemented RPMI 1640 medium with 25% (v/v) B16 conditioned medium for 48 h to generate 
tumor-activated MDSC expressing high levels of MPO. 
Cell proliferation assay 3LL cells were labeled with CellTracker™ Orange CMTMR (5-
(and-6)-(((4-chloromethyl)benzoyl)amino) tetramethylrhodamine) (Molecular Probes) and co-
incubated with free DOX and DOX-SWCNT in the presence of tumor-activated MDSC. Co-
incubation of 3LL cells with SWCNT, MDSC or both served as controls.  After 24 h of 
incubation, the number of labeled 3LL cells was determined by flow cytometry (FacsCalibur) 
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events calculated for 1 min.  Increased number of cells (vs. control medium group) indicates an 
increase in cell proliferation, while the lower cell number reflects cytotoxic (cell death) and/or 
cytostatic (inhibition of cell proliferation) effects on tumor cells. 
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3.4 RESULTS AND DISCUSSION 
3.4.1 Characterization of Doxorubicin and nanocarrier 
DOX-SWCNT was synthesized following a published procedure.
137,197
  DOX-SWCNT was 
prepared with the PL-PEG/ox-SWCNT composite that was described in Chapter 2 (Figure 3.3a 
and b).  Although most of the drug conjugate particles maintain high aspect ratios, agglomerates 
are relatively abundant.   
 UV-Vis-NIR absorption spectra confirm the presence of each component of the drug 
conjugate (Figure 3.3c). The suppressed S11 optical transitions near 870–1100 nm are 
characteristic of oxidized HiPco SWCNTs,
200
 in which the broad absorption band constitutes the 
residual peaks of numerous chiral species (n,m).
15
  A slightly red-shifted DOX absorption 
maximum at 495 nm from the free DOX absorption (480 nm) is indicative of noncovalent 
adsorption of drug molecules on the ox-SWCNT surface,
201
 which was further demonstrated by 
the quenched fluorescence emission of DOX by mainly π–π stacking154 at 555 and 595 nm 
(Figure 3.3d).  The drug loading capacity of DOX was measured by titrations using UV-Vis 
absorption spectroscopy (Figure. 3.10, Ch. 3.6) and zeta potential analysis under pH 7.0 (Figure 
3.11, Ch. 3.6).  The binding ratio of DOX to the nanocarrier (bound DOX/nanocarrier, w/w) was 
found to be approximately 1:1. 
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Figure 3.3  TEM micrographs of (a) PL-PEG/ox-SWCNT and (b) DOX-SWCNT. (c) UV-Vis-NIR absorption 
spectra for each functional nanomaterial.  The spectra for SWCNT samples were normalized at 364 nm for 
comparison. (d) Fluorescence emission spectra of DOX-SWCNT in comparison to free DOX of varying 
concentrations.
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3.4.2 Ex vivo oxidative degradation of Doxorubicin and nanocarrier  
3.4.2.1 Myeloperoxidase-catalyzed degradation 
The degradation profiles of ox-SWCNT and DOX in phosphate buffer solution (0.1 M, pH 7.4) 
were investigated by monitoring spectral changes in UV-Vis-NIR absorption spectroscopy.  Each 
sample contained NaCl (0.14 M) as a chloride source and diethylenetriamine pentaacetic acid 
(DTPA) as a chelating agent coordinating with residual transition metal catalyst ions present in 
the commercial HiPco CNTs.  The peroxidase-catalyzed oxidation cycle was initiated by 
addition of an aliquot of H2O2, which produced hypochlorous acid/hypochlorite (HOCl/OCl
−
) 
equilibrating at pH 7.4 and reactive intermediate species.
110,119
  Hypochlorite (OCl
−
) can further 
induce oxidation, and MPO-I and MPO-II, each of which drives one-electron oxidation,
202
 
promote the formation of reactive radical intermediates and electron transfer reactions.   
 The samples were incubated at 37 °C, and the resulting spectral changes were recorded 
periodically at room temperature.  In the presence of MPO/H2O2/Cl
−
, Figure. 3.4a and b show 
decreases in absorbance of DOX at 495 nm and the S11 region (900–1100 nm) of ox-SWCNT. 
The absorption profile of the residual peaks near 950 nm changed significantly.   Likewise, the 
NIR absorbance of PL-PEG/ox-SWCNT (no drug) decreased (Figure 3.4c), indicating that the 
nanotube surface coated with the PL-PEG had also undergone oxidative degradation, as 
demonstrated by TEM (Figure 3.4d–i).  This result is in good agreement with previous 
degradation studies of PEG-SWCNTs that were noncovalently functionalized with PEGs of 
various molecular weights (ca. 600–10 000 Da).95,121   
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Figure 3.4  MPO-catalyzed oxidative degradation under pH 7.4 at 37 °C. (a) Change in DOX absorbance (495 nm) 
and (b) S11 band (900–1100 nm) before and after 48 h. (c) Degradation of PL-PEG/ox-SWCNT under the same 
condition.  (d)–(i) TEM images of the degraded PL-PEG/ox-SWCNT over (d) 0 h, (e) and (f) 24 h, (g) 48 h, (h) 72 
h, and (i) 96 h.
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 The dramatically different NIR absorption profiles over the course of degradation (Figure 
3.4b) suggest that the altered energy band gaps of the nanotubes possibly resulted from changes 
in the electronic structures and functional groups of the nanotube sidewall and ends.  The 
oxidation of the drug carrier may disrupt the π–π stacking of DOX and initiate dissociations of 
the drug molecules from the CNT surface.  This observation further raises the concern that the 
drug molecules could be released in an untimely manner during circulation.  However, the 
relatively small change in the DOX absorption at 495 nm (Figure 3.4a) compared to free DOX 
(Figure 3.5a) indicates that most drug molecules still remained intact during the oxidation 
process.  In the presence of MPO/H2O2/Cl
−
, free DOX degraded about four times faster than 
DOX of the drug conjugate (Figure 3.5b), which suggests that the nanocarrier may serve as a 
scavenger for the strong oxidant (
−
OCl) and reactive intermediate species generated from the 
MPO cycle.  Because phenolic derivatives are especially good reducing substrates for conversion 
of MPO-I into MPO-II,
100
 ox-SWCNT carrier containing hydroxyl groups can facilitate 
competing reactions with DOX.  Interestingly, except for the free DOX under the MPO-
catalyzed oxidation, the drug molecules in all other samples degraded relatively evenly, 
considering that the error bars slightly overlap with one another.  These similar degradation 
patterns in the nonenzymatic oxidative conditions for both free DOX and DOX-SWCNT samples 
indicate that DOX is unstable to some extent and may undergo pH-dependent degradation in the 
pH 7.4 buffer at 37 °C.    
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Figure 3.5  MPO-catalyzed oxidative Degradation of free DOX and DOX-SWCNT. (a) Decreasing absorbance of 
free DOX over 20 h. (b) Degradation of DOX (free DOX vs. DOX-SWCNT) under four different conditions of (±) 
MPO/(±) H2O2. The error bars indicate the means ± SD of three replicate measurements.
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 We propose the major chemical transformations of DOX in Figure 3.6, where 1 is likely 
to undergo radical reactions due to the hydroquinone (B-ring) adjacent to the electrophilic 
quinone (C-ring) moieties.  The one-electron oxidation generates 2 (semiquinone (O
•−
) of B-
ring), and 3 can be formed through multiple steps by electron transfer and radical rearrangement 
on the carbons of A- and B-ring in the presence of excess H2O or 
−
OH.
203
  We attributed this 
result to pH-dependent degradation resulting from keto–enol tautomerization upon deprotonation 
at C14 of 1, followed by deacetylation and deglycosylation.
204
  Our analyses with 
1
H NMR and 
LC/MS confirmed the formation of 4 (Figure 3.12–3.14).   
 Other possible degradation products and competing reactions are listed in Figure 3.6.  
HOCl produced from MPO/H2O2/Clˉ can induce both oxidation and chlorination of DOX.  The 
hydroxyl groups undergo conversion into carbonyl groups of 6,
205
 and the primary amine group 
are chlorinated selectively in 7.
206
  Simultaneously, compound 11 can be formed from phenolic 
 79 
(ArOH) groups of ox-SWCNTs.  If CNTs contain dangling bonds terminated with –C=C–,123 
compound 12 may provide another competing reaction with DOX.  Compounds 8 and 9 were 
previously identified in MPO/H2O2/NO2ˉ, in which nitrite, a strong oxidant (or cofactor), 
promotes reduction of the hydroquinone moiety of the B-ring.
207
  However, this pathway seems 
to less likely occur in our MPO/H2O2/Cl
−
 system.  Compound 3 is a known metabolite resulting 
from cleavage of the daunosamine by hydrolysis although the mechanism has not been well 
understood.
208
  However, 3 was not found in the control experiment.  In the case of in vivo 
experiments, we may see different degradation pathways.  Compounds 3 and 5 can be formed 
under reductive cellular environments.  Enzymes such as NADPH-cytochrome P450 reductase 
and flavoenzymes initiate conversion of the quinone of DOX to a semiquinone (1-electron 
reduction) or hydroquinone (2-electron reduction).
209
  Compound 5 is formed by conversion of 
the ketone to an alcohol in ring A.  Compound 3 is associated with various pathways, including 
electron transfer and quinone methide formation.
210
  No matter how the reduction proceeds, 
DOX will eventually cleave the daunosamine, and a new bond is formed with nucleophiles, 
electrophiles, or radicals besides the hydroxyl group at C7 depending on the degradation 
pathway. 
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Figure 3.6  Degradation products of DOX possibly formed in the MPO-catalyzed oxidative and the control 
(nonoxidative) conditions. ox-SWCNT and possible products upon reaction with HOCl.
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3.4.2.2 Peroxynitrite-mediated degradation 
In the analysis of peroxynitrite-mediated oxidation, we utilized fluorescence emission 
spectroscopy to investigate the stability of DOX-SWCNT because the absorption band of the by-
product overlapped with that of free DOX (Figure 3.15).  The drug conjugate was incubated in 
phosphate buffer (0.1 M, pH 7.4) at 37 °C.  Peroxynitrite (ONOO
−
) was generated in situ by the 
reaction of superoxide radicals (O2
•−) with nitric oxide (•NO) as shown in Figure 3.7a.  Xanthine 
oxidase (XO) catalyzes the oxidation of xanthine and produces superoxide radicals; N3-(2-
hydroxy-2-nitroso-1-propylhydrazino)-1-propanamine (PAPA NONOate) serves as a nitric oxide 
donor.  Peroxynitrite randomly diffuses through biological compartments and directly oxidizes 
SWCNTs.  Similarly, HOCl produced during MPO catalytic cycle can permeate through the 
PEG-coated nanotubes, resulting in the stripping of PEG and biodegradation.
95
   
As in the MPO-catalyzed oxidation, the drug conjugate (DOX-SWCNT) shows a smaller 
change of DOX emission intensity than that of free DOX (Figure 3.7b).  It appears that the 
nanocarrier protects the drug molecules from the strong oxidant peroxynitrite (ONOO
−
). The 
TEM images and the NIR band profiles of degrading ox-SWCNT/PL-PEG (Figure 3.7c–f and 
Figure 3.15) demonstrate that the nanocarrier was subject to structural transformation, where 
peroxynitrite (ONOO
−
) can promote (1) direct nucleophilic reactions and (2) one- or two-
electron transfer oxidations.
119
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Figure 3.7 Peroxynitrite-mediated degradation. (a) Formation of peroxynitrite (b) peroxynitrite-mediated 
degradation of free DOX vs. DOX-SWCNT in phosphate buffer (0.1 M, pH 7.4) at 37 °C.  The error bars indicate 
the means ± SD of three replicate measurements.  (c)–(g)TEM images of peroxynitrite-mediated degradation in 
phosphate buffer (0.1M, pH 7.4) of PL-PEG/ox-SWCNT over (c) 0 h, (d) 24 h, (e) 48 h, (f) 72 h, and (g) 96 h.
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3.4.2.3 Binding interactions with myeloperoxidase 
Peroxynitrite randomly diffuses through biological compartments and directly oxidizes 
SWCNTs.  Similarly, HOCl produced during the MPO catalytic cycle can permeate through the 
PEG-coated nanotubes, resulting in the stripping of PEG and biodegradation.
95
  However, MPO 
recognizes ox-SWCNT first, which is an electrostatically driven and selective process.
119
  Once 
highly cationic MPO is positioned in close proximity to ox-SWCNT (mostly present as SWCNT-
COO
−
 under pH 7.4), oxidation of the nanotubes occurs in the vicinity of the bound enzyme. 
Because the surface charge of DOX-SWCNT is different from that of ox-SWCNT due to the 
functionalization with PL-PEG and DOX, we further implemented zeta potential analysis to 
characterize the surface charge of each functionalization and find the effective concentration 
range of MPO that can bind with the drug conjugate (Fig. 3.8).    
 PL-PEG and DOX reduced the negative charge effect of ox-SWCNT in the synthesis of 
DOX-SWCNT, as indicated in the zeta potential change from −48.3 mV to −14.2 mV (Table 
3.1), which could further delay the MPO-catalyzed oxidation.  To analyze the threshold binding 
ratio of MPO to DOX-SWCNT, we performed zeta potential titration by gradually adding MPO 
to a DOX-SWCNT solution.  It appears that the binding of MPO became saturated near 0.18 wt 
equiv.  We chose 0.13 wt equiv (lower than the threshold value) for our degradation experiment, 
which probably resulted in the effective enzymatic oxidation with the drug conjugate.  The fact 
that the addition of PL-PEG did not completely prevent the binding with MPO is interesting 
although, according to the literature,
176
 some PEGs could reduce the nonspecific interaction with 
MPO under certain circumstances. 
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Figure 3.8  Zeta potential titration of the DOX-SWCNT with MPO at pH 7.4.  Data are means ± SD of five replicate 
measurements. 
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Table 3.1  Zeta potential changes upon sequential addition of each component at pH 7.4. 
 
 
 
 
 
Sample Zeta Potential (mV) 
ox-SWCNT -48.3 ± 1.6 
PL-PEG/ox-SWCNT -34.3 ± 1.1 
DOX/PL-PEG/ox-SWCNT 
(DOX-SWCNT) 
-14.2 ± 2.0 
Free DOX +9.2 ± 1.2 
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3.4.3 In vitro study of Doxorubicin nanoconjugate in myeloid cells 
To investigate whether cellular MPO- and peroxynitrite-mediated pathways may exhibit 
differential biodegradation activity towards free DOX and nanotube-bound DOX, we cocultured 
fluorescent dye labeled B16 melanoma cells with each of the DOX samples in the presence of 
bone marrow-derived, tumor-activated, myeloid-derived suppressor cell (MDSC) known to 
express high levels of MPO and iNOS.
211
  This method indicates that both MPO- and 
peroxynitrite-mediated oxidative biodegradation pathways are active in these cells.  Importantly, 
both MPO and iNOS expression are essential for the immune-suppressive function of MDSC 
during growth of the tumor in the host.
212
  After 24 h, DOX-induced apoptosis was assessed in 
B16 melanoma cells by Annexin V binding.  Figure 3.9a demonstrates the results of a 
representative flow cytometry analysis, and Figure 3.9b shows the summary results from the 
triplicated experiments.  As expected, free DOX in moderate pharmacological dose of 5 μM 
increased the level of tumor cell death up to two-fold (p < 0.01) whereas DOX-SWCNT was 
significantly more potent and caused an up to six-fold increase of apoptosis (p < 0.01).  The 
concentrations of DOX released from the nanotubes in the cell medium remained constant (about 
1 μM) over 24 h whereas free DOX concentrations were three times higher than DOX-SWCNT 
initially and then dropped by about 50% after 24 h (Figure 3.16).  However, direct comparison of 
a cytotoxic effect of free DOX or nanotube-bound DOX is not appropriate in cell cultures due to 
the differences in concentrations and dynamics of DOX degradation.  Important to note is the 
fact that the addition of MDSC significantly abolished the cytotoxic effect of free DOX, but not 
nanotube-bound DOX, suggesting that the nanotube-bound cytotoxic drug exhibits a stronger 
antitumor potential in the in vitro model of the tumor microenvironment than the free 
chemotherapeutic agent.  As shown in Figure 3.9, the absence of the cytotoxic effects in all 
 86 
additional control groups (PL-PEG/ox-SWCNT, MDSC alone, and MDSC + ox-SWCNT/PL-
PEG) supports this conclusion. 
The effects of free DOX and DOX-SWCNT on tumor cells in the presence of tumor-
activated MDSC was confirmed using another tumor cell line –3LL Lewis lung carcinoma, 
where tumor cell proliferation was determined.  As shown in Figure 3.18, both free DOX and 
DOX-SWCNT decreased the number of 3LL cells in cultures up to two-fold (p < 0.01).  
However, addition of MDSC abolished the cytostatic/cytotoxic effect of free DOX but not DOX-
SWCNT, suggesting that nanotube-bound DOX exhibits a significantly stronger antitumor 
potential than free DOX in the presence of tumor-activated MDSC expressing high levels of 
MPO and iNOS. 
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Figure 3.9  Cytotoxic effects of free DOX vs. DOX-SWCNT in B16 melanoma cells and bone marrow-derived, 
tumor-activated MDSC. DOX-SWCNT but not free DOX induces significant apoptosis of B16 melanoma cells even 
in the presence of MDSC.  B16 melanoma cells and bone marrow-derived, tumor-activated MDSC were generated 
and cocultured in the presence of free DOX or DOX-SWCNT.  PL-PEG/ox-SWCNT served as a control. The level 
of tumor cell apoptosis was determined 24 h later by Annexin V binding.  All cell cultures were set in triplicates, 
and results are shown as representative flow cytometry dot plots in (a) and the mean ± SEM (standard error of the 
mean) (N = 3) in (b). *, p < 0.01 versus control (medium) group (one way ANOVA).
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3.5 CONCLUSION 
We have demonstrated a degradable carbon nanotube-drug conjugate (DOX-SWCNT) by MPO-
catalyzed and peroxynitrite-mediated oxidations. The degradation behavior of free DOX was 
analyzed in comparison to DOX-SWCNT under the same conditions, which allowed us to 
evaluate the effect of the nanotube carrier on the stability of DOX towards the oxidative 
reactions by enzymatic systems of innate immune cells—particularly neutrophils and 
macrophages.  In both of the oxidative conditions, the drug molecules (DOX-SWCNT) degraded 
more slowly than free DOX.  Our in vitro study also suggests that the chemotherapeutic agent 
delivered by the nanocarrier may be protected from the enzymatic inactivation associated with 
myeloid cells in the tumor microenvironment while exhibiting a constant DOX release rate. 
However, DOX demonstrated pH-dependent degradation in the nonoxidative conditions, and the 
nanotube carrier seems to be ineffective in slowing down this degradation process.  Optimizing 
the balance between the degradation and resistance of the drug carrier and the payload towards 
the oxidants generated by inflammatory cells is critical to meet the needs for safety and 
prolonged circulation while orchestrating the stability and therapeutic effect of the drug.  This 
strategy opens opportunities for exploring new parameters in biodegradation and developing 
controllable degradation properties by chemical modification of the surface of nanotubes. 
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3.6 SUPPORTING INFORMATION 
3.6.1 Material and instrumental  
All UV-Vis-NIR spectra were acquired using a Lambda 900 spectrophotometer (PerkinElmer).  
Fluorescent spectra were taken using a Horiba Jovin Yobin Fluoromax 3.  A reverse-phase 
LC/MS (LC/MS-2020 Shimadzu) equipped with a Phenomenex C18 column and a photodiode 
array (PDA) detector was utilized.  NMR spectra were acquired on a Bruker Avance III 400MHz 
NMR.  Chemical shifts were reported in ppm (δ) relative to residual solvent peaks (DMSO-d6 = 
2.50 ppm for 
1
H).  Coupling constants (J) were reported in Hz. C18 column chromatography was 
performed on a C18-reversed phase silica gel purchased from Sigma-Aldrich. 
 
3.6.2 Characterization of drug loading 
3.6.2.1 UV-Vis titration 
The maximum binding ratio of DOX to PL-PEG/ox-SWCNT was determined from the fitting 
curve. When the value of ΔA (ΔA = Abound DOX – AfreeDOX) reaches the maximum, the binding of 
DOX to the nanotube is saturated, in which the wt equiv value (x) of the maximum is 0.964. 
Therefore, a 1:1 weight ratio of DOX to PL-PEG/ox-SWCNT was obtained from the fitting 
equation below. 
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Figure 3.10  UV-Vis titration of PL-PEG/ox-SWCNT with DOX. The fitting curve was found using SigmaPlot 
11.0.  Parameters were obtained from the fitting curve.
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3.6.2.2 Zeta potential titration  
A solution of PL-PEG/ox-SWCNT in nanopure water (0.2 mg/mL) was prepared, and a 3 mL of 
the aliquot was transferred to a 20 mL scintillation vial.  Then the varying amount of DOX 
solution in water (1.3 mg/mL) was added to the vial.  After 30 min of sonication, the zeta 
potential of the solution mixture was measured with a dynamic light scattering detector.  Using a 
graphical linear fitting curve near the saturation point at y-axis (0 mV), the corresponding wt 
equiv value was estimated.  Approximately at 1.12 equiv, the zeta potential remains constant.  
Here, a 1.1:1 binding ratio of DOX to PL-PEG/ox-SWCNT was found.  The graphical linear fit 
was obtained by OriginPro 8.5. 
 
 
 
 
 
 
 
 
 
Figure 3.11  Zeta potential titration of PL-PEG/ox-SWCNT with DOX.
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3.6.3 Identification of degradation products 
3.6.3.1 1H NMR analysis 
In order to collect a large amount of sample for analysis, the weight and volume of each 
Doxorubicin solution was scaled up by 48 times while maintaining the same concentration used 
in the UV-Vis-NIR experiments. After incubation, the water in the samples was removed using 
SpeedVac over 6.5 h.  The collected solid contained Doxorubicin degradation products and 
phosphate salt.  Using methanol, N,N-dimethylformamide (DMF) and toluene, the collected 
samples were washed thoroughly and dried with a rotary evaporator and then a high vacuum 
pump over 24 h. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12  
1
H NMR spectrum of free DOX (dimethyl sulfoxide-d6, 400 MHz) at 0 h. 
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Figure 3.13  (a) 
1H NMR spectrum of free DOX (−MPO/−H2O2) without purification after 32 h and (b) the aromatic 
proton shift region (δ7.0–8.3) of the same spectrum. The protons of compound 4 were assigned based on a precedent 
analysis
213
 and a predicted NMR data using Advanced Chemistry Development, INC.  (ACS/Labs) Software V11.01 
(©1994–2013 ACD/Labs)173 
Reprinted with permission from Nanoscale 2015, 7 (19), 8689–8694. 
Copyright (2015) Royal Society of Chemistry 
 
 94 
3.6.3.2 LC/MS  
Electro spray ionization (ESI-MS) was used to measure the mass of the degradation products. 
The samples were scanned in both positive and negative modes.  H2O and CH3CN were used as 
eluents. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.14  LC/MS chromatograms and mass spectra of the control sample after 32 h. To remove the phosphate 
salt, these samples were purified with C18 mini-column chromatography. (a) The peak 359.15 (m/z) is an adduct of 
[MW + Na]. (b) The peak of 335 (m/z) is indicative of a negative adduct [MW−H].173 
Reprinted with permission from Nanoscale 2015, 7 (19), 8689–8694. 
Copyright (2015) Royal Society of Chemistry 
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3.6.4 Characterization of peroxynitrite-mediated oxidation  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.15   Peroxynitrite-mediated degradation of free DOX (UV-Vis-NIR). (a) Degradation of free DOX after 48 
h (UV-Vis-NIR).  Absorption increased at 480 nm probably due to the formation of a degradation product with the 
same absorption properties.  (b) NIR absorption spectra of PL-PEG/ox-SWCNT and (c) UV-Vis-NIR absorption 
spectra of DOX-SWCNT.  The spectra were normalized at 862 nm.
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3.6.5 Characterization of drug release  
3.6.5.1 Ex vivo pH-dependent DOX released from SWCNT  
 
 
 
 
 
 
 
 
 
 
Figure 3.16  MDSC were incubated in the medium containing 5 μM solutions of free DOX and DOX-SWCNT 
(with 100% drug loading).  After 25 h, each supernatant of the drug-incubated cell medium was collected by 
centrifugation (10,000 g, 15 min), and the concentration of free DOX was estimated by measuring fluorescence 
emission intensity at 590 nm (λexcitation=488 nm) using standard calibration fit.
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3.6.5.2 DOX released in cell medium 
 
 
 
 
 
 
 
 
 
 
Figure 3.17  The same concentration of DOX-SWCNT (with 100% drug loading) used in the degradation 
experiment was prepared in phosphate buffer (0.1 M, pH 7.4) and acetate buffer (0.1 M, pH 5.5) over 24 h, 
respectively.  The free DOX released from the nanotube carrier was collected by filtration through a 10kD Amicon 
centrifugal filter (11,000 rpm, 10 min), and the concentration of free DOX was measured using UV-Vis at 480 nm. 
The error bars indicate the means ± SD of three replicate measurements.173 
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3.6.6 MDSC abrogated cytotoxic/cytostatic effect of free DOX, but not DOX-SWCNT, on 
3LL cells in vitro 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.18  3LL lung carcinoma cells and bone marrow-derived tumor-activated MDSC were  generated and 
cultured as described in M&M.  Cells were co-cultured for 24 h in the presence of soluble free DOX or DOX-
SWCNT alone or together.  PL-PEG/ox-SWCNT and MDSC+ PL-PEG/ox-SWCNT served as controls.  The 
number of tumor cells was determined by assessing flow cytometry events for 60 sec as described in M&M.  All cell 
cultures were set in triplicates and results are shown as the mean SEM (N=2). *, p<0.01 versus control (medium) 
group (One way ANOVA).
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4.0  SYNTHESIS AND CHARACTERIZATION OF TWO-DIMENSIONAL 
SUPRAMOLECULAR POLYMERS   
4.1 CHAPTER PREFACE 
This study is described in a manuscript entitled Polybenzobisimidazole-Derived Two-
Dimensional Supramolecular Polymer, which was submitted for publication.  Additionally, a 
short application study of a surface catalyst for Fenton-like oxidation is described.  W. Seo 
thanks Damodaran Krishnan Achary for 
13
C CP MAS solid-state NMR analysis and Keith A. 
Werling and Professor Daniel S. Lambrecht Department of Chemistry at the University of 
Pittsburgh for computational modeling.  W. Seo synthesized and characterized the 
supramolecular polymer.  Philip M. Fournier performed SEM analysis; James A. Gaugler and 
Keith L. Carpenter assisted in preparation of monomers.   
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4.2 INTRODUCTION 
Chapter 4 describes the design and synthesis of a novel two-dimensional polymer (2DP).  
Envisioning realization of a 2D semiconducting and chemical sensing material for field effect 
transistor (FET) devices, we designed a novel covalent organic framework COF-Salophen 
consisting of multiple salophen macrocycles (Figure 4.1).  This covalent organic framework 
(COF) can be synthesized by condensation of aromatic monomers bearing aldehyde and amine 
functional groups,
214,215
 which provides an imine linker connecting salophen units and pores of 
two different sizes.  The salophen ligands can serve as a sensing moiety for the detection of 
Co(II) ions,
216
 and the extended π–conjugated system imparts planarity and rigidity, thereby 
providing semiconducting properties to the polymer.
217
 The high surface-to-volume ratio of 2D 
COFs allows for facile electron transfer due to the excellent surface contact with FET chips.
218
 
However, an initial effort for direct condensation of 1 and commercially available 1,2,4,5-
benzenetetramine tetrahydrochloride, the precursor of 2, in the presence of N,N-
diisopropylethylamine failed to provide COF-Salophen.  We also attempted to neutralize 1,2,4,5-
benzenetetramine tetrahydrochloride before polymerization, but found that spontaneous air-
oxidation of an unstable 2 provided 3 under atmospheric conditions.  Despite the conversion into 
the diamine group of 3, we have utilized it as a monomer for polycondensation with 1 to 
investigate whether the product forms a conjugated linear polymer that may possess electrical 
properties.  Interestingly, we have found that a novel supramolecular polymer (SP-PBBI) by self-
assembly of linear polybenzobisimidazole (PBBI) chains in a one-step reaction.  SP-PBBI 
features a regular arrangement of rigid rod-like PBBI chains stabilized by intramolecular 
hydrogen bonding within a planar sheet.  The size of SP-PBBI crystal growth can be tuned by 
employing a nonisothermal condition in the precipitation polymerization process. 
 101 
Liquid-phase exfoliation of as-synthesized, bulk SP-PBBI that is insoluble in most 
organic solvents provides thin layers of the polymer 2DSP-PBBI (thickness of <20 nm).  The 
surface morphology of the polymer is analyzed with liquid-exfoliated samples, based on which 
the supramolecular polymerization of PBBI building units is elucidated.  Titration with cobalt 
chloride (CoCl2) using UV-Vis spectroscopy confirms the presence of bidentate NO pendant 
ligands coordinating with Co(II) and Cu(II).  The Cu(II)/2DSP-PBBI complex is further utilized 
for catalyzing oxidation of highly ordered pyrolytic graphite (HOPG) by a Fenton-like process.  
The resulting defect formation is analyzed with Raman spectroscopy data and AFM micrographs 
of the oxidized HOPG surface.            
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Figure 4.1  Scheme of COF-Salophen and 2DSP-PBBI. Attempted synthesis of COF-Salophen yields a 
supramolecular polymer of polybenzobisimidazole (SP-PBBI) consisting of multiple polycrystalline domains, and 
exfoliation of the bulk SP-PBBI affords a two-dimensional supramolecular polymer (2DSP-PBBI). 
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4.2.1 Two-dimensional polymers  
The importance of two-dimensional graphene-like materials such as 2D polymers (2DPs), 
hexagonal boron nitride, organic/inorganic hybrids and hierarchically ordered various van der 
Waals heterostructures is rapidly recognized.
219-224
  The development of 2D materials will allow 
for exploration of novel properties that can greatly enhance the performance of materials and 
nanodevices.
220
  However, the synthesis of 2D materials, whether by top-down or bottom-up 
approaches, requires high precision at the atomic scale to achieve fine-tuned properties.
219,225
  2D 
materials processing has often encountered a great deal of difficulty translating benchtop 
research into scalable production.
226
   
 A large number of 2DPs have been studied as a new class of emerging materials for the 
last half a decade.
219,227,229
  The current and future applications of 2DPs include FETs, 
supercapacitors,
228
 photovoltaic cells,
215,229
 surface catalysts,
230
 and colorimetric sensing
231
.  
2DPs can be constructed by connecting building units covalently (e.g., COFs) or noncovalently 
(e.g., SPs).
58,219,227,232
   Supramolecular polymers are formed based on geometric preorganization 
generated by noncovalent intermolecular forces existing in the building unit, such as hydrogen 
bonding, π–π stacking, and metal–ligand complexation.233-236  Supramolecular systems provide 
convenient synthetic routes to build complex macromolecular frameworks.
233
  The intrinsically 
dynamic nature is suitable for recyclable, degradable, stimulus-responsive, sensing, and self-
healing materials.
235
  However, reversible noncovalent interactions in supramolecular systems 
could inadvertently be disrupted depending on the external environment and the entire polymer 
can disintegrate.
237
  Metallosupramolecular polymers (MSP) complement properties most 
organic macromolecules lack intrinsically.  A diverse range of metal ions offers great 
applications to optoelectronics, sensing, nanopatterning, and macromolecular catalysts.
235-236
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The properties of metal–polymer complexes can be tuned by employing different metal 
ions/ligands and altering the metal binding site (e.g., in the polymer backbone or in the pendant 
group).
236
   
 Although boronate-based COFs exhibited issues of hydrolysis at ambient conditions, 
COFs have been conceived as a stable alternative to SPs because all building units are secured by 
covalent bonds.
79
  Most COFs have been successfully prepared as polycrystalline materials using 
a few different monomers.
238
  Because as-synthesized COFs are obtained as bulk powders,
239
  
liquid-exfoliation is required in applications to thin films.
231
   However, poor solubility impedes 
the solution-based fabrication of COFs, which is a major obstacle to real world applications.
231
  
The solubility issue also complicates characterization because most instrumental methods require 
macromolecule samples dispersed in solution.  Thus unconventional techniques are utilized in 
determination of size, such as imaging analysis (e.g., AFM, SEM, and TEM) instead of gel 
permeation chromatography (GPC) and MALDI.
218,219
  The optical properties of exfoliated 2DP 
samples may not be the same as bulk samples, and different numbers of 2DP layers may change 
electronic transition in optical absorption spectroscopy.
240
   
  
4.2.2 Synthetic approaches for two-dimensional polymers  
Due to difficulties synthesizing well-ordered polymers on a large lateral scale (up to the size of 1 
m
2
), only a few methods have been available for synthesizing 2DPs.
241
  The most common 
approach is thermodynamically controlled polymerization under reversible reaction 
conditions.
227,239
  The polymerization continues until insoluble polymers form precipitates.  Slow 
polycondensation under solvothermal conditions, which proceeds at high temperature, typically 
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>100 °C, has been a standard procedure for COF synthesis.
239
  The continuous bond formation–
cleavage under equilibrium allows an error-correction mechanism while slowly driving the 
reaction to completion by removing water.
242-243
  Yaghi and coworkers hypothesized that a 
sparingly soluble monomer in the reaction solvent could control the diffusion of the building 
blocks and facilitate crystallite formation in the course of the condensation while sustaining the 
reversible reaction promoted by H2O in a completely sealed vessel at 120 °C.
244
  Although the 
nucleation process of COF crystallites has not been fully understood, most COFs have been 
synthesized under similar solvothermal conditions for 3–7 d, mostly at 120 °C with a few 
exceptions.
241
      
A similar synthetic approach is found in supramolecular polymerization.  Many examples 
of SPs have characteristics similar to step growth polymerization which usually yields polymers 
with high polydispersity indices.
235
  Two major growth mechanisms of supramolecular 
polymerization are (1) isodesmic and (2) cooperative growth (Figure 4.2a), analogous to 
kinetically and thermodynamically controlled reaction pathways (Figure 4.2b).
235,245
  Isodesmic 
polymerization maintains the same reactive site at the end of polymer chain and the polymer 
grows as monomers add to the reactive site.
237
  The polymerization of cooperative model initially 
proceeds isodesmically (nucleation, binding constant Kn), and then undergoes another isodesmic 
process with a different binding constant (elongation, binding constant Ke).
245
  The cooperative 
effect arises from the binding constant Ke, higher than Kn.
237
    
To control the shape, size, and stability of SPs, new strategies for controllable 
supramolecular polymerization have been introduced.
235
  One of them is living supramolecular 
polymerization which lowers the energy barrier of the initiation step and promotes chain growth-
like polymerization in the nucleation–elongation process.235  Sugiyasu and Takeuchi et al. 
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demonstrated an intricate reversible reaction pathway that converts kinetically formed porphyrin-
based aggregates into thermodynamically formed SP chains above the critical temperature, 
providing a narrow polydispersity index of 1.1.
245
        
   
 
 
 
 
 
 
 
 
Figure 4.2  Mechanistic models of supramolecular polymerization. (a) Illustration of two growth mechanisms, 
isodesmic and cooperative supramolecular polymerizations. (b) Energy pathways determined in supramolecular 
polymerization of a porphyrin-based monomer.
235
  
Reprinted with permission from Chem. Rev. 2015, 115 (15), 7196–7239. 
Copyright (2015) American Chemical Society 
 
 
4.2.3 Polybenzimidazole-based polymers 
Polybenzimidazoles (PBI) are aromatic heterocyclic high-performance polymers commercially 
used as heat-resistant materials.
246
  PBI can be synthesized with condensation of an amine and a 
carbonyl group (e.g., carboxylic acid,
247
 ester,
248
 or aldehyde
249
).  Polymerization occurs at high 
temperatures (100–350 °C) and a by-product such as H2O or ROH is driven out of the system 
during the reaction.
246
  The aromaticity and planar conformation of molecular chains impart 
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thermal stability, mechanical strength, and chemical resistance to the polymer.
250
  The rigid rod 
structure of crystalline PBI decomposes only with strong acids.
250
  Some PBI-based polymers 
bearing hydroxyl groups on the benzene ring can promote intramolecular hydrogen bonding of 
OH···N=C on the backbone, reinforcing the rigidity of PBI chain.
251
  Most commercial PBIs 
were successfully fabricated into spun fibers, but other shapes such as ribbon- and needle-like 
crystals were observed when prepared with different reaction solvents.
250
  Fiber XRD analysis of 
poly(pyridobisimidazole) (PIPD), a PBBI analogue with good mechanical strength (Figure 4.3), 
showed that PIPD could possess two possible crystal structures.
252-253
  The triclinic structure was 
preferred based on the ab initio total energy and molecular dynamics calculations, featuring a 
sheet-like structure.
252
  However, studies of PBI-based polymers have reported neither a two-
dimensional morphology nor supramolecular polymerization of PBI.
253-255
   
 
 
 
 
 
 
Figure 4.3  Monoclinic (left) and triclinic (right) structures of PIPD. Hydrogen bonds are indicated as dashed 
lines.
252
 
Reprinted with permission from Polymer 2005, 46, 9144–9154. 
Copyright (2005) Elsevier 
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4.3 EXPERIMENTAL 
4.3.1 Synthesis of SP-PBBI and 2DSP-PBBI  
Monomers 1 and 3 were synthesized as described in Ch. 4.6 Supporting Information.  A solution 
of 1 (6.0 mg, 0.04 mmol) and 3 (3.3 mg, 0.02 mmol) in N,N-dimethylformamide (1 mL) was 
prepared in a 25 mL round bottom flask.  The solution of the monomers was degassed by two 
freeze–pump–thaw cycles and was sealed with a septum and PTFE tape.  After sonication for 5 
min, the reaction mixture was kept at 95 °C (for 2 d) in an oil bath without stirring at 100 °C for 
1 d.  After raising the temperature to 145°C, the reaction was left undisturbed for 3 d.  After total 
6 d, the reaction flask was cooled to room temperature for 2 h, and the crude polymer was 
washed with dichloromethane (4 × 15 mL) and methanol (4 × 15 mL) over a Millipore filter and 
a 200 nm fluorophore filter membrane.  After drying in vacuo for 48 h over 100 °C, 2DSP–PBBI 
was obtained as a dark brown solid (89 %). 
13
C CP MAS solid-state NMR (15 kHz) δ ppm, 
198.6, 150.0, 147.0, 138.2, 129.9, 121.3, 119.0, 116.5, 99.0.  IR (KBr, ATR) 3327, 1641, 1440, 
1394, 1302, 1152, 839 cm
−1
.   
 Exfoliation was performed in a 100 mL round bottom flask containing dry SP-PBBI (2.0 
mg) and anhydrous DMF (12 mL) with gentle stirring for 24 h at 60 °C.     
 
4.3.2 Instrumentation 
Fourier transform infrared spectroscopy (FTIR) was performed using an IR-Prestige 
spectrophotometer (Shimadzu Scientific) outfitted with an EasiDiff accessory (Pike 
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Technologies).  Solid samples were ground with KBr to prepare a homogenous mixture.  
13
C CP 
MAS spectroscopy was performed on a Bruker Avance spectrometer (500 MHz).  Powder X-ray 
diffraction (PXRD) was recorded on a Bruker X8 Prospector Ultra equipped with a Bruker Smart 
Apex CCD diffractometer and a copper micro-focus X-ray source employing Cu Kα radiation at 
40 kV, 40 mA.  A ground sample was loaded in a capillary tube (D: 1 mm) for analysis.  The size 
and the morphology of materials were analyzed with transmission electron microscope (FEI-
Morgani, 80 keV).  TEM samples were prepared by drop-casting 3.5 µL of a sample onto a lacey 
carbon films/400 mesh copper grid and dried under ambient conditions over 24 h.  An Asylum 
MFP-3D atomic force microscope (AFM) was utilized with high resolution probes (Hi’Res-
C14/Cr-Au) purchased from MikroMasch.  AFM samples were prepared by deposition of 10 µL 
of an exfoliated solution onto freshly cleaved mica.  The sample was spin coated and then 
allowed to dry under ambient conditions over 24 h.  UV-Vis-NIR spectra were acquired using a 
Lambda 900 spectrophotometer (PerkinElmer).  Scanning Electron Microscopy (SEM) was 
performed with FEI XL-30 (20 keV).  The computational molecular structure optimizations were 
performed at the B3LYP/6-31g(d) level with Q-Chem software packages.
256-257
  A fine 
integration grid and stricter self-consistent-field and integral thresholds were utilized.   
 
4.3.3 Titration of metal–polybenzobisimidazole complexation  
A supernatant containing relatively well-suspended polymer flakes was collected from the 
exfoliated solution of 2DSP-PBBI for the spectroscopy measurements.  A 5.3 mM CoCl2 
solution was prepared in DMF, and 5 µL was delivered to an exfoliated polymer solution (600 
µL) for each titration at ambient conditions.  The optical change of 2DSP-PBBI solution was 
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measured using UV-Vis absorption spectroscopy immediately after each addition of CoCl2.  The 
exfoliated 2DSP-PBBI solution was also titrated with CuSO4 using the same protocol.  A Cu(II) 
solution (2.0 mM) was prepared with CuSO4∙5H2O and DMF for serial addition of 30 μL to an 
exfoliated 2DSP-PBBI solution (625 μL).  An estimated weight of the polymer in 625 μL was 
about 36 μg.    
 
4.3.4 Fabrication of porous graphene by Fenton-like oxidation 
HOPG flakes (0.5 mm × 0.5 mm) were mechanically cleaved with a razor.  The surface was 
mechanically exfoliated with cellophane tape to smoothen the HOPG surface.  Each flake was 
cleaned with CH2Cl2, acetone, DI water, and acetone sequentially.  The flake was dried over a 
hot plate at 50 °C for 24 h.  An exfoliated 2DSP–PBBI solution (625 uL) in DMF was gently 
mixed with Cu(II) (2 mM, 390 μL) at room temperature based on the titration experiment data. 
The cleaned HOPG flakes were placed on a glass slide and the aliquot of Cu(II)/2DSP–PBBI 
solution was drop-cast on the HOPG flake (20 μL).  After 6 h, the solution was applied to the 
other side of HOPG flakes and the samples were allowed to dry for 12 h at 50 °C.  
A polymer-deposited HOPG flake was placed in a 1 dram vial containing 0.2 mL of 
acetonitrile or a mixture of acetonitrile: pH 5.0 buffer (1:1, v/v).  A 20 μL of H2O2 solution 30% 
(w/w) was added, followed by gentle shaking for 30 sec, and the capped vial was placed in a 
sand bath at 65 °C.  The same amount of H2O2 solution was replenished at every 6 h (20 μL per 
addition).  For UV-activated photo-Fenton reactions, a quartz cuvette (3.5 mm × 12.5 mm × 45 
mm) was used to store the HOPG sample in the biphasic solution at room temperature and was 
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held ∼20 cm from a UV lamp (Blak-Ray B100AP, 100-W long wave UV, which produces 
fluorescence with a ballasted bulb). 
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4.4 RESULTS AND DISCUSSION 
4.4.1 Characterization of SP-PBBI 
In an attempt to perform imine condensation under neutral conditions, 1,2,4,5-benzenetetramine 
tetrahydrochloride was treated under a basic condition in air prior to polymerization.  However, 
rapid conversion of 2 to 3 led to polycondensation of 2,3-dihydroxybenzene-1,4-dicarbaldehyde 
1 and 3,6-diimino-1,4-cyclohexadiene-1,4-diamine 3 in N,N-dimethylformamide (DMF) at 95–
145 °C.  An aprotic polar solvent DMF was employed to completely solubilize both 1 and 3, 
thereby initiating precipitate polymerization in a homogenous solution.  DMF may also have 
facilitated π–π stacking due to the enhanced solvophobic effect and self-assembled 
macromolecular structures.
258-259
  Condensation of 1 and 3 allowed formation of two imine bonds 
and subsequent cyclization to a benzobisimidazole (PBBI) moiety.  To confirm the formation of 
benzobisimidazole from the diamino diene 3, a model compound 4 was prepared with 
salicylaldehyde and 3 under the same nonisothermal condition (Figure 4.10 and 4.12c–e).  The 
reaction afforded a brown powder of as-synthesized SP-PBBI in 89% yield, exhibiting 
insolubility in water and most common organic solvents at room temperature.  The sufficiently 
long reaction time (total 6 d) was crucial to high polymer conversions whereas reactions 
performed less than 3 d formed the precipitated product in much lower conversions.   
The FTIR spectrum (Figure 4.4a) of SP-PBBI confirms the formation of an imine (C=N) 
stretching at 1641 cm
−1
 in the polymer sample while peaks characteristic to the monomers such 
as the aldehyde C–H stretching (2866 and 2769 cm−1) of 1 and primary amine N–H stretching 
(3444 and 3417 cm
−1
) of 3 are clearly absent (Figure 4.11b–c).  The relatively high frequency of 
an imine stretching can be observed due to the highly rigid conformation arising from the cyclic 
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imine of benzobisimidazole and a strong intramolecular hydrogen bond occurring between the 
hydroxyl hydrogen and the imino nitrogen (OH···N=C)
260-262
 although a different hydrogen 
bonding motif (HO···H–N) was proposed in addition to the former by x-ray crystal structure 
analysis of PIPD.
251,253
  The distinct O–H stretching peak at 3321 cm−1 can be used as a marker 
for predicting the crystallinity of the polymer.  Also, the shift in O–H stretching by about 40 
cm
−1
 from the monomer 1 and a higher intensity suggest that a strong intramolecular hydrogen 
bond is present.
260
  When a less crystalline polymer sample was analyzed, only a broad O–H 
stretching was observed in the region between 3100 and 3400 cm
−1
 (Figure 4.11d).  The structure 
of the polymer was further confirmed by 
13
C cross-polarization magic-angle spinning (CP MAS) 
solid-state nuclear magnetic resonance (NMR) spectrum (Figure 4.4b).  The characteristic 
phenolic (C1) and cyclic imino (C2) carbons resonate at δ = 150.0 and 147.0 ppm respectively, 
and the resonance at δ = 129.2 ppm was attributed to C3 connecting the benzobisimidazole 
moiety.
261-262
  In the case of the less crystalline polymer sample, a weak resonance of downfield 
carbon was present at δ = 175.6 ppm, most likely a carbonyl carbon (C=O) resulting from the 
keto–enamine tautomerization (Figure 4.12a).   
 
 
 
 
 
 
 
 
Figure 4.4  Characterization of SP-PBBI using (a) FTIR and (b) 
13
C CP MAS solid state NMR. 
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To support the evidence of a periodic structure with well-defined crystalline parameters, 
powder X-ray diffraction (PXRD) was implemented.  As shown in the experimental PXRD 
spectrum (Figure 4.5a), d spacing values corresponding to the well-defined peaks were found 
(16.67, 8.43, 6.33, 5.86, and 3.31 Å), based on which a two-dimensional unit cell model (a and b 
axes) was proposed (Figure 4.5b).  To construct a periodic alignment of the PBBI chains, we 
referred to the structural analyses of PIPD that is very similar to PBBI except for the position of 
one hydroxyl group and the pyridine moiety.
251-253
   Based on the bond lengths and unit cell 
(either monoclinic or triclinic) data of PIPD provided by two different groups, we indexed a = 
16.67 Å and b = 6.63 Å for SP–PBBI parameters (Figure 4.5b).  These lattice parameters are 
very different from those of the COF-Salophen estimated at the B3LYP/6-31g(d) level (Figure 
4.5c). We reason that the interlayer spacing (c axis) is 3.31 Å (Figure 4.5d), which is within van 
der Waals contact distances arising from the π–π stacking of aromatic rings and comparable to 
previously synthesized arene-based polymers.
263
  Due to limited structural information gleaned 
from the powder diffraction data, the analysis of angles between unit cell parameters was not 
proposed.
253
    Thermogravimetric analysis (TGA) showed a weight loss of 10% around 330 °C 
and a slow decomposition of 20% up to approximately 400 °C (Figure 4.14).   
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Figure 4.5  Characterization of SP-PBBI. (a) Experimental PXRD spectra. (b) Proposed two-dimensional structures 
(ab plane) and optimization of the unit cell parameters calculated by B3LYP/6-31g(d) level (a = 16.13 Å) for SP-
PBBI, which is close to 16.67 Å of an experimental PXRD d spacing value. (c)  Unit cell parameters (a = 23.55 Å, b 
= 25.69 Å) of COF-Salophen. (d) Stacking distance (c = 3.31 Å) between the layers of SP-PBBI obtained from 
PXRD.    
 
 
 
4.4.2 Surface morphology of 2DSP-PBBI  
The morphology and the size of 2DSP-PBBI were investigated using TEM and noncontact-mode 
AFM shown in Figure 4.6a–e.  Both bulk SP-PBBI and exfoliated 2DSP-PBBI samples exhibit a 
planar morphology consisting of mostly stacked platelets (Figure 4.6a).  We confirmed the 
supramolecular polymerization process with SP-PBBI samples that were sonicated or manually 
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ground from 5 to 30 min in MeOH.  It appears that large planar sheets were disintegrated into 
small rods under the mechanical forces, probably due to weakened intermolecular bonds (Figure 
4.15a).  The planar configuration and rigidity arise from the individual PBBI chain capable of 
arranging in a quasi-aromatic six-membered chelate ring induced by intramolecular hydrogen 
bonding between the imino nitrogen and the o-hydroxyl group enolimine (OH···N=C).
251,254,264
  
Once linear PBBI backbones are formed and ready for self-preorganization, the secondary amine 
(NH), the imine (N=C), and 1,2-dihydroxyphenyl (OH) groups of PBBI provide intermolecular 
hydrogen bonding motifs for promoting self-assembly and the resulting formation of SP.  Each 
2DSP-PBBI layer consists of multiple crystallites aligned in various orientations, as indicated in 
the presence of moiré fringes shown in two different directions  (Figure 4.6b).
265
  A 100 nm-
lateral resolution AFM image also confirms the polycrystalline grain boundaries (Figure 4.6e).  
2DSP-PBBI also vertically grows into a 3D bulk (i.e., the formation of SP-PBBI), mainly driven 
by π–π stacking existing between the aromatic PBBI backbones.  Thus most as-synthesized 
samples were multiple stacks strongly held by each 2DSP-PBBI layer and poorly soluble in any 
solvents at room temperature.  However, we were successfully able to exfoliate bulk SP-PBBI in 
DMF at 60 °C.  After 2 h-exfoliation, mostly small molecular weight and amorphous-like flakes 
were visible under TEM, but larger flakes were slowly delaminated into thin layers (<30 layers) 
within 4–6 d (Figure 4.6c and 4.15c).  The height distribution of exfoliated layers analyzed by 
AFM ranges from 0.4 to 8.6 nm, equivalent to ca. 1–25 layers of the polymer in the sample 
(Figure 4.6d and e).     
Large polymer sheets up to 0.1–10 μm in lateral dimension were observed under both 
TEM (Figure 4.6a and 4.15b) and AFM (Figure 4.16a).  Given that cooperative supramolecular 
polymerization is based on the two-step mechanism of (1) nucleation and (2) elongation,
235
 the 
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formation of the large SP-PBBI seems reasonable.  The size of as-synthesized SP-PBBI was 
dependent on temperature control.  We tested it by initiating the reaction at 95 °C and 
completing it at 145 °C.  The SP-PBBI crystals grew in larger sheets if the temperature was 
gradually raised in multiple stages.  Precipitation polymerization involves monomers that are 
initially soluble in the reaction solvent, and the locus of polymerization remains in a 
homogeneous solution until the growing macromolecular network reaches the critical molecular 
weight for precipitation.
266
  We reason that slow diffusion of building blocks and formation of 
dynamic intermolecular bonds under the gradual increments of temperature (95–145 °C) would 
furnish slow nucleation and growth of structurally well-defined, large polymer crystallites (ca. 
>1 μm) over an extended period of time.  Notably, the growth rate of polymer layer postulated 
from the morphology of 2DSP-PBBI suggests that cooperative interchain hydrogen bonding was 
more effective in the elongation of polymer sheet than the interlayer π–π stacking under the 
given reaction condition (i.e., rateab–axis >> ratec–axis).  To further verify the temperature effect, a 
different reaction batch was stored at a constant temperature of 145 °C throughout the entire 
polymerization.  Interestingly, the isothermal condition resulted in the same PXRD pattern as 
that of the nonisothermally treated sample, but yielded much smaller and more monodisperse 
polymer flakes (Figure 4.7a).  To see the effect of temperature and solvent in supramolecular 
polymerization, we attempted a higher temperature increment (T1 = 95 °C, T2 = 170 °C) in a 
mixture of dimethylsulfoxide/mesitylene (10:1) for 6 d.  The reaction yielded a significantly 
different crystalline polymer PBBI-170 (see FTIR, 
13
C CP MAS solid-state NMR, and PXRD in 
Figure 4.11e, 4.12b, and 4.13, respectively).  PBBI-170 was hardly exfoliated in most organic 
solvents even after 7 d, and only small rod fragments were isolated, probably delaminated at the 
early stage of exfoliation (Figure 4.7b).   
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Figure 4.6  TEM (a–c) and AFM (d, e) micrographs of 2DSP-PBBI. (a) A large flake 2DSP-PBBI showing the 
stacked edges seen through multiple layers (1 d-exfoliation). (b) Moiré fringes marked in the red circle is indicative 
of high crystallinity.  (c) 4 d-exfoliation. (d) A height of 2.5 nm of exfoliated 2DSP-PBBI on mica and its height 
profile (below). (e) Grain boundaries of a polycrystalline sample show the height profile of 6–12 nm (below) in a 
100 nm lateral dimension. 
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Figure 4.7  TEM micrographs of (a) PBBI-2 and (b) PBBI-170. 
 
 
4.4.3 Optical properties of 2DSP-PBBI  
We investigated the optical properties of the exfoliated 2DSP-PBBI using UV-Vis absorption 
spectroscopy.  The absorption spectrum of 2DSP-PBBI exhibits a broad band with a maximum at 
381 nm and minor peaks at 274 nm and at 461 nm, clearly different from the absorption bands of 
compound 1 and 3 (Figure 4.17).  Each PBBI chain possesses bidentate pendant NO ligands, 
capable of forming complexation with Co(II), Cu(II), and Zn(II) ions (Figure 4.8a).
267-269 
 To 
confirm the complexation of NO–Co(II), titration of exfoliated 2DSP-PBBI in DMF was 
performed with cobalt(II) chloride (CoCl2).  Upon serial addition of a 5.2 mM CoCl2 aliquot to 
the polymer solution, the absorbance at 381 nm progressively decreases, indicative of the metal–
ligand complexation (Figure 4.8b).  The titration spectra also show a successively increasing 
absorption band at 609 and 674 nm with the addition of Co(II).  The inset of Figure 4.8b shows 
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the saturation point of NO–Co(II) complexation, based on which a 1.2:1 binding stoichiometry 
of Co(II) to the NO ligand was estimated.  The CoCl2 solution in DMF showed absorption bands 
at 609 and 674 nm, typical of pseudotetrahedral complexes of Co(II),
270
 and the wavelength of 
these bands did not change during the titration of 2DSP-PBBI.  This result indicates that ligand 
exchange between the NO and Cl
−
/DMF occurred while maintaining the pseudotetrahedral 
geometry in the CoCl2 solution (Figure 4.8c).
271
  After titration of 2DSP-PBBI with Co(II), the 
polymer sample was analyzed by SEM imaging, showing that the planar sheet-like shape 
remained intact.   
To test the realization of conjugated 2DSP-PBBI as a semiconducting material, the 
energy band gap was estimated from emission/excitation spectroscopy (Figure 4.18a).
272
  From 
the excitation (at 382 nm) and emission (at 512 nm) spectra, an energy band gap of 1.08 eV was 
calculated, indicating that exfoliated 2DSP-PBBI is semiconducting.  Having designed a 
semiconducting sensing material, we performed drop-casting of an exfoliated 2DSP-PBBI 
sample on a chip, but no significant conductance was observed in FET–IV curves (Figure 4.18b).   
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Figure 4.8  Titration of 2DSP-PBBI with Co(II). (a) Complexation between Co(II) ions and the bidentate ligands 
(NO) on the PBBI backbone (b) UV-Vis absorption spectra of an exfoliated 2DSP-PBBI solution in DMF upon 
addition of a 5.2 mM of CoCl2 prepared in DMF. The arrows indicate the direction of absorbance change with 
increasing concentration of Co(II).  Inset: Absorbance at 381 nm.  Instrumental artifacts at 319 and 378 nm. (c) A 
sample of exfoliated 2DSP-PBBI solution titrated with CoCl2 was deposited on a copper foil and dried at room 
temperature for SEM analysis.   
 
 
4.4.4 Cu(II)-PBBI complexation and Fenton-like catalyst 
A titration experiment with CuSO4 confirmed the formation of Cu(II)/2DSP-PBBI complex with 
2DSP-PBBI.  Based on the titration result, a Fenton-like catalyst was prepared with the 
Cu(II)/2DSP-PBBI and the 2D metallosupramolecular polymer was employed as a surface 
catalyst for oxidation of highly ordered pyrolytic graphite (HOPG).  Generally Fe(II)/Fe(III) has 
 122 
shown better catalytic activity for Fenton or Fenton-like reactions, but titration of 2DSP-PBBI 
with Fe(II) or Fe(III) did not show a binding pattern between the polymer and either of iron ions.    
 As shown in eq.(1), the Fenton-like system activated from Cu(II) with H2O2  has also 
been demonstrated as effective as Fe(II)/Fe(III)-based systems.
127
  Although reaction (1) is 
slower than (2), Cu(I) can generate a strong oxidant hydroxyl radical in (2); Cu(II) also directly 
oxidizes good reducing organic substrates, especially aromatic compounds (3).    
 
  Cu(II) + H2O2 → Cu(I) + HO2• + H
+ 
    (1) 
  Cu(I) + H2O2 → Cu(II) + HO• + HO
− 
   (2) 
  Cu(II) + Ar–H  → Cu(I) + H+ + Ar•    (3) 
 
Based on the oxidation condition optimized in a previous study using the Cu(II)/Cu(I) 
catalytic system,
127,129
 the oxidative degradation of HOPG was studied.  As the Cu(II)/Cu(I) 
catalyst is active in a broader pH range (4.0–7.0) compared to Fe(III)/Fe(II) (pH 2–3.5),127 the 
oxidation of HOPG was performed at pH 5.0.  After the Cu(II)/2DSP-PBBI catalyst was washed 
sequentially with base–acid and DMF/acetone, the defect density of the HOPG sample was 
analyzed with Raman spectroscopy.  Figure 4.9a shows that the ID/IG ratio increases in a H2O2 
dose-dependent manner.  Also, the UV-activated photo-Fenton-like system was more effective 
than the sample heated at 65 °C with the same amount of H2O2 addition.  TEM (Figure 4.9b) and 
AFM micrographs (Figure 4.9c–e) of the oxidized HOPG surfaces show defects in contrast to the 
pristine sample.   
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Figure 4.9  Fenton-like catalytic system of Cu(II)/Cu(I) and the oxidative degradation of HOPG using the 
Cu(II)/2DSP-PBBI catalyst.  (a) D/G ratios by Raman spectroscopy. (b) TEM image of oxidized HOPG (total 160 
μL addition of H2O2) under UV light. (c)–(e) AFM height micrographs of (c) pristine HOPG, (d) oxidized HOPG 
(total 160 μL addition of H2O2) at 65 °C,  and (e) oxidized HOPG (total 160 μL addition of H2O2) under UV light. 
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4.5 CONCLUSION 
We were able to develop a strategy for the one-step synthesis of 2DSP-PBBI by precipitation 
polymerization.  The slow crystallite growth and precipitation under controlled conditions 
allowed formation of well-defined 2DSP-PBBI, and the lateral dimension of <10 μm was 
achieved by the nonisothermally controlled reaction temperature.  PBBI building blocks were 
laterally grown into large self-assembled planar 2DSP sheets primarily by interchain hydrogen 
bonding.  Also, π–π stacking facilitated formation of an orderly stacked architecture from 
individual 2DSP sheets.  Liquid-exfoliation of the as-synthesized SP-PBBI polymer provided 
planar sheets of 2DSP-PBBI up to submicrometer lateral widths and nanometer heights.  In 
addition, the complexation with Cu(II) was confirmed by the Cu(II)/2DSP-PBBI catalyst for the 
Fenton-like oxidation of HOPG.  Despite some concerns regarding the susceptibility to 
mechanical forces, we anticipate that simple dropcast of exfoliated 2DSP-PBBI will provide 
convenient means for building various 2D heterostructures enabling cost-effective, scalable 
production. 
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4.6 SUPPORTING INFORMATION 
4.6.1 General and instrumentation 
Graphene oxide was purchased from Graphene Supermarket. All other chemicals were obtained 
from Sigma Aldrich and used without further purification.  All reaction solvents were anhydrous 
reagent graded. Silica gel for column chromatography was obtained from Selecto Scientific. Thin 
layer chromatography was performed on Merck TLC plates pre-coated with silica gel 60 F254.  
Visualization of the developed plates was performed by fluorescence quenching or by ninhydrin 
and phosphomolybdic acid (PMA) stain.   
 Emission and excitation spectra were recorded on a Horiba Jobin Yvon Nanolog 
fluorescence spectrophotometer equipped with a 450 W Xe lamp and double excitation/emission 
monochromators. Scanning Electron Microscopy (SEM) and SEM-EDS was performed with 
JEOL JSM-6510LV/LGS and an EDS detector equipped with Oxford X-Max large area SDD 
detector with INCA microanalysis system, INCAEnergy.  Thermogravimetric analysis (TGA) 
was conducted on a TGA Q500 thermal analysis system.  
1
H NMR spectra were recorded on a 
Bruker (400 MHz) and were internally referenced to residual protio solvent signals (TMS) at δ 
0.00 ppm (1H).  
13
C CP MAS spectra were recorded on a Bruker Avance spectrometer (500 
MHz).  Data were reported as chemical shift (δ ppm) and multiplicity (s = singlet, d = doublet, t 
= triplet, q = quartet, qn = quintet, m = multiplet, br = broad), integration, and coupling constant 
(J) in Hz.  Mass spectra were acquired on Q-Exactive, Thermo Scientific. 
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4.6.2 Synthesis 
Synthesis of monomer 2,3-dihydroxybenzene-1,4-dicarbaldehyde (1).  Compound 1 was 
prepared by the two-step synthesis based on literature procedures.
273  
To improve the purity, the 
crude product was vigorously stirred in 15% sodium thiosulfate solution with addition of 
dichloromethane for 6 h.  The organic layer was dried over Mg2SO4 and filtered, and then the 
solvent was dried in vacuo. Purification through silica gel flash chromatography 
(dichloromethane : methanol : acetic acid = 98:1:1) and further recrystallization from 100% 
hexanes afforded 83% yield of 1 as a yellow solid.  mp 100–101 °C. 1H NMR (400 MHz, CDCl3, 
δ) 7.28 (s, 2H), 10.03 (s, 2H), 10.91 (s, 2H). 13C NMR (125 MHz, CDCl3, δ) 196.3, 150.9, 123.2, 
122.2.  IR (KBr, ATR) 3371, 3051, 2866, 1654, 1562, 721 cm
−1
.  HRMS (Multimode-ESI/APCI) 
calc’d for  C8H6O4 [MH]
+
 = 167.08335; found 167.08245. 
Preparation of monomer 3,6-diimino-1,4-cyclohexadiene-1,4-diamine (3). 1,2,4,5-
Benzenetetramine tetrahydrochloride (1.0 g, 3.5 mmol) and Cs2CO3 (4.0 g, 12.3 mmol) 
suspended in MeOH (150 mL) was stirred at room temperature under air for 2 h.
274
  The 
precipitated solid was washed with cold ethanol and then boiling methanol.  The crude product 
was purified by soxhlet extraction using ethyl acetate as an extraction solvent for 2 d.  
Compound 3 was obtained as a dark brown solid (recovery: 63%). 
1
H NMR (400 MHz, DMSO-
d6, δ) 9.35 (s, 1H), 5.77 (s, 2H), 5.42 (s, 1H). 
13
C NMR (125 MHz, DMSO-d6, δ) 158.9, 148.4, 
97.5.  IR (KBr, ATR) 3444, 3417, 3286, 3244, 1631, 1446, 1346, 1280, 875 cm
−1
.  HRMS 
(Multimode-ESI/APCI) calc’d for  C6H8N4 [MH]
+
=137.0822; found 137.0812.   
Synthesis of SP-PBBI-LC.  To a solution of compound 1 (6.0 mg, 0.04 mmol) and 
1,2,3,4-tetrafluorobenzene (5.4 mg, 0.04 mmol) in N,N-dimethylformamide (1 mL) was added 
compound 3 (3.3 mg, 0.02 mmol) in a pyrex tube (OD: 1 mm, H: 18 cm) and degassed by two 
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freeze–pump–thaw cycles.  The reaction mixture was stored under the nonisothermal condition 
as described in the synthesis of SP-PBBI.  The tube was flame-sealed using a propane torch after 
two freeze–pump–thaw cycles.  Then the reaction was left undisturbed in a convection oven at 
95–145 °C for 6 d. 13C CP/MAS solid-state NMR (15 kHz, δ) 198.6, 175.6, 164.7, 150.0, 147.0, 
138.4, 130.1, 119.1, 116.5, 98.8.   IR (KBr, ATR). 3325–3118 (br), 2931, 1641, 1558, 1531, 
1390, 1300, 1249, 1219, 1153, 1060, 833 cm
−1
. 
Synthesis of PBBI-170.  A solution of 1 (12.0 mg, 0.072 mmol) and 3 (6.65 mg, 0.05 
mmol) in a mixture of dimethylsulfoxide (2 mL) and mesitylene (0.2 mL) was prepared in a 25 
mL round bottom flask fitted with a Dean–Stark apparatus and a reflux condenser under N2. The 
solution was heated as described in the synthesis of PBBI except for 170 °C as the final 
temperature.  The crude product was washed with dichloromethane and methanol, followed by 
drying in vacuo for 72 h over 100 °C heat.  PBBI-170 was obtained as a black solid (78 %).  
13
C 
CP/MAS NMR (10 kHz, δ) 175.9, 150.6, 129.1, 97.8.  IR (KBr, ATR) 3560–3360 (br), 2920, 
2854, 1693, 1600, 1535, 1435, 1249, 1195, 1161, 1118, 1041, 948 cm
−1
.   
Synthesis of a small molecule model compound (4).  Salicylaldehyde (0.12 g, 1.0 
mmol) and 3,6-diimino-1,4-cyclohexadiene-1,4-diamine 3 (34 mg, 0.25 mmol) were suspended 
in N,N-dimethylformamide (12 mL).  Using the same nonisothermal temperature control 
described in the SP-PBBI synthesis, the reaction mixture was heated over 3 d.  The crude product 
was triturated with hot acetone to give light dull yellow precipitates of compound 4 (65 mg, 0.19 
mmol, 77% yield). 
1
H NMR (400 MHz, DMSO-d6, δ) 13.28 (d, 2H), 13.17 (d, 2H), 8.10 (br, 
2H), 8.03 (br, 1H), 7.87 (s,1H), 7.67 (s,1H), 7.41 (t, 2H), 7.04–7.08 (dd, 4H). 13C NMR (125 
MHz, DMSO-d6, δ) 158.6, 132.2, 126.6, 119.6, 117.7, 113.2.  HRMS (Multimode-ESI/APCI) 
calc’d for C20H15O2N4 [MH]
+
=343.1190; found 343.1170. 
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Figure 4.10  Synthetic scheme of model compound 4. 
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4.6.3 FTIR spectra 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11  FTIR spectra of (a) SP-PBBI, (b) and (c) monomers (compound 1 and 3), (d) a less crystalline SP-
PBBI-LC sample, and (e) PBBI-170. 
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4.6.4 NMR Spectra 
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Figure 4.12  
13
C CP MAS solid state NMR spectra of (a) less crystalline SP-PBBI-LC and (b) PBBI-170. (c) and (d) 
1
H NMR spectra of model compound 4. (e) 
13
C NMR spectrum of model compound 4. 
 
 
4.6.5 PXRD 
 
 
 
 
Figure 4.13  PXRD of PBBI-170.  2θ (°) found: 3.80, 16.68, 28.92, 33.46. d spacing (Å) calc’d: 23.22, 5.31, 3.09, 
2.68. 
e
 133 
4.6.6 TGA analysis 
 
 
 
 
 
 
 
Figure 4.14  TGA trace of SP-PBBI.  The data was acquired up to 650 °C with a 5 °C/min ramp. 
 
4.6.7 TEM micrographs of SP-PBBI and 2DSP-PBBI 
 
 
 
 
 
Figure 4.15  (a) 10 min-manual grinding in methanol, (b) 9 d-exfoliation, and (c) 2 d-exfoliation of a SP-PBBI 
sample in DMF. 
 
 
  
40
50
60
70
80
90
100
0 100 200 300 400 500 600 700
W
e
ig
h
t 
lo
s
s
 (
%
)
T ( C)
 134 
4.6.8 AFM micrographs and height profiles 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.16  AFM microographs of 2DSP-PBBI. (a) Top-down surface and (b) stacked profile of bulk SP-PBBI 
samples. (c) Exfoliated 2DSP-PBBI samples on mica and their height profiles.  
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4.6.9 UV-Vis spectra for 2DSP-PBBI and monomers (compound 1 and 3) 
 
 
 
 
 
 
 
 
Figure 4.17  UV-Vis absorption spectra of 2DSP-PBBI and the monomers in DMF. 
 
4.6.10 Energy band gap of 2DSP-PBBI and conductance 
 
 
 
 
 
 
 
Figure 4.18  (a) Emission (582 nm) and excitation (382 nm) spectra of 2 d-exfoliated 2DSP-PBBI.  Conductance 
measurement of 2DSP-PBBI. (b) Conductance measurement of 2DSP-PBBI. 
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5.0  COVALENT ORGANIC FRAMEWORKS AS SURFACE CATALYSTS FOR 
FABRICATING PATTERNED GRAPHENE   
5.1 CHAPTER PREFACE 
A communication entitled Fabrication of Holey Graphene: Catalytic Oxidation by a 
Metalloporphyrin–Based Covalent Organic Framework Immobilized on Highly Ordered 
Pyrolytic Graphite was prepared based on this project described in Chapter 5 and submitted to 
Chem. Commun.              
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5.2 INTRODUCTION 
General properties of covalent organic frameworks (COFs) and some aspects of solution-phase 
synthetic strategies were described in Chapter 4 within the context of 2DP synthesis.  Chapter 5 
focuses on metallated COFs as macromolecular surface catalysts, and discusses an effective 
chemical approach to the preparation of nanopatterned graphene using catalytic oxidation.  The 
surface morphology and chemical transformation of the patterned surface are analyzed with 
respect to fabrication processes such as deposition methods of COF films on graphite.    
     Our strategy for developing a new type of nanopatterning employs a bifunctional 
metallated COF which serves as a surface catalyst and a master template for creating holes on the 
graphite surface that is subsequently exfoliated into multilayers of patterned graphene.  This 
novel concept of copy–print process eliminates the need of preparing graphene–template 
superlattices on a solid support, and ultimately allows for scalable production of patterned 
graphene.  The metalloporphyrin units covalently connected in a large polymer matrix are 
immobilized on the graphite surface.  The network of the metal–ligand catalyst maintains the 
catalytic center and reactive site for oxidation at the interface of catalyst–substrate.  Once the 
catalytic oxidation is complete, the COF layer is chemically removed and the patterned graphite 
is exfoliated into a few layers of graphene.   
 Inspired by the studies of peroxidase-catalyzed oxidative biodegradation of carbon 
nanomaterials
90, 99, 110
 and the use of synthetic Fe(III) porphyrin catalysts for oxidation of 
polycyclic aromatic hydrocarbons (PAHs),
275-276
 we develop an catalytic oxidative method of 
patterning holes on the basal plane of graphite using a synthetic Fe(III) porphyrin COF as a 
catalyst–template.  The catalytic oxidation is initiated with oxidant(s) (e.g., H2O2, NaOCl) and 
porous graphene is prepared on the highly ordered pyrolytic graphite (HOPG) surface.  
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Figure 5.1  Illustration of fabricating porous graphene with Fe-DhaTph-COF catalyst deposited on HOPG and 
exfoliation of the patterned bulk graphite.   
 
5.2.1 Metallated covalent organic frameworks  
COFs can serve as excellent molecular platforms for high catalyst loadings and catalytic 
activities due to porosity and large surface-to-volume ratios.
277-278
  Good thermal stability and 
resistance against swelling in solvents are advantageous for developing sustainable catalysts 
which can be easily separated from products and recycled.
268
   A vast range of chemical 
modifications can be realized by employing different building blocks and linkers (or monomers), 
allowing for convenient tuning of electronic and redox properties.
278
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 Catalytic functionalities are directly incorporated into the macromolecular framework, 
either in the main framework or in sidechains, providing dense catalytically reactive sites for 
chemical conversions.
277
  Laterally, catalytic centers are homogeneously distributed; vertically, 
pore networks create molecular channels that facilitate mass transfer.
277
  The easy accessibility to 
catalytically reactive sites on the substrate through porous networks can raise the effective 
concentration of reactants near the interface of catalyst–substrate and accelerate chemical 
reactions.
268
  Studies demonstrated that the catalytic activity of a highly ordered, conjugated 
metalloporphyrin COF was higher than that of a linear polymer or a metal coordinated small 
porphyrin unit.
280
  Metallated COFs can be prepared using two different methods (Figure 5.2): 
(1) co-ordination of metal ions with COF ligands, and (2) physical adsorption of metal NPs with 
different sizes onto COF layers.
281
  Thus, NPs can be less stable and less recyclable over multiple 
catalytic cycles of reactions.  In contrast, metal-COF complexation allows the metal ion catalytic 
center to be securely anchored. 
 In nanopatterning of porous graphene, metal-coordinated COFs provide unique 
advantages: (1) the regular arrangement of the repeating catalytic centers enables precise 
localization of chemical reactions, (2) hole periodicity (the center-to-center distance between two 
neighboring holes) can be conveniently controlled by reticular synthesis with different spacers or 
linkers, (3) COFs can be directly grown on solid substrates such as graphite and metals, 
simplifying the cumbersome pre-patterning step for template deposition, and (4) COF ligands 
can prevent aggregation of metal ions resulting from metal leaching and Fe(III) dimerization 
initiated by hydrolysis in aqueous environments and thus generate relatively uniform hole sizes 
in contrast to metal or metal oxide NPs.  
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Figure 5.2  Metallated COF catalysts. (a) AuNPs are randomly adsorbed to the COF network.
281
 (b) Metal ions are 
incorporated into the porphyrin COF building unit by forming metal–ligand complexes and regularly positioned.278   
Ref. 281.  Reprinted with permission from Chem. Commun. 2014, 50 (24), 3169–3172. 
Copyright (2014) Royal Society of Chemistry. 
Ref. 278.  Reprinted with permission from Science 2015, 349 (6253), 1208–1213. 
Copyright (2015) The American Association for the Advancement of Science. 
 
 
5.2.2 On-surface synthesis of covalent organic frameworks  
The preparation of uniform COF thin films on solid substrates is important to achieve good 
catalytic performance.  The deposited COF catalyst should homogenously coat solid substrates in 
both lateral and vertical directions, so that well-aligned catalytic functional moieties can 
efficiently promote reactions on selective sites.  To this end, different bottom-up synthetic 
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strategies are required as most COF powders synthesized under solvothermal conditions are 
obtained as bulk materials.
282
  To precisely control the position of catalytic functional moieties, 
direct synthesis (or growth) of COF films on the solid surface may improve film orientation.
282-
283
  Such thin composite architectures have been constructed by drop-cast of monomers on the 
solid support,
279
 followed by polymerization under desired conditions.
284
  The temperature range 
of on-surface COF synthesis varies significantly with the polymerization method.
84
  
Occasionally, an additional high-temperature annealing step is performed to remove water 
formed during polymerization, particularly polycondensation, and to increase the crystalline 
domain size.
282
  For graphene/graphite substrates, aromatic species are good molecular surface 
assembly units.    Cooperative  π–π stacking can enhance the adhesion strength of COFs bearing 
multiple aromatic rings onto graphene, as corroborated by the superior stability of a tripod 
pyrene anchor to that of a single pyrene molecule on graphene.
285
  To assemble organic 
precursors for the formation of well-defined surface architectures, high diffusion energy barriers 
should be overcome.
286
  Finding the thermal activation energy for on-surface reactions is crucial 
because thermally activated decomposition and desorption of precursors are competing with the 
polymerization process.
286
   
 Examples of direct COF synthesis include scanning tunneling microscopy (STM) tip-
induced polymerization, solid vaporization under ultrahigh vacuum (UHV) conditions,
284,287-288
 
electropolymerization, and solvothermal polymerization.
288
  Although thin films prepared by 
solid vaporization have successfully shown the monolayer coverage of well-ordered COF 
structures on metal surfaces with the lateral growth of 10–40 nm, the process requires highly 
controlled environments and is impractical in regards to scalable fabrication.  Dichtel and 
coworkers demonstrated multilayers of a boronate-based COF (COF-5) polymerized on graphene 
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using a solvothermal approach (Figure 5.3).
84
  The film thickness range of 75–195 nm deposited 
on graphene with different solid supports (Cu, SiO2, and SiC) and a lateral grain size of 46 nm 
were observed.
84
   The most significant discovery of this study is that COF films can form in a 
gas tight glass vessel at 90 °C under atmospheric conditions within 0.5–8 h.84  The same research 
group reported an oriented thin film of an anthraquinone-based COF directly grown on Au 
electrodes for the fabrication of a supercapacitance.  The COF synthesis proceeded by slow 
introduction of a monomer into the reaction mixture already deposited on the Au surface at 90 
°C.
283
   
 Generally, the bottom-up approach simplifies processing time but is challenging to 
optimize reaction conditions, and the surface quality of substrates can greatly affect film growth.  
Post-synthesis involves separate steps of exfoliation and deposition (e.g., dip and spin coating, 
drop-casting), and is more applicable to the scalable production of polymer films on graphene.  
However, the uniform alignment of COFs can be disrupted during the deposition process, which 
could lose desired material performance.      
 
 
 
 
 
 
 
Figure 5.3  COF-5 grown on graphene. Solvothermal condensation of HHTP and PBBA in the presence of a 
substrate-supported single layer graphene surface provides COF-5 as both a film on graphene and a powder.
84
 
Reprinted with permission from Science 2011, 332 (6026), 228–231. 
Copyright (2011) The American Association for the Advancement of Science 
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5.2.3 Fabrication of porous graphene  
Porous graphene comprises single- or few-layer graphene, an important substrate for 
nanoelectronics.
289
  The fabrication of porous graphene (i.e., holey graphene,
117,290-291
 graphene 
nanomesh,
292-294
 graphene foam
295-296
) began mainly for modification of the intrinsic zero energy 
bandgap of semimetallic graphene.
32,292
  Recently, porous graphene-based gas separation 
membranes have been developed, which exhibit high separation capacity and good mechanical 
properties.
297-299
  A high-density array of nanoscale holes in large graphene sheets imparts 
semiconducting characteristics that are lacking in pristine graphene.
32,293
  The energy band gap 
can be tuned by controlling the neck width between pores, the size and shape of pores, and the 
pore lattice symmetry.
291,293
   Edges of periodic or quasi-periodic holes facilitate faster electron 
transport and higher electrocatalytic activity.
293
  With high field transport efficiency and on–off 
ratios, porous graphene has shown great promise for high-performance FET devices and 
bio/chemical sensing.
293
   
 A variety of fabrication methods have been reported, including chemical (e.g., KOH,
300
 
HNO3 oxidation,
301
 and catalytic oxidation
117,126,302
) and physical etching (e.g., photo-, electron 
beam, oxygen plasma, and ion irradiation).
289,294
  Top-down nanolithography, such as block 
copolymer lithography,
292
 self-assembled monolayers of colloidal nano- and microspheres,
32
 and 
photocatalytic patterning,
302
 provides patterned graphene with high resolution.
289
  Most 
lithography processes involve graphene mounted on a solid support before patterning, so that 
isolation of free standing patterned graphene is unnecessary (Figure 5.4a).
293
  Lithographic 
patterning affords the pore size range from meso (2–50 nm) to microscale (<2 nm),293 but have 
issues of high cost and low throughput.
303
  A few approaches including metal NPs as hard 
templates under high temperatures (>500 °C) or using aggressive chemicals such as HF were 
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reported, but these conditions are not ideal for industrial applications (Figure 5.4b).
303
  Non-
lithographic methods using catalysts or reagents in solution are environmentally benign and may 
be more applicable in industry, but isolation and transfer of free standing graphene sheets 
without creating wrinkles is extremely difficult.
126,301
  In addition, the generation of regular holey 
structures on selective sites is almost impossible given the current advancement of the 
technique.
290,301
  Future directions for pattering graphene/graphite should aim at developing 
simple synthetic routes that are environmentally benign and industrially applicable.   
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4  Patterned porous graphene. (a) Block copolymer lithography. Pristine graphene is covered by a thin 
layer of evaporated SiOx (protecting layer) and a spin-coated block copolymer poly(styrene block-methyl 
methacrylate). After annealing, the porous polystyrene (PS) matrix is formed as a template. Fluoride-based reactive 
ion etching (RIE) reveals the SiOx hard mask. Etching graphene by O2 plasma and HF dip cleaning provides 
graphene nanomesh. TEM images below show a periodicity of 39 nm and a neck width of 7.1 nm (left) and a 
periodicity of 27 nm and a neck width of 9.3 nm (right) prepared by the different MWs  (77 kDa and 48 kDa, 
respectively) of block copolymer.
292
 (b) Uneven sizes of holes on graphene by catalytic air oxidation with AgNPs.
125
  
Ref. 292.  Reprinted with permission from Nat. Nanotechnol. 2010, 5 (3), 190–194. 
Copyright (2010) Nature Publishing Group. 
Ref. 125.  Reprinted with permission from Nanoscale 2013, 5 (17), 7814–7824. 
Copyright (2013) Royal Society of Chemistry.  
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5.3 EXPERIMENTAL 
5.3.1 Synthesis and characterization of Fe-DpaTph-COF 
Iron(III)-tetrakis(4-aminophenyl)porphyrin chloride (Fe-TAP-Cl) was prepared with iron(II) 
chloride tetrahydrate (FeCl2∙4H2O) and 5,10,15,20-tetrakis(4-aminophenyl)porphyrin.
304
  The 
isolated 2 (8 mg, 0.01 mmol) and 2,3-dihydroxybenzene-1,4-dicarbaldehyde (3.4 mg, 0.02 
mmol) were transferred to a glass tube (OD: 1 mm, H: 18 cm) dispersed in dimethylacetamide 
(DMA) (1.5 mL) and 1,2-dichlorobenzene (0.1 mL).  After the starting compounds were 
completely dissolved, 6.0 M acetic acid (0.2 mL) was added to the reaction mixture and 
sonicated for 1 min, which precipitated out some of the starting compounds.   The reaction tube 
was degassed by three freeze-pump-thaw cycles at 77 K (liquid N2) and brought to room 
temperature for flame seal.  Then the tube was stored in a convection oven at 120 °C for 6 d.  
The product was collected after two wash cycles using CH2Cl2 (100 mL) and MeOH (100 mL) 
over a PTFE membrane Millipore filter (0.2 μm) and dry over high vacuum for 24 h (yield, 
76%).  FTIR (KBr, ATR) ῡmax, 3666–2826, 1646, 1617, 1512, 1414, 1347, 1289, 1184, 1068, 
1002, 813, 715, 574.  PXRD, 2θ (°) found: 3.70, 7.08–7.76 (br), 25.8, 44.64. d spacing (Å) 
calc’d: 23.9, 12.5–11.4 (br), 3.45, 2.03 (br, weak).    
 To grow the metallated COF (Fe(III)-DhaTph-COF), about 5–8 pieces of mechanically 
cleaved HOPG (0.5 mm × 0.5 mm) flakes were placed with the reaction mixture in a flame 
sealed test tube.  After 6 d of condensation under the solvothermal condition, Fe-DhaTph-COF-
deposited HOPG flakes were collected.  A black powder of Fe-DhaTph-COF was collected from 
the same reaction batch for further characterization.  The Fe-DhaTph-COF catalyst was also 
prepared by complexation of Fe(III) with DhaTph-COF in a separate post-polymerization step.
304
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DhaTph-COF (2.5 mg) was allowed to stir in NMP (7.0 mL) under N2 at 160 °C for 24 h.  Then 
FeCl2∙4H2O (32 mg, 0.16 mmol) was added to the DhaTph-COF solution and stirred  for 24 h for 
complexation.  After the reaction mixture was cooled to room temperature, the crude product 
was washed with H2O and MeOH over a milipore filter (pore size: 0.2 μm).  A black solid 
powder was collected and dried in vacuo.  A solution of Fe-DhaTph-COF (1.2 mg) was prepared 
in DMF 1.0 mL).  After stirring for 2 h at 80 °C, the metallated COF solution was deposited on 
HOPG flakes by either dip-coating or drop-casting and was allowed to dry over a hot plate at 50 
°C.   
 
5.3.2 Fabrication of porous graphene 
Deposition of Fe-DhaTph-COF. The solution of Fe-DhaTph-COF in post-polymerization 
process was prepared in DMF (1 mg/1 mL).  Mechanically cleaved HOPG flakes were 
sequentially rinsed with DI H2O, ethanol, and hexanes and then dried in a petri dish on a hot 
plate for 24 h at 50 °C.  About 100 μL of the solution was drop-cast on a HOPG flakes on a glass 
slide and dried at 100 °C.  The dip-coating method was performed on clean HOPG flakes that 
were completely immersed in the COF solution with tweezers and were stored for about 12 h.  
Then the flakes were dried over a hot plate in the same fashion.   
 Addition of oxidants.  A dried Fe-DhaTph-COF on HOPG flake was placed in a 1-dram 
vial containing 0.2 mL of acetonitrile or a mixture of acetonitrile: pH 5.0 buffer (1:1, v/v).  A 20 
μL of H2O2 solution 30% (w/w) was added, followed by gentle shaking for 30 sec, and the 
capped vial was placed in a sand bath at 65 °C.  The same amount H2O2 solution was replenished 
at every 6 h (20 μL per addition).  When NaOCl was employed as a co-oxidant, 20 μL of a 
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NaOCl solution (available chlorine 10–15 %) was added after 2 h of the H2O2 addition and kept 
at the same temperature.  When the oxidative patterning was completed, the oxidant-treated COF 
on HOPG was removed by the wash cycle of NaOH (5 M solution), HCl (7M solution), NaOH 
(1 M solution), DI water, and acetone.  The sample was stored in each different solution of the 
acid and the base over 12 h with occasional stirring.  The rinsed HOPG was dried at 50 °C and 
the smooth side of HOPG flake was used for characterization.     
Exfoliation of patterned HOPG flakes with phosphoric acid (H3PO4).  An oxidized 
HOPG flake was transferred to a 1-dram vial and 2 mL of DMF was added to the vial.  After 
bath sonication for 10–30 min, the HOPG suspended DMF solution was collected with a 
disposable pipette and transferred to a new 1-dram vial.  After DMF was dried off at 120 °C, 
concentrated phosphoric acid (0.5 mL) was transferred to the vial containing the small exfoliated 
HOPG particles.  The mixture of HOPG and phosphoric acid was ground with a glass rod and 
heated in air at 125 °C for about 12 h.  Fresh DMF (2 mL) was added to the acid treated HOPG 
and bath sonicated for about 30 min, followed by stirring in total 6 mL of DMF at room 
temperature.        
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5.4 RESULTS AND DISCUSSION 
5.4.1 Characterization of Fe-DhaTph-COF 
On-surface synthesis of DhaTph-COF on HOPG was attempted in a gas-tight vessel under 
atmospheric conditions at 90 °C using the same solvent condition and monomer stoichiometry 
reported in the previous study.
306
 However, there was no sign of COF formation after 4 d based 
on the crude mixture collected from the bottom of the reaction vessel.  Instead, a flame-sealed 
pyrex tube was used, in which HOPG flakes were immersed in the reaction mixture before the 
flame seal.  The COF reaction proceeded in vacuo at 120 °C, and a DhaTph-COF powder and 
COF-deposited HOPG flakes were collected after 6 d.  Under the same condition, the metallated 
porphyrin COF (Fe-DhaTph-COF) was prepared with an amine functionalized metalloporphyrin 
(Fe-TPA-Cl) monomer.  The blue shift in the Soret bands of porphyrin (from 426 to 418 nm) 
shown in the UV–Vis spectra confirms the Fe(III) complexation with the porphyrin monomer 
(Figure 5.9).  FTIR spectra of both DhaTph-COF and Fe-DhaTph-COF show the presence of an 
imine group at 1617 cm
−1
 (Figure 5.11b–d).  The Fe-DhaTph-COFs samples were synthesized by 
different methods: (1) Polymerization with Fe-TPA-Cl, and (2) Polymerization of DhaTph-COF, 
followed by Fe(III)-complexation with DhaTph-COF.  Both the spectra of Fe-TPA-Cl show less 
defined, broad imine peaks and a very distinct O–H stretching at 3666–2826 cm−1 in contrast to 
DhaTph-COF.  The different procedures for synthesizing Fe-DhaTph-COF are further described 
in Ch.5.6.2.   
 The surface characteristics of Fe-DhaTph-COF and DhaTph-COF deposited on HOPG 
were very different. The dark purple layer of DhaTph-COF on HOPG exhibited a much 
smoother surface than dark brown Fe-DhaTph-COF.  AFM micrographs confirm the different 
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surface textures of DhaTph-COF and Fe-DhaTph-COF (Figure 5.5).  The directly grown and 
drop-cast Fe-DhaTph-COF layers exhibit different domain sizes.  The direct growth method 
typically did not yield perfect surface coverage over the area of 0.25 mm
2 
and some areas were 
not evenly coated.  Post-synthetic deposition methods, either drop-casting or dip-coating, 
provided relatively thin, smooth films but large aggregates were visible under AFM (Figure 
5.5c).  Regardless of the synthetic method, the Fe-DhaTph-COF samples had rough, grainy 
surfaces compared to nonmetallated DhaTph-COF.  These different surface morphologies may 
arise from conformational changes of the planar porphyrin ring upon metal complexation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5  AFM micrographs of COF and metallated COFs. (a) DhaTph-COF grown on HOPG, (b) Fe-DhaTph-
COF (drop-cast), (c) Fe-DhaTph-COF (drop-cast), (d) Fe-DhaTph-COF (direct growth). All samples were prepared 
on HOPG substrates.  
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5.4.2 Oxidative conditions for patterning graphite  
As demonstrated in the MPO-catalyzed oxidation where an oxidant such as H2O2 converts 
Fe(III) into a reactive intermediate species Fe(IV=O•) and produces hydroxyl radical,90, 110 we 
hypothesize that synthetic Fe(III)-porphyrin catalysts would oxidize graphite in a similar fashion.  
The oxidative condition was adjusted based on the Fe(III)-catalyzed oxidation of benzene and 
polycyclic aromatic hydrocarbons (PAHs).
275-276
  The use of co-oxidants H2O2/NaOCl with a 
synthetic porphyrin catalyst is unprecedented although the noncatalytic oxidation of organic 
substrates has been reported.
307-308
  Nonetheless, we sought to examine if the role of hypochlorite 
(
−
OCl) formed in situ in the MPO-catalytic cycle would be also applicable to the COF-catalytic 
system.  The catalytic cycle of Fe(III) was activated by addition of H2O2 at every 4 h.  The co-
oxidant system was tested by addition of NaOCl 2 h after the H2O2-activation.  Upon addition of 
NaOCl, it immediately reacted with extra H2O2 remaining in the solution, resulting in vigorous 
formation of oxygen gas that can initiate singlet oxygen-mediated oxidation.
307-308
   
After the metallated COF was removed from the HOPG surface, the morphology of 
HOPG was analyzed by TEM and AFM.  The pristine HOPG sheets exfoliated with H3PO4
309
 do 
not exhibit significant defects (Figure 5.6a, d, and g).  In contrast, the HOPG samples treated 
with oxidants (H2O2/NaOCl) at 65 °C clearly show dense holes on the surface.  Catalytic 
oxidation on the Fe-DhaTph-COF deposited graphite resulted in the formation of continuous 
hole arrays of 4–50 nm in diameter under TEM (Figure 5.6c), consistent with holes of 8–40 nm 
found in the AFM image (Figure 5.6f).  This patterned surface suggests that the Fe(III) ions 
coordinated to the COF were anchored to the graphite surface and facilitated oxidative 
degradation.  Based on the pore size of DhaTph-COF (ca. 2.3 nm) reported in the previous 
study,
306
 the hypothetical hole periodicity can be roughly estimated by measuring the distance 
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between Fe-DhaTph-COF catalytic centers.  The average hole periodicity of 8.3 nm and the 
average neck width (the smallest edge-to-edge distance between two neighboring holes) of 2.0 
nm measured on TEM images were larger than the periodicity of Fe(III) catalytic center (i.e., the 
distance between porphyrin rings).  The elongated shapes suggest that defect formation laterally 
propagated over the nearby graphitic surface.   
 When a pH 5.0 acetate buffer solution was mixed with acetonitrile (1:1, v/v) to examine 
the pH effect on HOCl formation over 
−
OCl, samples exhibited large, random holes (Figure 
5.12a–c and e).  The hole nanoarrays were also created by H2O2-activated oxidation (Figure 
5.12d and f), but a larger amount of oxidant was required to generate a significant holey structure 
than the co-oxidant system.  The co-oxidant system of H2O2/NaOCl is efficient for a short-term 
treatment probably because hypochlorite can induce reactive singlet oxygen-mediated oxidation 
by insertion of peroxy groups (O–O) on the graphitic carbons without a catalyst.  Once sp2 
carbons are substituted with oxygen-containing groups, bond cleavage of C–C can undergo 
readily.
307
  As hypochlorite can serve solely as an effective oxidant under noncatalytic 
conditions, we conducted a control reaction with only hypochlorite (
−
OCl).  However, no 
repeating holey structure was observed, suggesting that the Fe-DhaTph-COF catalytic systems 
were critical to generating site-selectivity for patterning.  To verify our initial hypothesis of Fe-
DhaTph-COF’s bifunctional role of catalyst–template, we investigated the catalytic activity of 
iron(III)-tetrakis(4-aminophenyl)porphyrin chloride (Fe-TAP-Cl) that may be self-assembled 
into nanoaggregates with sufficient surface coverage on HOPG (Figure 5.13).
310-313
  The 
excellent catalytic performance of small porphyrin units noncovalently bound to graphene was 
reported although Fe(III) porphyrin centers were randomly positioned on the graphene surface.
134
  
Nevertheless, the interactions and morphology of metal–ligand complexes were relatively 
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difficult to control in small-molecule catalyst systems.
279
  TEM (Figure 5.6b) and AFM (Figure 
5.6e) images show that Fe-TAP-Cl-catalyzed oxidation generated sparse holes, very different 
from the patterned surface with the metallated COF.  This uneven distribution may suggest poor 
adhesion between HOPG and Fe-TAP-Cl aggregates (Figure 5.13), revealing the dynamic nature 
of association/dissociation when they are in contact with solvents.  It is inconclusive whether 
some large holes observed under AFM resulted from those catalyst aggregates.   
To successfully realize the copy–print concept in the fabrication of multiple holey 
graphene sheets, defect formation needs to propagate vertically and create regular nanochannel 
arrays through several graphitic layers.  AFM height analysis in Figure 5.14 reveals that the 
vertical channel propagated from the top surface is about 1–3 nm (up to ~12 layers of graphene).  
However, the oxidation process appears to have also laterally expanded the defect area on the 
same plane of graphene to some extent, unavoidably generating some large holes.  The lateral 
propagation is more pronounced near the metal catalytic center than the inner graphite.  In 
addition, the irregular shapes might have resulted from the disintegrating COF catalyst under the 
oxidative condition.  Thus the morphologies of Fe-DhaTph-COF deposited on HOPG before and 
after oxidation were analyzed with AFM.  As shown in Figure 5.15, much of the COF catalyst 
remained intact under the oxidative condition.  However, it is unclear if the degradation products 
or intermediate species of graphite that were produced during oxidation reacted with the inner 
COF layer, thereby disrupting the metal catalytic center.    
The number of patterned graphene layers was also estimated from exfoliated samples 
(Figure 5.6g–i).  The exfoliation of the pristine HOPG sample with phosphoric acid was not 
greatly effective.  After an extensive amount of time of sonication (6 h) and stirring (2 d) in 
DMF at room temperature, the pristine HOPG sample afforded graphene sheets of 2–4 nm 
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(Figure 5.6g).  Oxidized samples were easily exfoliated by sonication in 10–30 min, depending 
on the extent of oxidation applied to a sample, and stirring for about 1 d at room temperature.  
Despite the long hours of stirring, a few 2- or 3-layer (<1 nm in height) patterned graphene were 
observed with AFM analysis (Figure 5.6h).  Mostly, the height of exfoliated patterned samples 
was 1–3 nm (Figure 5.6i).  It appears that sonication was more effective in the exfoliation of 
oxidized HOPG than stirring.  Longer sonication times (>total 1 h) were attempted, but reduced 
the size of graphene sheets, which may not be ideal for achieving high surface-volume-ratios.  
Exfoliation should be optimized further and other chemicals besides phosphoric acid should be 
explored to isolate single-layer graphene.      
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Figure 5.6  Micrographs of TEM (a)–(c) and noncontact mode AFM amplitude (d)–(f) and height (g)–(i).  (a) and 
(d) Pristine HOPG. (b) and (e) Oxidized HOPG with Fe-TPA-Cl and H2O2/NaOCl. (c) and (f) Patterned HOPG with 
Fe-DhaTph-COF and H2O2/NaOCl. (g) Exfoliated pristine HOPG (Height: 2.9 nm). (h) and (i) Exfoliated ox- 
HOPG samples with Fe-TPA-Cl and H2O2/NaOCl. (h) Height: 0.73 nm. (i) Height1: 1.2 nm. 
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5.4.3 Characterization of patterned graphite with FTIR and Raman spectroscopy  
Changes in the functional group of HOPG before and after oxidation were analyzed using FTIR.  
The spectra of patterned HOPG and freshly cleaved pristine HOPG samples are almost identical 
(Figure 5.7a).  Generally, IR absorption spectra for HOPG and graphite samples are featureless, 
but the overall band profile of pristine HOPG appears close to those of graphene and graphene 
oxide.
314-315
  The patterned HOPG shows a new peak at 1705 cm
−1
 can be attributed to C=O 
stretching modes due to oxidation.
316
   
Raman spectroscopy was utilized to quantify the number of newly formed sp
3
 defects 
relative to pristine sp
2
 graphitic carbons and characterize the defect type.  Figure 5.7b shows the 
average ID/IG of 0.31 for H2O2/NaOCl-treated samples whereas only a residual peak (1331 cm
−1
) 
is shown in the pristine HOPG spectrum.  The peak width (fwhm) of D′ band at 1607–1635 
cm
−1
, indicative of the formation of vacancy-like defects, appears far more pronounced than 
those of other samples.  The spectrum of the small porphyrin unit (Fe-TAP-Cl)-catalyzed 
oxidation shows a clear indication of sp
3
 defect formation despite the low average ID/IG of 0.15 
and the barely noticeable D′ peak.  The TEM image in Figure 5.6b shows that the self-assembled 
metalloporphyrin (Fe-TAP-Cl) aggregates can catalyze oxidation on the HOPG surface and 
generate vacancy-like defects.  However, the uneven distribution of holes could result in a very 
subtle D′ band.  This inconsistency may be due to the skewing of data from sampling spots 
randomly selected for Raman analysis.  Table 5.1 lists the ID/IG values of the samples catalyzed 
by Fe-DhaTph-COF.  To investigate the difference in catalytic activity between direct growth 
and drop-casting of Fe-DhaTph-COF, the average ID/IG values are compared.  The direct growth 
method has slightly higher ID/IG values (higher degrees of oxidation) than drop-casting for both 
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H2O2 and H2O2/NaOCl systems.  Based on Raman spectroscopic data, both deposition methods 
were effective in oxidatively patterning graphite.      
 
 
 
 
 
 
 
Figure 5.7 (a) ATR-FTIR spectra of HOPG samples before and after oxidation. (b) Raman spectrum of the 
patterned HOPG sample (Fe-DhaTph-COF in the presence of H2O2/NaOCl, total addition 80 μL/80 μL) shows 
distinct D and D′ bands.  The metalloprophyrin (Fe-TAP-Cl)-catalyzed sample shows only sp3-defects at D peak.  
Each of the spectra was normalized to the G peak for ease of comparison.  
 
 
           Table 5.1 Raman ID/IG values of oxidatively patterned HOPG with Fe-DhaTph-COF 
Deposition method 
Oxidant  
(total addition, μL) 
ID/IG 
Drop-casting H2O2 (160) 0.23 
Drop-casting H2O2/NaOCl (80/80) 0.31 
Direct growth H2O2 (160) 0.26 
Direct growth H2O2/NaOCl (80/80) 0.38 
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5.5 CONCLUSION 
We demonstrated a new chemical patterning method of utilizing an Fe(III) prophyrin COF as a 
surface catalyst and a template on HOPG.  Few-layer patterned graphene sheets exhibited holey 
structures after treatment with H2O2 or H2O2/NaOCl.  AFM imaging analysis showed that the 
oxidation process propagated vertically (oxidative perforation 12 layers of graphene), forming 
multiple layers of patterned graphene.  The size and shape of holes varied with the oxidative 
condition and the proximity to the catalytic site.  Metallated COFs can be an effective, robust 
catalyst for creating holes on graphitic carbon network under mild catalytically oxidative 
conditions that can be potentially translated into industrial processes.  The copy-print concept of 
oxidative patterning–exfoliation will allow for facile processing and scalable production of 
patterned holey graphene.  Future studies should focus on tuning the oxidative condition to 
achieve precise, uniform hole morphology.  In addition, exfoliation methods should be improved 
to produce single-layer graphene.    
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5.6 SUPPORTING INFORMATION 
5.6.1 Materials and instrumentation 
Highly ordered pyrolytic graphite (HOPG SPI-1 Grade: #439HP-AB) was purchased from SPI 
Supplies (Westchester, PA).  5,10,15,20-tetrakis(4-aminophenyl)porphyrin was obtained from 
TCI America.  Hydrogen peroxide (30% in solution) was purchased from EMD Chemical.  All 
other chemicals were obtained from Sigma Aldrich and used without further purification.  All 
reaction solvents were anhydrous reagent graded.  Silica gel for column chromatography was 
purchased from Selecto Scientific. Thin layer chromatography was performed on Merck TLC 
plates pre-coated with silica gel 60 F254.  Visualization of the developed plates was performed 
by fluorescence quenching or by phosphomolybdic acid (PMA) stain. 
Fourier Transform spectroscopy (FTIR) was performed using an IR-Prestige 
spectrophotometer (Shimadzu Scientific) outfitted with an EasiDiff accessory (Pike 
Technologies).  Solid samples were ground with KBr to prepare a homogenous mixture. Spectra 
were collected for 32 scans at 2 cm
−1
 resolution. Powder x-ray diffraction (PXRD) was recorded 
on a Bruker X8 Prospector Ultra equipped with a Bruker Smart Apex CCD diffractometer and a 
Copper micro-focus X-ray source employing Cu Kα radiation at 40 kV, 40 mA.  A ground 
sample was loaded in a capillary tube (D: 1 mm) for analysis.  The size and the morphology were 
analyzed with Transmission Electron Microscopy (FEI-Morgani, 80 keV).  All TEM samples 
were prepared by drop-casting 3.5 µL of a sample onto a lacey carbon films/400 mesh copper 
grid and dried under ambient conditions over 24 h.  An Asylum MFP-3D Atomic Force 
Microscope (AFM) was utilized with high resolution probes (Hi’Res-C14/Cr-Au) purchased 
from MikroMasch. Patterned HOPG samples were directly mounted on a metal disc using 
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double-sided scotch tape.   UV-Vis-NIR spectra were acquired using a Lambda 900 
spectrophotometer (PerkinElmer).   
1
H NMR spectra were recorded on a Bruker (400 MHz) and 
were internally referenced to residual protio solvent signals (TMS) at δ 0.00 ppm (1H).  Data 
were reported as chemical shift (δ ppm) and multiplicity (s = singlet, d = doublet, t = triplet, q = 
quartet, qn = quintet, m = multiplet, br = broad), integration, and coupling constant (J) in Hz.  
Mass spectra were acquired on Q-Exactive, Thermo Scientific. 
 
5.6.2 Synthesis 
 
 
 
 
 
 
 
Figure 5.8  Scheme of the synthesis of 2 and Fe-DhaTph-COF. 
 
Synthesis of iron(III)-tetrakis(4-aminophenyl)porphyrin chloride (Fe-TAP-Cl) (Compound 
2). 5,10,15,20-tetrakis(4-aminophenyl)porphyrin (45 mg, 0.067 mmol) was suspended in CHCl3 
(2 mL) and then a FeCl2•4H2O (35 mg, 0.18 mmol) dissolved in 2 mL of N,N-dimethyl 
formamide was added to the porphyrin solution.  The reaction was heated under N2 at 100 °C for 
16 h.  After the reaction solvent mixture was completely dried in vacuo, the crude product loaded 
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on a deactivated Al2O3 column was purified sequentially using 100% acetone and a mixture of 
ethyl acetate : acetonitrile : methanol (3:1:1, v/v/v) gave a dark green powder of Fe-TAP-Cl 
(yield, 64%). HRMS (Multimode-ESI/APCI) calc’d for C44H32N8ClFe [MH]
+=763.17824; found 
763.17590.  FTIR (KBr, ATR) ῡmax, 3426, 3365, 3222, 3028, 2957, 2924, 2854, 1668, 1610, 
1515, 1339, 1290, 1202, 1000, 875, 804 cm
−1
.  UV-Vis (CH3CN) λmax,  244, 315, 419, 576, 623 
nm.    
 Synthesis of 2,3-dihydroxybenzene-1,4-dicarbaldehyde (Compound 1).  1 was 
prepared by the two-step synthesis based on the procedures previously reported.1  To improve 
the purity, the crude product was vigorously stirred in 15% sodium thiosulfate solution with 
addition of dichloromethane for 6 h. The organic layer was dried over Mg2SO4 and filtered, and 
then the solvent was dried in vacuo. Purification through silica gel flash chromatography 
(dichloromethane : methanol : acetic acid = 98:1:1) and further recrystallization from 100% 
hexanes afforded 83% yield as a yellow solid.  mp 100–101 °C. 1H NMR (400 MHz, CDCl3, δ) 
7.28 (s, 2H), 10.03 (s, 2H), 10.91 (s, 2H). 
13
C NMR (125 MHz, CDCl3, δ) 196.3, 150.9, 123.2, 
122.2.  IR (KBr, ATR) 3371, 3128, 3051, 2866, 2769, 1689, 1654, 1562, 721 cm
−1
.  HRMS 
(Multimode-ESI/APCI) calc’d for  C8H6O4 [MH]
+
 = 167.08335; found 167.08245.   
 Synthesis of Fe-DhaTph-COF. The isolated 2 (8 mg, 0.01 mmol) and 2,3-
dihydroxybenzene-1,4-dicarbaldehyde (3.4 mg,  0.02 mmol) were transferred to a glass tube 
(OD: 1 mm, H: 18 cm) dispersed in dimethylacetamide(DMA) (1.5 mL) and 1,2-
dichlorobenzene (0.1 mL).  After the starting compounds were completely dissolved, 6.0 M 
acetic acid (0.2 mL) was added to the reaction mixture and sonicated for 1 min, which 
precipitated out some of the starting compounds.   The reaction tube was degassed by three 
freeze-pump-thaw cycles at 77 K (liquid N2) and brought to room temperature for flame seal.  
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Then the tube was stored in a convection oven at 120 °C for 6 d.  The product was collected after 
two wash cycles using CH2Cl2 (100 mL) and MeOH (100 mL) over a PTFE membrane Millipore 
filter (0.2 μm) and dry over high vacuum for 24 h (yield, 76%). FTIR (KBr, ATR) ῡmax, 3666–
2826, 1646, 1617, 1512, 1414, 1347, 1289, 1184, 1068, 1002, 813, 715, 574. PXRD, 2θ (°) 
found: 3.70, 7.08–7.76 (br), 25.8, 44.64. d spacing (Å) calc’d: 23.9, 12.5–11.4 (br), 3.45, 2.03 
(br, weak).    
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5.6.3 Characterization of Fe-DhaTph-COF  
 
 
 
 
 
 
Figure 5.9  UV-Vis spectra of iron-metallated-porphyrin (Fe-TAP-Cl) and porphyrin monomer (5,10,15,20-
tetrakis(4-aminophenyl)porphyrin) in acetonitrile.  After the iron complexation, the Soret band of the monomer has 
blue-shifted by 8.5 nm and the entire Q-bands in 500–700 nm has significantly changed.    
 
 
 
 
 
 
 
 
 
 
 
Figure 5.10  PXRD spectrum of Fe-DhaTph-COF.  The 2θ (°) values of 3.7 and 7.08–7.76 are almost identical to 
the reported data.
305
  The peak at 2θ =25.8 and 44.6 were not previously observed in DhaTph-COF spectrum. 
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5.6.4 FTIR spectra 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.11  FTIR spectra of (a) Fe-TAP-Cl, (b) DhaTph-COF, (c) Fe-DhaTph-COF: The powder sample was 
collected from the reaction batch where the COF was grown on HOPG. (d) Fe-DhaTph-COF powder: Fe(III) was 
coordinated with DhaTph-COF after polymerization. 
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5.6.5 AFM and TEM micrographs of patterned HOPG after oxidation 
  
 
 
 
 
 
 
 
 
 
 
Figure 5.12  (a)–(d) AFM height images. (e) and (f) TEM images. COF deposition: (a) and (e) Fe-DhaTph-COF 
drop-cast, (b)–(d) Fe-DhaTph-COF grown on HOPG.  Oxidant addition: (d) and (f) H2O2-initiated oxidation (total 
addition: 16 × 20 μL). (a)–(c) & (e) H2O2/NaOCl (4 × 20 μL/4 × 20 μL) at pH 5.0.   
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5.6.6 AFM Height analysis before oxidative patterning 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.13  (a) and (b) Fe-DhaTph-COF grown on HOPG before oxidation. (c) Fe-TAP-Cl drop-cast on HOPG 
before oxidation. 
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5.6.7 AFM Height analysis after oxidative patterning  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.14  AFM height analysis of patterned HOPG. (a) Drop-cast and (b) Direct growth of Fe-DhaTph-COF on 
HOPG. The samples were patterned with (a) 4 × 20 μL/4 × 20 μL and (b) 4 × 20 μL/4 × 20 μL of H2O2/NaOCl.   
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5.6.8 AFM micrographs of remaining Fe-DhaTph-COF deposited on HOPG before and 
after removal of the metallated COF layer  
  
 
 
 
 
 
 
Figure 5.15  After oxidative treatment with H2O2/NaOCl. (a) The remaining metallated COF layer is still intact 
(AFM amplitude image). (b) After removal of the metallated COF with NaOH (5 M) and HCl (7 M) solutions.  
Generally, wash with HCl leaves large aggregates on the surface (AFM height image). 
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